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“I am fond of pigs.  
Dogs look up to us. Cats look down on us. Pigs treat us as equals.” 
 
Winston Churchill 
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PIG PRODUCTION AND ANTIMICROBIAL USAGE 
1. The discovery of antimicrobials  
The first to see bacteria under a microscope was Antoni van Leeuwenhoek in the 1670s, but it took until 
the early 1800s before Christian Gottfried Ehrenberg classified them as bacteria (Citizendium, 2011; Senior, 
2015). Antimicrobials (AMs) were first discovered, by coincidence, by Alexander Fleming in 1928. The term 
antibiotic was first used in 1942 by Selman Waksman as “a chemical substance, produced by micro-
organisms, which has the capacity to inhibit the growth of and even to destroy bacteria and other micro-
organisms” (Waksman, 1947). The first discovered AM, penicillin, was very important in World War II since 
it allowed the treatment of infected war injuries of soldiers who otherwise would not have survived (Quinn, 
2013; Ventola, 2015). AMs became first available in veterinary medicine in the 1940s for the treatment of 
animal diseases, and soon after (1950s) also as growth promotors (Jukes and Williams, 1953; Castanon, 
2007; MicrobeWiki, 2012; Ogle, 2013). Sulphonamide was the first AM available for use in animal 
husbandry, but the in 1943 by Waksman discovered streptomycin was effective against more diseases 
(Waksman, 1947; Michigan State University, 2011). Applying AMs in human medicine led to successful 
treatment of human bacterial streptococcal or staphylococcal infections and reduced morbidity and 
mortality of severe bacterial diseases such as brucellosis and tuberculosis (CDC, 1999; Schlipköter and 
Flahault, 2010). 
Antimicrobial, derived from the Greek words anti (against), mikros (little) and bios (life), has a broader 
definition compared to just the term antibiotic and includes agents (both synthetic or natural), that act 
against bacteria, viruses, fungi and protozoa (Michigan State University, 2011; HMA, 2012). In the scope 
of this dissertation AM will be used to describe agents with an antibacterial range of action. 
2. The origin of pig production and pork consumption 
Our current domestic pig originates from Sus scrofa, the Eurasian wild boar and was described by Carl 
Linnaeus in 1758 as the Sus domesticus (Valerie Porter and Jake Tebbit, 1993; AF news agency, 2015). The 
first evidence of domestication of pigs came from around 9000 years ago in the Near East (Valerie Porter 
and Jake Tebbit, 1993; Giuffra et al., 2000). Already in 3000 before Christ (BC) immigrated pigs were found 
in Sweden and there is evidence that already around 1500 BC in Denmark pigs were living in close 
association with human settlements. In the Roman era husbandry and breeding techniques improved, 
methods of curing ham and bacon were known and sausages were sold for human consumption (Valerie 
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Porter and Jake Tebbit, 1993). In Medieval Europe the pig was an important animal and mainly the poorer 
inhabitants in rural areas consumed pork (Valerie Porter and Jake Tebbit, 1993). In the Middle ages pigs 
were mainly kept in the woodlands and with increasing deforestation keeping pigs became less common 
(AF news agency, 2015). However, by the 18th Century pigs were ideal to be fed the waste products from 
diverse industries. Furthermore, farmers started to create new breeds of pigs in attempts to create the 
ideal pig, which was related to the start of agricultural shows in the 19th Century  (AF news agency, 2015). 
Nowadays the consumption of pork in the world almost equals the consumption of the number one 
consumed animal product, poultry meat (12.6 kilograms/capita/year versus 13.2 kg/capita/year), and in 
the EU pork is even the most consumed meat with 30.9 kilograms/capita/year (OECD, 2015). 
2.1 Current pig production in Europe 
The European Union (EU) is the world’s second biggest producer of pork, after China, with 150 million pigs 
and a yearly production of about 22 million ton carcass weight. For export of pork and pigmeat products 
the EU is the biggest (European Commission, 2015a). Pork production in the EU reached 252.9 million head 
in 2013 (EUROSTAT, 2014). The self-sufficiency is about 111% and 13% of the total production is being 
exported, mainly to East Asia (European Commission, 2015a) and a small percentage is imported from 
third countries (European Commission, 2015b). Seventy-five percent of the total extra-EU export was done 
by Denmark, Germany, Spain and the Netherlands (EUROSTAT, 2014). The main producer countries are 
Germany, Spain and France, who together represent half of the total EU slaughter capacity. Germany had 
28.3 million pigs in 2014, Spain 26.6 million and France 13.9 million (European Commission, 2015a). The 
pig production in Belgium is described in detail below. The EU region with the major production, 
accounting for 30% of EU sows, extends from Germany (Nordrhein-Westfalen) to Belgium (Flemish region) 
(EUROSTAT, 2014). In the projects described in this thesis data on Belgium, France, Germany and Sweden 
will be presented. Sweden had 1.5 million pigs in 2014 (EUROSTAT, 2015b). In all these countries the 
majority of herds (> 90%) have at least 400 fattening pigs (EUROSTAT, 2014). According to Eurostat, larger 
farms (herds with more than 400 sows) produce more technically efficient compared to medium- and 
small-sized farms (EUROSTAT, 2014).  
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2.2 The importance of pig production in Belgium 
Pig production is one of the most important agricultural sectors in Belgium (Instituut voor de Nationale 
Rekeningen, 2015). Belgian farmers housed 6.25 million pigs in 2015 (Statistics Belgium, 2015b). The 
number of herds housing pigs was just over 5000 in 2013 (Statistics Belgium, 2013). The number of places 
for breeding animals was 488 986, the number of finisher places 4 824 415 in 2014 (DGZ, 2014). The 
number of slaughtered pigs in Belgium in 2015 was 11 886 693 (Statistics Belgium, 2015c). Pig production 
in Belgium is mainly located in Flanders (95% of total Belgian pig production (Statistics Belgium, 2013)). 
The human population of Flanders only represents 58% of the total population in Belgium (Statistics 
Belgium, 2015a). The majority of the herds are constituted of sows, piglets and finishers in closed herds or 
are specialized finisher herds, which represent together approximately 75% of the total number of pigs 
(Instituut voor de Nationale Rekeningen, 2015). Export of pork is an important element in the Belgian 
national economy with export of over 70% of the pork produced in 2014 (~ 1.120.000 tonnes produced, ~ 
800.000 tonnes exported). The production value of yearly pig production in Belgium was 1.5 billion euro 
in the period 2006-2013, which is about 20% of the total production value of Belgian agriculture 
(EUROSTAT, 2014; Instituut voor de Nationale Rekeningen, 2015). 
3. Antimicrobial usage in pig production 
3.1 Qualitative antimicrobial usage in Belgium and the European Union 
Pig production is highly efficient and economically driven in the EU. The animals are mostly raised in large 
groups in intensive production systems. As profit margins for pig producers are low, high performance is 
expected and the risks for disease that may decrease performance should be kept to a minimum. This has 
resulted in a high use of veterinary medicinal products.  The pig sector is one of the agricultural sectors 
applying high numbers of AM therapies, resulting in high amounts of AMs consumed (Bos et al., 2013; 
Filippitzi et al., 2014). The main purpose of AM treatment is the reduction of morbidity and mortality and 
to prevent a subsequent loss in production. Routine prophylactic therapies are therapies to prevent 
disease outbreaks before clinical signs of the disease are observable. Metaphylactic therapies are 
administered when small numbers of diseased animals pose a risk to a larger proportion of the herd. Finally, 
curative treatments are used to treat sick animals. These are the three possible reasons for AM treatment 
that are defined in veterinary medicine for the treatment of animals (EPRUMA, 2013). In pig production, 
which is an intensive form of livestock production, often groups of animals are treated, either via (routine) 
prophylactic therapy or metaphylactically. At certain time periods in the life of the pig, depending on the 
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probability of occurrence of disease and the susceptibility of the pig at that stage, preventive AM therapies 
are common. Examples are treatment at the moment of castration of male suckling piglets or AM therapy 
for prevention of diarrhea after weaning (Callens et al., 2012a). In 2006 the use of AM growth promotors 
(AGP, i.e. monensin for cattle, salinomycin sodium for pigs, avilamycin for pigs, chickens and turkeys and 
flavophospholipol in rabbits, chickens, turkey, pigs, calves and cattle) in feed was banned in the EU 
(European commission, 2005). 
In pig production AM products are licensed for administration via feed or water, oral drench, topical use, 
intra-uterine application or intramuscular injection (BCFIvet, 2015; ESVAC, 2015b). Since administration 
via feed or water is the easiest and least labour intensive this is the most frequently used route of 
administration, at least for (routine) prophylactic or metaphylactic treatments (ESVAC, 2015c). Individual 
curative treatments are more often administered via the parenteral route (i.e. mostly intramuscularly) 
(Callens et al., 2012a). 
Currently around 30 different AM classes are licensed. According to Collignon et al. (2009) an AM class 
should be defined as “a group of agents with a similar mechanism of action, regardless of chemical 
structure”. In this dissertation, AMs are classified based on their mechanism of action and their active 
substance (AS). The World Health Organization (WHO) has developed a classification system of AM classes 
according to their relative importance for use in humans. They define “critically important antimicrobials” 
(CIAs), “highly important antimicrobials” and “important antimicrobials” (Collignon et al., 2009; WHO, 
2011b). This classification is based on two criteria: 1) “the AM agent or class is the sole therapy or one of 
few alternatives to treat serious human disease”, 2) “the AM agent or class is used to treat diseases caused 
by organisms that may be transmitted via nonhuman sources or diseases caused by organisms that may 
acquire resistance genes from nonhuman sources” (Collignon et al., 2009). Critically important AM meet 
both criteria for importance. The world Organisation for Animal Health (OIE) developed a comparable 
classification for AM used in veterinary medicine which was recently updated in collaboration with the 
WHO and Food and Agricultural Organization of the United Nations (FAO) (OIE, 2015b). Several veterinary 
AMs licensed for use in pig production fall under the CIAs, but the AM classes that are the most 
controversial are 3rd and 4th generation cephalosporins and (fluoro)quinolones.  
In Belgium total sales of AMs (expressed in mg of active substance) for veterinary purposes in 2013 was 
highest for tetracyclines, penicillins and sulfonamides (ESVAC, 2015c). Callens et al. (2012a) found that in 
2010 at herd level the most frequently used orally applied AM products (expressed as number of treatment 
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days) were colistin (30.7%), amoxicillin (30.0%), trimethoprim-sulfonamide (13.1%), doxycycline (9.9%) 
and tylosin (8.1%), and for injectables tulathromycin (45.0%), long acting ceftiofur (40.1%) and long actin 
amoxicillin (8.4%). 
3.2 Quantitative antimicrobial usage in Belgium and the European Union 
Since 2005 antimicrobial usage (AMU) is being quantified in Europe at country level for all animals by the 
European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project. In the last report, all 
antimicrobial use for animals was included except products specifically licensed for use in companion 
animals (ESVAC, 2015c). This quantification is based on national sales data of AMs. The last report provided 
information on sales of AM in 26 EU countries (ESVAC, 2015c).  
 
Figure 1 Sales of veterinary antimicrobial agents expressed in mg per population correction unit (PCU) for 
26 EU countries for 2010, 2011, 2012 and 2013 based on the data provided by ESVAC (2015d). 
Cyprus was the highest using country in this report. Belgium was ranked as seventh with data of 2013 with 
156.6 mg/PCU, which is slightly lower compared to 2010, 2011 and 2012 (180 mg/PCU, 175 mg/PCU, 161.1 
mg/PCU respectively) (ESVAC, 2015c) (Figure 1). Based on an extrapolation of data from species specific 
studies, Filippitzi et al. (2014) estimated that the pig production accounts for approximately 75% of the 
total AMU usage in white veal calves, pigs and poultry (expressed in mg / kg biomass) and should therefore 
be able to achieve the largest reduction (Filippitzi et al., 2014). 
At a national level, the 2014 BelVet-SAC report with national sales data from both food-producing and 
companion animals showed a slight increase in AMU compared to 2013 (129.4 mg/kg biomass versus 128.0 
mg/kg biomass) (Van Steenwinkel et al., 2011; Dewulf et al., 2012, 2013; Dewulf et al., 2014, 2015). 
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However when using 2011 as a reference a reduction of 11.8% is observed over the period 2011-2014 
(Figure 2). 
 
Figure 2 Sales of veterinary antimicrobial agents expressed in mg per population correction unit (PCU) in 
Belgium over the period 2007 – 2014. Graph adapted from BelVet-SAC (Dewulf et al., 2015). 
These reports do not allow for comparison on actual usage data between and within countries or on 
species and herd level. They also do not allow to identify factors influencing the level of antimicrobial use. 
4. The problem of antimicrobial resistance 
Antimicrobial resistance (AMR) may cause treatment failure, both in humans (Barriere, 2015; Friedman et 
al., 2016) and animals (Bengtsson and Greko, 2014). This treatment failure results in a higher morbidity 
and mortality. The ECDC and EMA (2009) estimated that in the EU each year about 25000 human patients 
die from an infection with multidrug-resistant bacteria. Treatment failure might also lead to other adverse 
outcomes such as economic losses. The healthcare costs related to antimicrobial resistance in humans is 
estimated to be at least € 1.5 billion each year in the EU (ECDC and EMA, 2009). In animal production AMR 
might, besides an increased morbidity and mortality, lead to a reduced productivity and a declined 
economic profitability (Bengtsson and Greko, 2014). Along with treatment failure animal welfare will also 
be impaired (Vaarten, 2012). Eventually these consequences will negatively influence animal food 
production, food security and hence the end consumer. 
AMR can be intrinsic or acquired. Intrinsic or natural resistance is a trait of all bacteria belonging to a 
specific taxon such as a subspecies, species, genus, family or even higher taxonomic rank. It may be due 
to an inherited structural or functional characteristic, such as the absence of the right target points, 
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insufficient penetration or the production of neutralizing enzymes, resulting in the inability of an AM to 
eliminate or attack the bacterium adequately (Boerlin and White, 2013). A good example of intrinsic 
resistance is the resistance of Mycoplasma an Ureaplasma species against penicillins and cephalosporins, 
both targeting the bacterial cell wall synthesis, as these bacteria do not have a cell wall. Acquired 
resistance refers to a situation where the bacterium has acquired a characteristic that makes the AM less 
or no longer effective. One way to acquire this resistance is for bacteria to integrate resistance genes, 
located on chromosomal DNA, into mobile genetic elements such as plasmids or transposons. A stepwise 
mutation of the genes playing a role in the production of products needed for physiological cell 
metabolism is a second way to acquire resistance. Genes are modified in such a way that their spectrum 
of activity will narrow. A third way for bacteria to gain resistance is a (series of) mutation(s) resulting in 
resistance against inhibitory effects of the AM (Schwarz and Chaslus-Dancla, 2001). 
In 1945 Alexander Fleming mentioned, only a couple of years after his discovery of AMs, that there was a 
great public demand for AMs to come, which could lead to possible abuse of AMs (Fleming, 1945; Bartlett 
et al., 2013). The statement that the use or even more the abuse of AMs would lead to AMR was supported 
by findings in the years following the discovery of AMs. Resistance against penicillins was first described 
in 1940 (CDC, 2013) and was often reported in scientific papers from the 1940s and 1950s onwards (Barber, 
1947; Barber and Whitehead, 1949; Chambers, 2001; Spellberg and Gilbert, 2014). In the following years, 
along with the introduction of new AMs, many types of resistance arose (CDC, 2013; Brown and Wright, 
2016). In human medicine cases of multiple resistance become more and more of a threat (Morrill et al., 
2015). In case of infections with multiple resistant bacteria medical doctors sometimes revert to older, and 
due to negative side effects previously considered unfavourable AMs, such as colistin. However, very 
recently also horizontally transmittable resistance against colistin was reported (Liu et al., 2015; Arcilla et 
al., 2016).  
AMR, by means of resistance genes, was found in 30.000 year old permafrost sediments from the Beringian 
region and recently in an 11th century anno domini pre-Columbian Andean mummy preserved in soil in 
Peru (D'Costa et al., 2011; Santiago-Rodriguez et al., 2015). This shows that resistance is a natural process 
in which the bacterium tries to protect itself against AM compounds (Schwarz and Chaslus-Dancla, 2001). 
Contact between AM substances and sensitive microorganisms represented a selective pressure forcing 
these microorganisms to develop mechanisms to escape the inhibitory activities of AM agents (Schwarz 
and Chaslus-Dancla, 2001). By using AMs, the sensitive bacteria are killed or disabled in their growth 
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whereas the resistant bacteria are not affected and can continue to replicate under this selection pressure, 
resulting in larger numbers of resistant bacteria in the environment. In some cases this resistance is very 
persistent, illustrated by the high levels of chloramphenicol resistance, an AM which is already banned 
from usage in food-producing animals in the EU since 1994 (European Commission, 1994; Bischoff et al., 
2005; Chantziaras et al., 2014). The mechanisms behind this persistence are described in detail by Callens 
et al. (2015 submitted). Previously already direct relationships, between the use of specific AM and the 
emergence of resistance against these AM, were described (Huber, 1970; Aarestrup et al., 2000; Mateus 
et al., 2011; Persoons et al., 2011; Liebana et al., 2013). Recently more general direct correlations between 
AMU and AMR were shown with scientific proof both in human and veterinary medicine (Verraes et al., 
2013; Bosman et al., 2014; Callens et al., 2014; Chantziaras et al., 2014; ECDC/EFSA/EMA, 2015; Joseph et 
al., 2015). The amount of AMs used, the dose and duration of treatment, choice of AM agent or the 
administration route may all play a role in the selection and spread of AMR (Dewulf et al., 2007a; Devreese 
et al., 2014; Callens, 2015). Some studies describe that a reduction in the prevalence of resistance is 
possible when the selection pressure of AMU was significantly reduced (Andersson, 2006; Figueiredo et 
al., 2014; Dorado-García et al., 2015; Sarma et al., 2015). The recent Dutch observation where a 
remarkable decline in the resistance levels was found the year after a strong reduction in antimicrobial 
usage was experienced (Speksnijder et al., 2015c; Van Geijlswijk et al., 2015) further provides evidence 
that this reversion of resistance is possible when reducing AMU.  
Factors determining the emergence, selection, spread, persistence and reversion of resistance are 
described in detail in Callens et al. (2015 submitted).   
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CHECK: QUANTIFYING ANTIMICROBIAL USAGE 
Only on the basis of an adequate quantification of AMU, benchmarking is possible and conclusions can be 
drawn. Denmark, Norway and Sweden started with the collection of national AM sales data from 1996, 
1999 and 2000 respectively (DANMAP, 2015; NORM-VET, 2015; Swedres-Svarm, 2015), followed by the 
Netherlands in 2002 (MARAN, 2015). These reports use the national sales data of AMs in kg or tons of 
active substance and relate these to the biomass of the animal population in the country (DANMAP, 2015; 
MARAN, 2015; NORM-VET, 2015; Swedres-Svarm, 2015). In Belgium, the BelVet-SAC reports these 
estimations since 2007 (BelVet-SAC, 2015) and in a same matter ESVAC reports estimations and evolutions 
of AMU over EU countries (ESVAC, 2015a). These estimations however relate to all animals and 
reallocation to specific species is not possible since the majority of veterinary AM products are licensed 
for several species. Another limitation of this quantification method is the fact that the potency of a AM 
product is not taken into account (Jensen et al., 2004). Therefore there is a need for species specific data 
(ESVAC et al., 2013). In general, the more recently marketed active substances or updated formulations 
(e.g. 3rd and 4th generation cephalosporins) have a lower molecular weight compared to older active 
substances (e.g. tetracyclines). To account for these limitations several AMU quantification systems 
developed have been as recently reviewed by Collineau et al. (2016, submitted) (Figure 3). The most 
detailed quantification system is the expression of the number of daily dosages per product and per age 
category. This quantification system allows for comparison of AMU between and within countries, species, 
herds and prescribers. The formula used to express this quantification method and its peculiarities is 
described below. 
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Number of 
packages or 
items 
Weight of active 
substance (Kg) 
Number of 
individuals 
receiving a full 
treatment course 
Number of live 
kilogram-days 
treated 
Live weight 
receiving a full 
treatment 
course (Kg) 
Number of 
individuals at 
risk of being 
treated 
Biomass at risk 
of being treated 
(Kg) 
x volume (L or Kg) x 
dose (mg/L or mg/Kg) 
/ daily dose 
(mg/Kg/day) 
Number of  
individual-days 
treated 
/weight at 
treatment (Kg) 
/ treatment 
length (days) 
/ treatment 
length (days) 
 PID, PIID, PCD (Coenen et al., 
2014) 
 Items/1000/day (Scottish 
Antimicrobial  Prescribing  Group, 
2014) 
• TID, TIID, TCD (Coenen et al., 
2014) 
• DCDvet/1000 animals/year 
(European Medicines Agency, 2013) 
Amount of active 
substance /PCU 
(European 
Medicines Agency, 
2014) 
• DDD/1000 inhabitants/year (World 
Health Organization, 2015a) 
• DDD/FCE (Curtis et al., 2004) 
• DDDvet/1000 animals/year 
(European Medicines Agency, 2013) 
• nDDay (NETHMAP and MARAN, 
2013) 
Number of 
individuals daily 
treated 
• DID, DIID, DCD (Coenen et al., 2014) 
• DDD/100 bed-day (World Health 
Organization, 2015a) 
• DDD/100 admitted patients (DANMAP,  
2013) 
• TIDDDvet, TIUDDvet (Timmerman et al, 
2006) 
• DAPD (DANMAP, 2013) 
Amount of active substance/1000 
animals/year (European 
Medicines Agency, 2013) 
ALEA (Anses, 
2014) 
/ period at risk of 
being treated (days) 
Number of 
packages or 
items daily used 
/ period at risk of 
being treated (days) 
Treatment 
costs 
Treatment 
cost/Kg carcass 
(Corrégé et al., 
2014) 
x unit 
price 
Figure 3 Technical units of measurement indirectly accessed from number of packages or items and corresponding indicators of antimicrobial usage in humans and 
animals. The white boxes describe the technical units of measurement of antimicrobial usage with the solid arrows presenting the calculation steps between them. 
The grey boxes describe the unit of measurement of the population at risk of being treated. Dash arrows represent the normalization of the technical unit of 
measurement by the population at risk of being treated that leads to the different indicators of antimicrobial usage (in bold). For explanations of the abbreviations, 
see below in Table 1. Source: Collineau et al. (2016, submitted). 
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In words [Technical unit of measurement] / [Population at risk of being treated] 
Period at risk of being 
treated 
Reference* 
Treatment cost/kg carcass 
Antimicrobial treatment cost per 
kilogram of pig carcass produced 
[Total antimicrobial expenditures] / [Annual weight of carcass produced] 
1 year  
(from January to December) 
Corrégé et al., 2014  
PID 
Number of packages per 1000 
inhabitants per day 
[Number of packages daily reimbursed] / [Number of inhabitants] x 1000 1 year (from July to June) Coenen et al., 2014  
PIID 
Number of packages per 1000 
insured individuals per day 
[Number of packages daily  reimbursed ] / [Number of insured individuals] x 1000 1 year (from July to June) Coenen et al., 2014 
PCD 
Number of packages per 1000 
physician contacts per day 
[Number of packages daily  reimbursed ] / [Number of physician contacts] x 1000 1 year (from July to June) Coenen et al., 2014 
Items/1000/day  
Number of items per 1000 population 
per day 
[Number of items prescribed] / [Number of inhabitants] x 1000 2 year-period 
Scottish Antimicrobial  
Prescribing  Group, 2014 
Amount of active 
substance/PCU 
Amount of active substance per 
Population Correction Unit 
[Total amount of active substance sold] / [Number of live and slaughtered animals 
x Standard weight at treatment] 
1 year  
(from January to December) 
European Medicines 
Agency, 2014 
Amount of active 
substance/1000 
animals/year 
Amount of active substance per 
1000 animals and per year 
[Total amount of active substance sold] / [ Number of animals produced or as 
livestock] x 1000 
1 year  
(from January to December) 
European Medicines 
Agency, 2013 
ALEA (Animal Level of 
Exposure to Antimicrobials) 
Percentage of the animal biomass 
exposed to antimicrobials 
[Total amount of active substance sold / (DDDvet x treatment length)] / [Number of 
live and slaughtered animals x Standard weight of adults and slaughtered animals] 
1 year  
(from January to December) 
Anses, 2014 
DDD/1000 inhabitants/year 
Number of DDD per 1000 inhabitants 
and per year 
[Total amount of active substance sold / DDD] / [Number of inhabitants] x 1000 
1 year  
(from January to December) 
World Health 
Organization, 2015a 
DDD/FCE 
Number of DDD per Finished 
Consultant Episode 
[Total amount of active substance sold / DDD] / [Number of finished consultant 
episodes]  
1 year  
(from January to December) 
Curtis et al., 2004  
DDDvet/1000 animals/year 
Number of DDDvet per 1000 animals 
and per year 
[Total amount of active substance sold / DDDvet] / [Number of  animals produced 
or as livestock x Standard weight at treatment] x 1000 
1 year  
from January to December) 
European Medicines 
Agency, 2013 
nDDay 
Number of DDDvet per animal and 
per year 
[Total amount of active substance sold / DDDvet] / [Number of live and slaughtered 
animals x Standard weight at treatment] 
1 year  
(from January to December) 
NETHMAP and MARAN, 
2013 
TID 
Number of treatments per 1000 
inhabitants per day 
[Number of treatments daily prescribed] / [Number of inhabitants] x 1000 1 year (from July to June) Coenen et al., 2014 
TIID 
Number of treatments per 1000 
insured individuals per day 
[Number of  treatments  daily  prescribed ] / [Number of insured individuals] x 1000 1 year (from July to June) Coenen et al., 2014 
TCD 
Number of treatments per 1000 
physician contacts per day 
[Number of  treatments  daily  prescribed] / [Number of physician contacts] x 1000 1 year (from July to June) Coenen et al., 2014 
Table 1 Indicators of human and animal antimicrobial usage calculated from sales, deliveries and reimbursement data. Source: Collineau et al. (2016, submitted).  
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DCDvet/1000 animals/year 
Number of DCDvet per 1000 animals 
and per year 
[Total amount of active substance sold / (DDDvet x Treatment length)] / [Number 
of  animals produced or as livestock x Standard weight at treatment] x 1000 
1 year  
(from January to December) 
European Medicines 
Agency, 2013 
DID 
Number of DDD per 1000 inhabitants 
per day 
[Number of DDD per day] / [Number of inhabitants] x 1000 1 year (from July to June) Coenen et al., 2014 
DIID 
Number of DDD per 1000 insured 
individuals per day 
[Number of  DDD per day ] / [Number of insured individuals] x 1000 1 year (from July to June) Coenen et al., 2014 
DCD 
Number of DDD per 1000 physician 
contacts per day 
[Number of  DDD per day] / [Number of physician contacts] x 1000 1 year (from July to June) Coenen et al., 2014 
DDD/100 bed-day Number of DDD per 100 bed days 
[Total amount of active substance sold / (DDD x 365 days)] / [Number of occupied 
beds] x 100 
1 year  
(from January to December) 
World Health 
Organization, 2015a 
DDD/100 admitted patients 
Number of DDD per 100 admitted 
patients 
[Total amount of active substance sold / (DDD x 365 days)] / [Number of admitted 
patients] x 100 
1 year  
(from January to December) 
World Health 
Organization, 2015a 
TIDDDvet, TIUDDvet (Treatment 
incidence) 
Number of animals per 1000 
receiving a DDDvet or a UDDvet. 
Also expressed as the percentage of 
animal life expectancy treated with 1 
DDDvet or UDDvet 
[Total amount of active substance sold / (DDDvet or UDDvet x  Standard weight x 
production length)] / [Number of animals at risk of being treated] x 1000 
1 production period (for 
growing animals)  
Timmerman et al., 2006  
  
DAPD 
Proportion (in thousands) of animals 
treated daily with a DDDvet 
[Total amount of active substance sold / (DDDvet x 365 days)] / [Estimated average 
biomass of the population on any given day] x 1000 
1 year  
(from January to December) 
DANMAP, 2013 
Indicators are presented here in the same order than in the Figure 3, reading from top to bottom and in case of similar technical units, from left to right.  
* References accompanying the displayed indicators only provide illustrations of possible applications of the indicators and are not intended to be exhaustive. 
 
Anses, French Agency for Food, Environmental and Occupational Health and Safety, 2014: Sales survey of veterinary medicinal products containing antimicrobials in France in 2013. Available at: 
https://www.anses.fr/en/system/files/ANMV-Ra-Antibiotiques2013EN.pdf (accessed on 12 November 2015). 
Coenen, S., B. Gielen, A. Blommaert, P. Beutels, N. Hens, H. Goossens, 2014: Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of 
different measures. J. Antimicrob. Chemother. 69, 529–534.  
Corrégé I., B. Badouard, A. Hémonic, 2014: Medication costs in French pig farms: evolution and herd typology. In: Abstracts of the Forty-sixth Journées de la Recherche Porcine, Paris, France, 2014. Abstract p. 147-52. Ed. IFIP, 
INRA, France. 
Curtis, C., J. Marriott, C. Langley, 2004: Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. J. Antimicrob. Chemother. 54, 529–533. 
DANMAP, 2013: The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in 
Denmark. Available at: http://www.danmap.org/~/media/Projekt%20sites/Danmap/DANMAP%20reports/DANMAP%202013/DANMAP%202013.ashx (accessed on 6 October 2015). 
European Medicines Agency, 2014: Sales of veterinary antimicrobial agents in 26 EU/EEA countries in 2012: Fourth ESVAC report. Available at: 
http://www.ema.europa.eu/docs/en_GB/document_library/Report/2014/10/WC500175671.pdf (accessed on 12 November 2015). 
European Medicines Agency, 2013: Revised ESVAC reflection paper on collecting data on consumption of antimicrobial agents per animal species, on technical units of measurement and indicators for reporting consumption of 
antimicrobial agents in animals. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/12/WC500136456.pdf (accessed on 12 November 2015). 
NETHMAP and MARAN, 2013: Consumption of antimicrobial agents and  antimicrobial resistance  among medically important bacteria  in the Netherlands. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals 
in the Netherlands in 2012. Available at: https://www.wageningenur.nl/upload_mm/7/8/9/52388c6c-858c-483c-b57d-227029fe778a_005738_Nethmap_2013%20def_web.pdf (accessed on 12 November 2015).  
Scottish Antimicrobial  Prescribing  Group, 2014: Primary Care Prescribing  Indicators. Annual Report 2013-14.  
Timmerman, T., J. Dewulf, B. Catry, B. Feyen, G. Opsomer, A. de Kruif, D. Maes, 2006: Quantification and evaluation of antimicrobial drug use in group treatments for fattening pigs in Belgium. Prev. Vet. Med. 74, 251–263. 
World Health Organization, 2015a: Guidelines for ATC classification and DDD assignment. Available at: http://www.whocc.no/filearchive/publications/2015_guidelines.pdf (accessed on 12 November 2015). 
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1. The antimicrobial usage formula 
When detailed information at herd or country level is available on the total amount of AMs purchased or 
administered, as well as information on the period the animals are at risk of receiving a treatment with 
AMs and the numbers of animals treated and their respective weights, we can calculate a treatment 
incidence (TI). This TI provides a standardized technical unit of measurement that quantifies how many 
animals out of a theoretical group of 1000 animals receive daily an AM treatment. Or, if one animal would 
live for a theoretical period of 1000 days, how many of these days it would have been treated with an AM. 
Divided by 10 this gives the percentage of the lifespan an average animal on a specific herd was treated 
with a daily dose of AMs. 
The TI formula is as follows: 
TI =
Total amount of active substance (mg)
DDDA1 (
mg
kg ) ∗ number of days at risk ∗ kg animal at risk
∗ 1000 pigs at risk 
The TI for AMU quantification in veterinary medicine was first described by Timmerman et al. (2006) and 
later used in several other publications (Callens et al., 2012a; Laanen et al., 2013; Sjölund et al., 2015; 
Sjölund et al., 2016, submitted). At Ghent University, an online calculation tool was developed that 
calculates the TI based on herd specific details on purchase and administration of AMs (Ghent University, 
2010b). The principle of the formula is based on the methodology used in human medicine where they 
report defined daily doses (DDD) per 1000 inhabitants per day or DDDs per 100 bed days (WHO, 2011a). 
The numerator represents the total amount of AMs administered in milligrams (mg) of active substance 
(AS) applied during a certain period for a certain group of animals (defined in the denominator). The 
amount of products administered may come from purchase documentation (e.g. veterinarians’ or feed 
mills’ invoices), administration log books or personal communication from the herd veterinarian or farmer. 
Often the provided information represents the amount of AM product purchased/administered. In order 
to get to the amount of AS, a recalculation is needed based upon the multiplication of the amount of 
product with the amount of AS per unit of product. Information on the amount of AS in a certain AM 
product can be found in the summary of product characteristics (SPC) information, in Belgium available 
via the Belgian Center for Farmacotherapeutical Information (BCFI) (BCFIvet, 2015). Conversion factors 
                                                          
1 DDDA = Defined Daily Dose Animal 
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(into mg) for products where the AS is provided in international units (IU) can be found in table 4 of the 
most recent report of ESVAC (2015d).  
The denominator consists of three parts; the number of animals at risk of being treated with an AM times 
their weight at treatment, the period at risk and a technical unit of measurement to compare different AM 
classes or products in potency and licensed dosage prescription. The latter will be described in detail in 
the next paragraph. The number of animals at risk of being treated refers to the total number of animals 
in a herd, age category, compartment, group, etc. on a yearly, monthly, etc. period multiplied by a specific 
weight which reflects an assumed standard weight at treatment. The reporting period can be freely chosen, 
but should be reflected in a similar manner in all parameters of the formula, i.e. when the AMU is 
quantified over one compartment housing 1000 animals for 130 days, the number of animals at risk is 
1000 and the period at risk is 130 days. As standard weight, it is suggested to use the by ESVAC proposed 
weights mentioned in table 4 of the revised ESVAC reflection paper (ESVAC et al., 2013), which are for pigs; 
suckling piglets = 4 kg, weaned piglets = 12 kg, sows/boars = 220 kg, finishers = 50 kg. As period at risk, 
often the duration of a production round is taken for the animal categories that are being slaughtered. For 
pigs we can chose to take the period from birth till slaughter, which is often around 200 days. Or, we take 
the duration of a specific age category; for suckling piglets this is the period between birth and the day of 
weaning (varying between 21 and 28 days), for weaners this is the period between weaning and their 
transfer to the finisher stable (varying between 42 and 49 days), resulting in a total piglet period of ~ 70 
days, for finishers this is the period from the start of the finisher period until slaughter (generally around 
130 days). For the breeding animals (sows, boars and gilts), it is recommended to take one year as 
reference duration. The combination of number of animals present times the weight at treatment times 
the period at risk of being treated provides the number of kg animal at risk of being treated during the 
selected time period. Currently several quantification methods are being used (Table 1). These differ in 
many different aspects which jeopardizes comparability of the data. Therefore there is a need for 
standardisation in the used quantification methodology as well as used technical units (e.g. DDDA, weight 
at treatment, …). 
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2. The Defined Daily Dose Animal 
The third parameter in the TI formula is the DDDA, or the Defined Daily Dose Animal. ESVAC defines the 
DDDA as “the assumed average dose for a specific product per kg animal per species per day” (ESVAC, 
2015b). These DDDAs are assigned per AS class, administration route and species, as averages over the 
input at national level from the EU countries obtained from the SPCs (ESVAC, 2015b). The lack of a 
standardized DDDA list or a methodology to develop such a list in veterinary medicine is hampering the 
comparability of the data. In the end ESVAC strives to establish a general list of DDDAs useful in the whole 
EU based on the arithmetic mean of all veterinary medicinal products per species, substance and 
administration route (ESVAC, 2015b). A specific long-acting factor (LA-factor), for products which should 
only be administered once but have a duration of activity lasting for over one day, should be established 
in a similar way as the DDDA. This LA-factor is of importance for taking into account the duration of activity 
of these kind of products. 
Other available technical units of AMU measurement are the Defined Course Dose Animal (DCDA), 
Prescribed Daily Dose Animal (PDDA) and the Used Daily Dose Animal (UDDA). The DCDA could, similar to 
the DDDA, be used in the TI formula in order to determine the incidence of complete courses of an AM 
treatment. When using the PDDA the amount of AM use is calculated based upon the prescription of the 
veterinarian. The UDDA can be used when very detailed information at herd level is available providing 
information on the exact amount of treatment dose and the exact weight of the animals at the moment 
of treatment. 
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IMPROVE: HERD MANAGEMENT & BIOSECURITY 
Herd management or “good farming practice” in pig production could be defined as “all measures that 
address animal health and welfare, environmental, economic and social sustainability for on-farm 
processes and result in healthy animals and safe and quality pork products” (adapted from FAO (2003)). 
Many alternatives to AMU which can be categorized under herd management have been described and 
suggested. They may relate to feed additives such as AM peptides, pre- and probiotics, phytotherapeutics 
and immunity stimulants (Jacela et al., 2010; Seal et al., 2013; Cheng et al., 2014; Ducatelle et al., 2015). 
Vaccines are meant to increase the immunological status of an animal against one or more specific 
pathogens, resulting in a reduced risk for (secondary) infection and overall improved health (CDC, 2012, 
2014; Hajj Hussein et al., 2015). The (proper) use of vaccines might therefore be indicated as an alternative 
to AM as well (Bak, 2011; Coube et al., 2012; Del Pozo Sacristán et al., 2014). Another promising alternative 
to AMU is an optimized biosecurity level (Laanen et al., 2013; RUMA, 2013; Stärk, 2013). Biosecurity could 
be identified as an elementary component of herd management and the basis of any infectious disease 
control program which should result in improved animal health and a reduced need for AM treatments.  
1. What is biosecurity 
Biosecurity on pig farms strives for the minimized risk of introduction and spread of infectious agents and 
to ultimately keep pigs healthy without the need to apply AM products or veterinary medicinal products 
in general. In veterinary medicine biosecurity is the term used to describe measures in the prevention of 
pathogens entering a farm (external biosecurity) or the spreading of pathogens within the farm (internal 
biosecurity) (Amass and Clark, 1999; Vangroenweghe et al., 2009). Neumann (2012) describes 
transmission of disease, based on the definition of Zimmerman J. (2003), as follows: “Transmission 
requires that a pathogen successfully exits an infected host, escapes potential threats to its existence in 
the environments, breaches the innate defence systems of a new and susceptible host, and then reaches 
an anatomical site suitable for further replication or perpetuation in that host”. Improvement in the level 
of biosecurity is considered to result in a limited introduction and spread of disease, resulting in reduced 
morbidity and mortality rates, making biosecurity a tool in eradication programs as well as the daily herd 
health management (Maes et al., 2008; Lambert et al., 2012a; Zhang et al., 2013; Gillespie et al., 2015). 
Many studies throughout Europe have indicated that there is room for improvement in the biosecurity 
level in pig production (Laanen et al., 2013). Obviously, biosecurity is also promoted in other animal 
production sectors such as ruminants (Sahlström et al., 2014; Sarrazin et al., 2014; Pritchard et al., 2015), 
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horses (Nixon, 2015), goats (Bond et al., 2015), sheep (Sahlström et al., 2014; Schimmer et al., 2014) and 
poultry (Gelaude et al., 2014; Meunier et al., 2015). Previous studies showed that improved biosecurity 
may enhance production results such as reproduction, growth and feed conversion (Laanen et al., 2013) 
as well reducing the risk of transmission of zoonotic pathogens (Fraser et al., 2010; Pletinckx et al., 2013; 
Ikwap et al., 2014; Schimmer et al., 2014).  
The basic principles of all biosecurity measures are: 
- the separation of infected and diseased animals through the prevention of direct and indirect 
contact between these groups of animals, 
- the reduction of the general infection pressure through breaking the infection cycle and reducing 
the burden on the immune system. 
In 2005, Amass (2005) prepared a table with routes of indirect transmission of important porcine 
pathogens/diseases. Amass furthermore mentions that direct contact between animals through ex- and 
secretions is for the majority of the diseases the most effective way of transmission (Amass, 2005).  This 
direct contact between animals of a same age category or group is called horizontal transmission. Vertical 
transmission, from the sow to her piglets (via the placenta or contaminated colostrum/milk), is also 
considered a direct route of transmission (Olsen et al., 2012; Register et al., 2012; Segalés et al., 2012; 
Zimmerman et al., 2012). In this dissertation, the table of Amass is updated with insights from scientific 
literature published in the period between 2005 and January 2016 (Table 2). The transmission routes of 
the pathogens/diseases that were listed by Amass (2005) were supplemented with pathogens/diseases 
that are currently present and of relevance in Belgium. The list is not meant to be exhaustive in possible 
pathogens/diseases, nor in the references that listed possible routes of transmission. The routes of indirect 
contact included in this table are similar to the original table of Amass and included transmission via; 
people, air, material, manure, feral and pet animals, birds, insects or rodents, aerosol, animal feed and 
water. Additionally transmission via direct contact is included in the table.  
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Table 2 Direct and indirect transmission routes of swine pathogens/diseases (adapted from Amass (2005)). Erysipelothrix rhusiopathiae, Haemophilus parasuis, 
Lawsonia intracellularis, Porcine circovirus and Porcine epidemic diarrhea were added as pathogens since they are relevant in Belgian pig production. The 
indirect transmission routes listed via feed are often only related to swill feeding. “X” represents possible (indirect) transmission routes described by Amass. 
“O” describes new possible transmission (direct and indirect) routes based on studies published between 2005 and January 2016. 
Disease/pathogen  Direct contact  Indirect contact 
Indirect contact     People  Semen  Manure  Domestic/feral 
animals  
Rodents  Insects  Aerosol  Animal 
feed  
Water  Fomites  
Actinobacillus pleuropneumoniae  O1, 2, 3, 4        O2, 5, 6      X    O2, 7, 8  O7  
Bordetella bronchiseptica  O9, 10        X  X  O10  X    X  O10  
Brachyspira hyodysenteriae  O11, 12, 13  O12    X  X  X  O13    O12  X  O12  
Brucella suis  O14, 15  X  X  O15  X    O15  O15  O15      
Classical swine fever virus  O16, 17, 18  O17, 19  X  X  X    X  X  O17    X  
Clostridium perfringens  O20, 21      O20, 21      O20  X    X  O20  
Erysipelothrix rhusiopathiae†  O22      O22  O6, 22, 23  O22      O22  O22, 24  O22  
Escherichia coli  O25, 26, 27  X    X  O27, 28  X  X  X  O27  X  X  
Foot-and-mouth disease virus  O13, 29, 30, 31  X  X  X  O32, 33      X  O34, 35  O36  X  
Haemophilus parasuis† O4, 37, 38        O37              
Lawsonia intracellularis†  O39      O39  O5, 28  O28, 39, 40  O39        O39  
Leptospires  O41  X  O42, 43    X  X        X    
Mycoplasma hyopneumoniae  O3, 4, 44, 45  O46      O4, 5, 6, 28      X    X  X  
Pasteurella multocida  O4, 13, 47 O13    X  O13, 47      X    X  O13, 47  
Porcine circovirus type 2†  O3, 4, 48   O42, 43, 48, 49  O50  O5, 23, 48, 51  O52, 53  O54    O55      
Porcine Epidemic diarrhea virus † O56 O57    O57  O57      O58  O57, 59    O56, 57  
Porcine parvovirus  O60, 61    X  X  O61, 62  O61        O61  X  
Porcine Reproductive and 
Respiratory Syndrome virus 
O3, 4, 63, 64 X  X  X  O4, 5, 23, 51, 63  O6, 63  X  X  O65  X  X  
Pseudorabies virus  O66   X  X  X  X  X  X    O66  X  
Salmonella spp.  O67, 68  X    X  X  X  X  X  X  X  X  
Streptococcus suis  O4, 69 X    X  X    X  X    X  X  
Swine influenza virus  O3, 4, 70  X    X  X      X        
Swine vesicular disease virus  O71  X  X  O71  O71      X  O71    X  
Transmissible gastroenteritis virus  O56  X    X  X    X        X  
                                                          
† Added to the original list of Amass, S.F., 2005. Biosecurity: Stopping the bugs from getting in. The Pig Journal 55, 104-114.  
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The importance of indirect disease transmission is strongly influenced by the survival of the pathogen in 
the environment. The results of breaking the infectious cycle or at least slowing down the process of 
transmission might benefit from optimized biosecurity levels. Ribbens et al. (2009) studied the type and 
frequency of contacts between Belgian pig herds. It was demonstrated that a high pig density with multiple 
contact structures in Belgium, making these frequent contacts between herds an important risk factor for 
spread of disease. Especially in high density regions, such as Belgium, a sufficient level of biosecurity is 
therefore very important. Knowledge on the average biosecurity level in Belgian pig herds and the 
comparison with other countries is lacking. This information would be very informative to be able to 
evaluate the current Belgian situation and determine the room for improvement. 
The design of biosecurity measures is always based on the possibility of preventing these direct and 
indirect transmission routes. Consequent and adequate performance of the necessary biosecurity 
measures is of utmost importance for biosecurity to have its maximum impact. The main factors of 
external and internal biosecurity are discussed below. 
External biosecurity 
Purchasing policy 
Via direct contact between infected and susceptible animals, transmission of pathogens occurs very 
effectively. Tobias et al. (2014) described a ten times higher transmission rate of Actinobacillus 
pleuropneumoniae for direct contact between pigs compared to indirect transmission. Similar findings 
were obtained for porcine circovirus (Andraud et al., 2008), foot-and-mouth disease (Eblé et al., 2006), 
Streptococcus suis (Dekker et al., 2013), classical swine fever (Klinkenberg et al., 2002) and Mycoplasma 
hyopneumoniae (Morris et al., 1995). Oral contact with other se- or excretions (e.g. milk, urine) might also 
lead to transmission. Physical contact between animals can also transmit pathogens from one animal to 
the other via e.g. the skin (Neumann, 2012). Introduction of disease via infected semen, which is 
considered to fall under indirect contact according to Amass (2005), is well known for Porcine 
Reproductive and Respiratory Syndrome virus (PRRSv) (Zimmerman et al., 2012; Maes et al., 2016), but 
can also occur for other pathogens (Table 2). Thus, introduction of non-proprietary animals or genetic 
material might lead to introduction of animals or materials that are carrier of pathogens against which no 
herd immunity exist and therefore risks the possible onset of disease.  
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Restriction of contact with live animals from other herds limits the risk of introduction of infections. When 
it is nonetheless necessary to purchase animals (e.g. to introduce new genetic material), one should try to 
limit the number of origin farms to a minimum to limit the diversity of the pool of pathogens that could 
possibly be introduced. Moreover, if new animals are introduced in a herd, adequate quarantine measures 
should be taken as described by Vangroenweghe et al. (2009). 
Removing animals, manure and carcasses 
Se- and excreta, in which pathogens often survive, are excreted by diseased animals and may even 
originate from cadavers of dead animals and are posing a risk for direct transmission to susceptible animals. 
Also indirect transmission of pathogens from cadavers may occur via fomites, the rendering truck, people 
and their material, rodents, domestic animals etcetera. The risk of transmission via infectious cadavers is 
well known for foot-and-mouth disease, hence the burning of cadavers during the outbreaks in 2001 (de 
Klerk, 2002; Scudamore et al., 2002; De Vos et al., 2010; Hayama et al., 2015). However, not only foot-and-
mouth disease, but all pathogens that are capable of surviving in normal environmental conditions can 
easily be spread by cadavers. A timely, consequent and careful removal of dead animals is therefore 
recommended (Figure 4).  
 
Figure 4 Example of a desired situation for the pick-up of cadavers by the rendering company.  
Source: Merel Postma, RED AB project. 
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Table 2 shows that for the majority of the listed pathogens/diseases, faeces can play an important role in 
the transmission of pathogens and often pathogens are able to survive for long periods in manure, such 
as for example the classical swine fever virus (Kirkland et al., 2012), swine vesicular disease virus 
(Alexandersen et al., 2012), Streptococcus suis (Gottschalk, 2012) and Escherichia coli (Fairbrother and 
Gyles, 2012). Also the use of contaminated manure pipes, used for manure transport, is considered to be 
a risk for introduction of pathogens such as Brachyspira spp. (Hampson, 2012; Holinger et al., 2015) or 
Salmonella spp. (Gray and Fedorka-Cray, 2001; Carlson et al., 2012). Transport of sows to the 
slaughterhouse generates a high risk of introduction of disease since often the truck picking up the sows 
already contains animals from other herds. 
Supply of feed, water and equipment 
The feed delivery truck enters multiple premises a day often without being cleaned and disinfected in-
between. Transmission of pathogens by material or vehicles related to feed has been described (Bottoms 
et al., 2015). One explanation for the transmission of disease in the recent outbreak of porcine epidemic 
diarrhea virus (PEDv) in the USA and Canada was the use of contaminated bulk feed containers (Scott et 
al., 2016).  
Feed itself should normally not pose a risk of disease introduction since it is generally produced under 
strict hygienic procedures, although introduction of Salmonella spp. via feed has been described in the 
past (Österberg et al., 2006). However, when swill feeding is used, this may cause substantial risks (table 
1) as demonstrated in several classical swine fever outbreaks in the past. This has been the reason for 
banning swill feeding in the EU (European Commission, 2001). Currently there is an renewed interest in 
the use of swill feeding as part of “circular economy“ concept where left over of one process serves as the 
basis for another process. In this tendency it will be of crucial importance to correctly manage the risks of 
disease transmission (e.g. through decontamination or heating processes).  
Water might also play a role in transmission of disease since many pathogens can survive in water. Bender 
et al. (2010) found Erysipelothrix rhusiopathiae in the central water lines of several herds. Exposure to the 
erysipelas bacterium, in sufficient doses, via the oral route will most likely result in disease within 24 hours 
in the absence of an effective immune response according to Opriessnig and Wood (2012). Evidence is 
available for the presence and possible multiplication of bacteria, especially coliforms, in (biofilms in 
(Figure 5)) water pipes (Szabo and Minamyer, 2014), but also for Actinobacillus pleuropneumoniae this 
was recently described (Loera-Muro et al., 2013). 
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Figure 5 Cross section of a water pipe from a pig farm. The inside of the pipe is heavily silted and might 
serve as an ideal environment for pathogens to grow. Another problem might be that the flow at the 
nipples in the pens is too low because of the reduced diameter. Photo property of: Prof. Jeroen Dewulf. 
 
Access check 
The farmer, employees or herd visitors can function as mechanical vectors by spreading disease via e.g. 
their footwear or clothes, but also via their hands. The veterinarians should not be forgotten in this light 
as a visitor of the herd (Alarcon et al., 2011). Ribbens et al. (2007) showed that contaminated boots, gloves 
and coveralls may be involved in the transmission of classical swine fever virus. A reduction in the number 
of Streptococcus suis bacteria was obtained by thoroughly washing hands and donning clean outerwear, 
while showering was able to prevent transmission of Streptococcus suis from a person to the pigs (Amass 
et al., 2003). Nathues et al. (2012) reported that farmers could be a risk factor for transmission and spread 
of Mycoplasma hyopneumoniae since they can carry the pathogen in their nasal cavity. Carriage and 
transmission via (nasal) mucosa could not easily be prevented, but by taking hygienic measures and 
wearing herd and preferably also age specific clothing and footwear introduction and spread via people 
can be reduced. Showering could further reduce the risk of transmission of disease, but should only be 
performed after all other biosecurity measure are attended to. Biological transmission of zoonotic 
pathogens, such as Salmonella spp. or influenza viruses, should be considered another important route of 
transmission from humans to pigs and vice versa (Amass, 2005). 
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Vermin and bird control 
Rodents are well known as spreaders of disease (Table 2) and pig herds are almost always harbouring 
rodents to some extent (Figure 6).  
 
Figure 6 Rats can transmit pathogens from outside to the animals or within the herd from one age category 
to another. They furthermore cause damage to e.g. insulation in the stables. They have a short 
reproduction cycle with around 8 litters with 10 newborns / year. Source: Merel Postma, RED AB project. 
Pearson et al. (2016) demonstrated that rats presented the highest probability of exposure of pathogens 
to domestic pigs. The most likely pathogens to be transmitted were Lawsonia intracellularis, Brachyspira 
hyodysenteriae and Salmonella spp. Furthermore they found that birds resembled a median probability of 
exposure of pigs to pathogenic Escherichia coli (Pearson et al., 2016). Adequate external biosecurity is 
needed to reduce the risk of introduction of pathogens via these routes. On the other hand, domestic 
animals such as dogs and cats may also serve as possible introducers or spreaders of disease since they, 
just like rats, also have paws and a fur where pathogens could reside and from there be transmitted to 
fomites or directly to the pigs (Figure 7). Desrosiers (2011) for example mentioned that dogs, but also 
insects, were able to transmit Brachyspira hyodysenteriae and that cats and dogs could transmit 
Pasteurella multocida. Mettenleiter et al. (2012) mentioned the (limited) role of dogs and cats in earlier 
years in the transmission of Aujeszky’s disease, while Saif et al. (2012) reported the shedding of 
transmissible gastroenteritis  as well as porcine epidemic diarrhea by dogs and cats and Opriessnig and 
Wood (2012) described domestic animals as potential reservoirs for Erysipelothrix rhusiopathiae. 
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Figure 7 Unwanted situation of a companion dog in the farrowing unit. This might cause stress for the sows 
and their litter and poses a risk for introduction of pathogens via for example the paws or fur of the dog. 
Source: Merel Postma, RED AB project. 
 
Location and environment 
Several pathogens important in pig production (Table 2) can be spread through the air such as Mycoplasma 
hyopneumoniae, swine influenza virus and PRRSv (Otake et al., 2010; Desrosiers, 2011). Almost all 
pathogens can be found in the air in the close proximity of the animals, especially respiratory pathogens 
such as Actinobacillus pleuropneumonia (Tobias et al., 2014). The location of the herd and the density of 
pig farming in the proximity are thus important factors in the risk of disease transmission. The Flanders 
region in Belgium is very pig and herd dense in general (Vangroenweghe et al., 2009) (Figure 8) and Maes 
et al. (2000) reported that increased seroprevalences for Mycoplasma hyopneumoniae, swine influenza 
(H1N1 and H3N2) and Aujeszky’s disease virus were mostly associated with herd density. 
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Figure 8 Geographical location of active pig herds in Belgium in 2006. Source: Vangroenweghe et al. 
(2009). 
 
Also feral animals, with an important role of wild boar, are able to transmit almost all pathogens/diseases 
listed in Table 2.  
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Internal biosecurity 
Management of diseases 
As mentioned before, diseased animals may pose a substantial threat to susceptible animals. Correct 
handling and treatment of diseased animals is therefore of great importance in the reduction of 
transmission of disease. Improving the immunity status of susceptible animals, e.g. by vaccination, could 
significantly reduce the risk of introduction into and spread within the herd and should be part of the 
management of diseases. From an economical point of view, good management of diseases is also 
important for a farmer as disease is most likely to cause reduced production results and mortality. Figi et 
al. (2014) reported an economic benefit of € 16795 per year (18500 CHF3) as a result of a higher daily 
weight gain after modified partial depopulation (costs once € 94871 (104500 CHF3)) in a Swiss nucleus sow 
breeding farm with problems of Brachyspira hyodysenteriae. Nieuwenhuis et al. (2012) estimated the 
mean loss per sow per outbreak of PRRSv to be € 126. Related to African swine fever, Fasina et al. (2012) 
reported a cost-benefit ratio of 29 for the implementation of biosecurity measures and its monitoring. 
Alarcon et al. (2013a) modelled the effect of a combination of vaccination and biosecurity measures in 
farms highly affected with porcine circovirus and post-weaning multi-systemic wasting syndrome (PMWS) 
to be € 74012 (mean expected value) (£ 576483)  after 5 years. They also estimated that the mean loss for 
a pig infected with PMWS but reaching slaughter age was € 10.40 (£ 8.13) with, at farm level, the greatest 
proportion of negative economic impact resulting from these infected pigs (Alarcon et al., 2013b).  
Farrowing and suckling period 
Sows can transmit pathogens to their offspring. Especially cross fostering will increase the risk of contact 
between infected or carrier sows and susceptible piglets without maternal antibodies as was described for 
PRRSv (Zimmerman et al., 2012). Bacterial pathogens that reside on the skin around the genital tract or 
udder pose a risk to the piglet as well. Contamination of the udder and nipples is for example described 
for Escherichia coli (Fairbrother and Gyles, 2012) or inoculation of piglets with Staphylococcus hyicus when 
passing through the vagina during birth (Frana, 2012). Even transmission of AMR from the sow to the 
piglets has recently been documented (Callens et al., 2014). Materials that are used from piglet to piglet 
without cleaning and disinfection pose another possible route of pathogen transmission in the farrowing 
unit (Figure 9). 
                                                          
3 Exchanges rates of 16 February 2016. 
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Figure 9 Undesirable example of a treatment box. Materials that come into direct contact with the pig 
should be cleaned and disinfected preferably between every piglet. Cleaning and disinfection per litter and 
per production round is also advisable. Source: Merel Postma, RED AB project. 
 
Nursery unit 
Nursery pigs are a vulnerable age group for contracting diseases. The abrupt changes in feed composition, 
loss of lactogenic immunity and mixing of groups at weaning lead to a temporary lower immunity status 
in combination with a high presence of diverse pathogens (Johnson et al., 2012; Thomson and Friendship, 
2012a). Fighting and biting when piglets are mixed will increase the incidence of epidermitis and can result 
in an entry port for pathogens (Cameron, 2012). The principle of all in – all out, in combination with keeping 
together litters of the same age, assures that age groups are not mixed, no returning of pig to younger age 
groups is possible, stables/pens can be cleaned and disinfected properly and cross-contamination between 
age groups is strongly reduced. Stocking density may also influence the transmission or severity of disease 
(Dewulf et al., 2007b). A low stocking density for example was found as a factor associated with a 
decreased PMWS severity (Alarcon et al., 2011). In general a high stocking density gives the most problems 
at the end of the nursery period. 
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Fattening period 
The principle of all in – all out should also be respected in the finisher unit during the fattening period. Also 
stocking density was found to be an important risk factor in the seroprevalence of Ausjeszky’s disease and 
swine influenza (Maes et al., 2000) in the finisher period. 
Compartmentalizing, working lines and equipment 
Keeping age groups separate and working in a well-defined sequence is recommended i.e. first the 
youngest animals, followed by the older age groups, and thereafter the quarantine and sick bay and finally 
the cadaver storage. The immune status of young animals is generally lesser developed compared to older 
animals, except maybe for newborns where maternal immunity is present and when they are provided 
with passive immunity from colostrum (Neumann, 2012). 
As shown in Table 2 materials and equipment are very important in the transmission of a large number of 
diseases (Figure 10). Allaart et al. (2013) described the isolation of Clostridium perfringens from bedding 
material, drinking water, boots, fans and fly strips on farms. Syringes and needles might also serve as 
transmitters of disease, for example for PRRSv (Otake et al., 2002) and porcine circovirus (Patterson et al., 
2011b). 
 
Figure 10 Colored material and equipment makes it easy to recognize to which age group it belongs. 
Materials should also be place in line with the working lines from young to old and cleaned and disinfected 
regularly. Source: Merel Postma, RED AB project. 
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Cleaning and disinfection 
Following the correct procedure of cleaning, disinfection and empty period in the compartments/pens will 
reduce the infection pressure. A lack of cleaning after batches was seen as a risk factor for several zoonotic 
pathogens such as Salmonella spp., Campylobacter spp. and Listeria monocytogenes (Fosse et al., 2009; 
De Busser et al., 2013). Cleaning and disinfection of boots (Figure 11), materials, etc. was already described 
above to be important in the reduction of disease transmission. A hygienogram (testing of bacterial 
contamination of surfaces) can be used to check whether the cleaning and disinfection was sufficiently 
performed. The report of Rutala et al. (2008) provides an overview of disinfection products available in 
healthcare and their activity against different pathogens. 
 
Figure 11 Example of a visually dirty footbath which is not desirable since it might serve as a contamination 
bath rather than a disinfection bath. Source: Merel Postma, RED AB project. 
 
2. How to quantify the biosecurity status at herd level 
Several systems were developed to make an inventory of biosecurity measures taken on pig herds, often 
developed as checklists or as manuals. The dichotomous checklist of Wageningen University was 
developed to gain insight in the risks factors for introduction and spread of Streptococcus suis on a herd 
(Wageningen University, 2008). The American Association of Swine Veterinarians (AASV) (2007) developed, 
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in collaboration with Iowa State University (Holtkamp et al., 2010), a system (PADRAP) that evaluates the 
biosecurity protocols used in breeding or growing pig herds and identifies possible risk factors, along with 
a benchmarking of the herd compared to other herds. The PADRAP risk assessment is mainly targeted for 
PRRSv. Other countries published fact sheets on the principles of biosecurity, for example to reduce the 
risk of introduction and spread of classical swine fever (Defra, 2007). In Australia information on 
biosecurity is also available for pig producers via Australian Pork Industry (2003). Recently they also 
developed manuals for pig producers including an internal audit system called APIQ (Australian Pork 
Industry, 2015). 
The same principle as described for quantification of AMU holds true for quantification of the level of 
biosecurity; only a standardized, comparable, comprehensive method could lead to a system that can be 
used to draw conclusions over multiple herds and/or countries.  
The above mentioned systems are not really capable of quantifying biosecurity, or they are mainly 
targeting a specific pathogen or disease. After years of scientific research the Biocheck.UGent™ risk-based 
scoring system to quantify the biosecurity status was developed and is currently available for use in pig 
herds and poultry flocks (Ribbens et al., 2008; Laanen et al., 2010; Gelaude et al., 2014; Ghent University, 
2015). The Biocheck.UGent™ system for pig production consists of a total of 109, mainly di- or 
trichotomous questions subdivided into six subcategories for internal biosecurity and six for external 
biosecurity. The subcategories were described in detail above. Every subcategory consists of 2-13 
questions, where the answer to every question results in a score between 0 when this measure is not 
implemented and 1 when the measure is implemented. Depending on the importance of the measure the 
score per question is multiplied by a weight factor (see Supplementary data in (Laanen et al., 2013). Also 
the subcategories have a specific weight factor to account for their assessed relative importance for 
disease prevention (see supplementary data of Laanen et al. (2013)). The final score for both internal and 
external biosecurity ranges from 0, indicating a total absence of the described biosecurity measures, to 
100, indicating full application of the described measures. The average over internal and external 
biosecurity results in a score for the total biosecurity. 
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REDUCE: ACTION & PSYCHOLOGY 
As described in CHAPTER 1.1 the most important method to slow down resistance selection and make 
reversion of resistance possible is the reduced use of AM. This reduction should however be accompanied 
by an improvement of general animal health to reduce the need for AMs. Yet there is little scientific data 
available studying the possibility of combining both a decreased antimicrobial use with an improved animal 
health. Yet this type of data is needed to be able to convince farmers and veterinarians on the possibilities 
of implementing the requested changes and AMU reduction. As mentioned before, herd management 
includes animal health, animal welfare and environmental, economic and social sustainability. In the action 
against high AMU and AMR all these aspects are of equal importance. Only a change in attitude and 
behaviour of farmers, veterinarians, herd advisors, teachers, legislators and all others involved, can lead 
to a favourable situation at herd as well as at country level, especially if combined with the above described 
improvement of herd management. 
1. Prudent use and reduction 
Whenever the disease prevention, as discussed above, has fallen short and clinical problems occur on a 
herd, recognition by the farmer of (emerging) disease problems followed by a diagnosis of the veterinarian 
should form the basis of a correct action for curing or culling the diseased animals. Registration of disease 
outbreaks, occurrence of symptoms per age is of utmost importance to be able to make a herd specific 
analysis of the infection dynamics and influencing factors. When disease is observed, the herd veterinarian 
should be consulted to establish a diagnosis, if needed based on diagnostic information such as serology 
or detection of the pathogen. Historical knowledge, slaughter findings and other herd and environmental 
information have to be considered as well in the development of an action plan. When a bacterial infection 
is identified as the causal reason for disease, the herd veterinarian should decide whether an AM therapy 
is appropriate. Again, other preventive measures such as vaccination, optimization of biosecurity, climate, 
feed quality etc. should also be taken into account, not only from an animal health and welfare point of 
view, but also for economic reasons (Alarcon et al., 2013b). When an AM treatment is justified the 
veterinarian should prescribe the correct AM products/AS, based on AM sensitivity testing and in Belgium 
according to the formularies of the Belgian Center of Expertise on Antimicrobial Consumption and 
Resistance in Animals (AMCRA) who issues these formularies and guidelines for prudent AMU (AMCRA, 
2014a).  This will also assure that not only AMs are used restrictively but in case of use they are also used 
correctly according to the SPC (EPRUMA, 2008; RUMA, 2013; AMCRA, 2015).  
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In pig production, (routine) prophylactic group therapies are commonly used (Callens et al., 2012a). A 
switch away from unnecessary (routine) prophylactic group therapies towards individual treatment of 
diseased animals allows to substantially reduce the amount of AMs used without denying the animals in 
need of treatments the access to this treatment. In some cases treatment of a (small) group of animals 
should be possible, although preferable in the form of a metaphylactic therapy rather than a strict 
prophylactic therapy. For example the treatment of a whole litter when in the first occasion “only” 3 out 
of 14 piglets showed signs of diarrhea is recommended. Infection of newborn piglets with neonatal 
diarrhea caused by Escherichia coli results from a contaminated environment (high infection pressure), a 
high susceptibility of the piglets during the first days of life and low antibody titres in the colostrum from 
the sow (Fairbrother and Gyles, 2012). Since all piglets within the litter are raised under the same 
conditions, they are all at high risk of contracting neonatal diarrhea, even more since they will readily 
transmit the pathogen between them once some suffer from diarrhea. Therefore treatment of the whole 
litter is justified. When treatment is really necessary, but individual treatment is possible based on the 
symptoms and diagnosis, this should be the preferred therapy. The use of critically important AMs should 
be restricted to an absolute minimum. A correct dosage with taking into account the correct estimated 
weight of the animals at treatment and a sufficient, well considered treatment duration are the two other 
points the veterinarian should pay attention to when prescribing an AM therapy (Day and Read, 2016). 
Finally a correct storage of AM and other veterinary medicinal products is important as well as a correct 
route and method of administration performed according to prescriptions. 
2. Breaking routines 
Humans are creatures of habit. Farmers are no exception when it comes to herd management and 
treatment plans for their animals. However, to make the desired changes, routines need to be broken and 
to do so external support and counselling or even pressure is often needed.  
Before 2013, the number of studies reporting on changes in behaviour related to (human) AM stewardship 
were limited according to Davey et al. (2015). Due to the increased interest in the need to reduce AMU 
recently more studies were published that address the behavioural sciences side of the field of AM 
stewardship. Well known in relation to high AMU and the AMR problems is the use of the yellow card 
system in Denmark which focuses on the high users in pig production. These high users first receive a 
warning that they are above a certain threshold and when they subsequently do not alter their AMU habits 
within a nine months period, a second opinion veterinarian has to be engaged to develop an improvement 
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strategy. All related costs have to be paid by the farmer. This yellow card system can therefore be seen as 
a penalizing system for the farmer. Jensen et al. (2014) recently described that the Danish yellow card 
system only had a transient effect in the reduction of AMU in pig production. The use of penalties and 
rewards is also reported in disease control programmes, such as for paratuberculosis in cattle (Benedictus 
et al., 2000) or related to zoonotic pathogens in cattle (Ellis-Iversen et al., 2010). This last study identified 
veterinarians as the preferred motivator of farmers and showed the importance of rewards and penalties. 
An important remark in this study was that the intent to change should be present in the farmer, both for 
positive and negative incentives to have effect (Ellis-Iversen et al., 2010). On the other hand, Speksnijder 
et al. (2015a) suggested that policy interventions should target veterinarians’ attitude and advisory skills 
and that they should provide tools for them to deal with (perceived) pressure from farmers to prescribe 
AMs. The importance of awareness creation and the demonstration of the potential benefits of the advice 
by veterinarians towards farmers was also  highlighted by van Soest  et al. (2015) and Tschopp et al. (2015) 
in dairy cattle farmers. Summarizing we can state that farmers and veterinarians (and other herd advisors) 
should work together to achieve the best result in prudent AMU. 
To achieve this, herd advisors should not be afraid to provide advice. Belgian veterinarians tend to be more 
risk averse compared to veterinarians in other countries (Postma M. and Speksnijder D. C. et al., 2016; 
Visschers et al., 2016). In human medicine this pattern of risk averseness was described before In Belgian 
general practitioners (Grol et al., 1990; Coenen et al., 2004; Deschepper et al., 2008). At least part of the 
(routine) prophylactic AM therapies used in Belgium are likely the result of this risk aversive behaviour and 
a cooping strategy of including some kind of “health-insurance” in the production cycle. One of the 
important measures to reduce the use of (routine) prophylactic treatment should be the breaking of these 
often unnecessary routine treatments. To be able to take on this responsibility, veterinarians should have 
sufficient sociological skills to help the farmer in the process of change and improvement. The farmer 
should be coached in the optimization of herd management, biosecurity, vaccination and additionally 
other alternatives in pursuit for better animal health and reduced AMU. 
At the same time, suggested interventions for improvements in biosecurity and herd health management 
and AMU reduction should be accepted by the farmer. This needs awareness of the risks related to AMR 
and the needs of an reduction in use at the individual farm level. This awareness can be created by 
informing the farmer on the problem of AMU and AMR through information and sensitization campaigns. 
The need for individual action can be triggered by benchmarking the AMU at the herd level which on its 
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turn will lead to awareness as well (Speksnijder et al., 2015c). The economic aspect of reduction of AMU 
and improvement of herd management is of course very important for the farmer. The farmer is generally 
only willing to make adjustments if they are believed to be economically beneficial. In general farmers 
perceive biosecurity measures to be expensive or impractical and mention the costs often as a reason not 
to implement (extra) biosecurity measures (Fraser et al., 2010; Laanen et al., 2014). One of the main 
conclusions of the study of Laanen et al. (2014) is the primary interest of Belgian farmers to gain more 
information on the economic benefits of biosecurity and disease prevention measures. Veterinarians also 
suggested that one of the main reasons for farmers not to comply to veterinary advise for improvement 
in animal health, is related to financial and time restrictions (Speksnijder et al., 2015b). Recent publications 
in pig production showed however that after implementation of biosecurity and management changes 
economically profitable results could be obtained due to reduced morbidity and mortality and increased 
production results (Fasina et al., 2012; Alarcon et al., 2013a; Rojo-Gimeno C. and Postma M. et al., 2016). 
 
 
Figure 12 Suggested actions to point the balance towards the reversion of antimicrobial resistance.
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SCIENTIFIC AIMS 
Antimicrobial usage (AMU) in pig production is high and Belgium is among the higher users in the EU based 
on sales data of AM. Quantification of AMU is however preferably performed in a more comprehensive 
and comparable way than based on sales data only to describe the use in a more detailed manner and 
achieve a rational reduction. Ultimately a reduction in the AMU should result in a halt in AMR selection or 
even reversion to susceptibility. To limit the need for AMU treatment animal health should be stimulated 
by improving herd management. An important part of herd management, especially related to controlling 
introduction and spread of infectious diseases, is a good biosecurity. Previously a positive association 
between biosecurity, lower AMU and beneficial production was described in a cross-sectional study in 
Belgium. It remained however unknown whether these results were reproducible, how these associations 
relate to other countries and, whether they would also hold true in an intervention study. 
The above described problem definitions resulted in the following questions and hypotheses that were 
tried to be answered and validated in this dissertation: 
1. Provided that the formula for treatment incidence is the preferable choice for a comprehensive 
and comparable quantification of AMU, how should the denominator values be standardized over 
herds and countries?  
 
2. Which improvements in herd management and animal health are available serving as alternatives 
to AMU?  
 
3. Is biosecurity indeed an effective strategy in the improvement of animal health and productivity? 
And, how does the biosecurity status of Belgian pig herds relate to pig production in other EU 
countries?  
 
4. Is a higher biosecurity associated with a lower AMU? And how does this relate to other production 
and herd management characteristics?  
 
5. Is a substantial reduction of AMU possible when farmers are guided in prudent use of AM and 
improved biosecurity and herd health management? And, how does this affect the herds’ 
production performances? 
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ABSTRACT 
Objectives To establish a consensus defined daily dose animal (DDDA) for each active substance (AS) 
and administration route for porcine veterinary antimicrobial (AM) products authorized in four 
European countries, thus allowing cross-country quantification and comparison of antimicrobial usage 
(AMU) data.  
Methods All veterinary AM products authorized for porcine use in Belgium, France, Germany and 
Sweden were listed for each administration route. First, separate DDDAs for each product were 
defined based on the recommended dosing for the main indication. Second, a consensus DDDA was 
established by taking the mean of the DDDAs for each product within a certain category of AS plus 
administration route.  
Results One-hundred-and-fifty-nine, 240, 281 and 50 AM products were licensed in February 2013 in 
Belgium, France, Germany and Sweden, respectively. Large variations were observed for dosage and 
treatment duration recommendations between products and between countries for the same ASs. 
Only 6.8% of feed/water and 29.4% of parenteral AS groups had the same recommended dosage in 
the four countries.  
Conclusions This study presents a consensus DDDA list for use in the quantification and comparison of 
AM consumption. Four major recommendations have been formulated: (i) urgent need for 
harmonization of authorization and recommended summary of product characteristics (SPC) dosages; 
(ii) expand the developed preliminary DDDA list to include all authorized veterinary medicinal products 
in all EU member states and for all (food-producing) animal species; (iii) improved accessibility of 
country-specific SPC data would be preferable; and (iv) statement of the ‘long-acting’ duration of a 
product in the SPC.  
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INTRODUCTION 
Antimicrobial usage (AMU) in food-producing animals is high on the European scientific and political 
agendas (European Commission, 2011a) Of major concern is the development and selection of 
antimicrobial resistance (AMR) in bacteria, impeding the adequate treatment of bacterial infections in 
animals and humans. A recent paper described a strong correlation between the level of animal AMU 
and the level of resistance in commensal Escherichia coli at the national level (Chantziaras et al., 2014). 
A meta-analysis in human medicine has also described an association between antibiotic consumption 
and the development of antibiotic resistance (Bell et al., 2014). The World Health Organization (WHO) 
refers to AMR as a global concern and emphasizes the importance of reliable data collection and 
monitoring systems (WHO, 2013a) When establishing these monitoring systems, harmonization of 
both AM consumption quantification and resistance determination is crucial for enabling objective 
comparisons and risk assessments within and between countries.  
Gaining insight into the amount of AMs used in livestock production requires an accepted method for 
objective comparison across animal species within and between countries in a way that represents the 
AMR selection pressure that is exerted in the best possible way. Given the huge differences in 
molecular weight among AM compounds, the use of a weight parameter such as the milligram or 
kilogram is not advisable. The European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) 
consortium of the European Medicines Agency (EMA) has recently proposed the use of the defined 
daily dose animal (DDDA) as a quantification unit of AM consumption (ESVAC et al., 2012). This 
measure is derived from the established method of the defined daily dose (DDD) (WHO, 2011a) used 
in human medicine since 1991. In human medicine the DDD is defined by the WHO as ‘the assumed 
average maintenance dose per day for a drug used for its main indication in adults’ (WHO, 2011a). 
In veterinary medicine, the ESVAC consortium has defined the DDDA as ‘the assumed average 
maintenance dose per day per kg body weight for the main indication in a specified species’. The 
defined course dose animal (DCDA) is defined as ‘the assumed average maintenance dose per day per 
kg body weight for the main indication in a specified species (DDDA) multiplied by the assumed 
duration of treatment’ (ESVAC et al., 2013). 
In its 2012 reflection paper (ESVAC et al., 2012), ESVAC requests the development of a standardized 
DDDA list among EU member states. To the best of our knowledge this list has not been developed yet. 
Quantification and cross-country analysis of AMU in pig production in several EU countries is one of 
the aims of the MINAPIG consortium (www.minapig.eu). Assigning DDDAs for AMs used in pig 
production was therefore a necessary first step. Use of the DCDA is another method for describing 
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AMU, which incorporates treatment duration. Establishment of the DCDA was therefore considered a 
useful addition to the established DDDA. ESVAC also mentions the use of the DCDA in its reflection 
paper (ESVAC et al., 2012). 
The aim of this article is to describe the procedures used to assign standardized DDDAs for four EU 
countries and to highlight the differences found within and between countries in dosage 
recommendations for the same active compounds and administration route combinations. The 
consensus DDDA is not to be seen as a gold standard or as a tool to assess prudent AMU, but rather as 
a reference point for quantification of AMU in a standardized manner across different countries.  
 
MATERIALS AND METHODS 
Data collection 
AM products authorized for use in pig production in February 2013 were listed for Belgium, Germany, 
France and Sweden. These data were obtained from the national regulatory institutions involved in 
the authorization and registration of veterinary medicinal products. In Belgium this is Het Belgische 
Centrum voor Farmacotherapeutische Informatie (BCFI vet) (BCFIvet, 2015), for France it is the Index 
des Médicaments vétérinaires autorisés en France (IRCP) (ANSES, 2014) and for Sweden it is either 
Fakta för förskrivare (FASS) (FASS, 2014) or Läkemedelsverket (Läkemedelsverket, 2014). For Germany 
the university service Veterinärmedizinischer Informationsdienst für Arzneimittelanwendung, 
Toxikologie und Arzneimittelrecht (Vetidata) (Vetidata, 2014) was used. For each authorized product, 
detailed information on the active substances (ASs) in the product, the concentration, the 
administration route, long-acting (LA) activity (i.e. the duration of activity of an AS after administration 
of a dose) and whether the AS is categorized as critically important by the WHO (WHO, 2013c) or World 
Organisation for Animal Health (OIE) (OIE, 2007) were recorded. A total of six administration routes 
were differentiated: feed/water, oral non-feed/water (i.e. drench, tablet), parenteral, topical, topical 
eye ointment and intrauterine.  
In this paper AMs are defined as products with an AM mechanism of action falling within WHO ATCvet 
first level codes (WHO, 2013b) QD, QG, QJ and QS (FASS, 2012). Zinc oxide was considered separately, 
since this is considered to be an alternative to AMs in pig production in some EU countries. During the 
data collection zinc oxide was only authorized in Sweden. In Germany zinc oxide was only available in 
combination with colistin and in Belgium zinc oxide was only allowed as a single in-feed additive from 
September 2013 onwards.  
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Method of DDDA determination for individual products 
A DDDA was assigned for each individual AM product authorized, based on the dosage for the main 
indication provided in the country-specific summary of product characteristics (SPC). In guidelines, 
prudent AMU is described as using the products in accordance with the SPC (EPRUMA, 2008; OIE, 2010; 
Federation of Veterinarians of, 2012). The recommended dosage is therefore the dosage 
recommended by the license holder and might not be the proposed dosage based on the scientific 
literature. The DDDA was listed in mg/kg body weight (mg/kg) and per day. Doses of products with an 
AS expressed in IU in their SPC were recalculated to mg/kg using the conversion rates published in the 
second ESVAC report (ESVAC, 2012). 
When a clear main indication was stated in the SPC, this dosage was used to assign the product DDDA. 
The specified main indications used are listed in Table 3. In a few cases the main indication in the SPC 
varied between countries. In these cases the main indication was agreed upon by consensus, mainly 
after consulting pharmaceutical laboratories. When a dosage range was given in the SPC, the mean of 
the minimal and maximal dosages was selected. If no indication was listed and a range was provided, 
the mean value was also used.  
Table 3 Main indications from Summary of Product Characteristics for active substances with several 
dosage recommendations for different indications. The recommended dosage for the main indication 
was chosen for further analysis. 
ACTIVE SUBSTANCE ADMINISTRATION ROUTE MAIN INDICATION 
LINCOMYCIN Feed/water Enzootic pneumonia 
LINCOMYCIN + SPECTINOMYCIN Feed/water Dysentery 
TIAMULIN Feed/water Dysentery 
TIAMULIN Parenteral Dysentery 
TYLOSIN Feed/water Porcine Proliferative Enteropathy 
TYLVALOSIN Feed/water Dysentery 
VALNEMULIN Feed/water Dysentery 
If the SPC stated a double or even triple daily treatment with the same dosage in severe cases, it was, 
by consensus, agreed upon that the DDDA would consist of the mean of the normal daily dose and the 
double dose.  
Treatment duration was also listed for each product. By the same procedure as for the DDDA 
assignment, the main indication was used to set the treatment duration. If the SPC provided a range 
or there was a discrepancy in main indication, the mean of the minimal and maximal recommended 
treatment durations was taken.  
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DDDAs for combination products were determined as the sum of the DDDAs for the separate ASs. Zinc 
oxide was also included if it was combined with an AM AS. Using the same procedure as that used for 
products with a single AS, the mean was calculated if there was a range, and when a clear main 
indication was stated this value was used.  
LA products received an LA factor (i.e. value that represents the duration of activity of an LA product) 
depending on the estimated duration of AM activity to determine the number of DDDAs resulting from 
one treatment. These LA factors were assigned based on available research information in the 
European Public Assessment Reports (EPAR) of the EMA or the treatment interval described in the SPC. 
When a clear, single duration of action for an LA product was not provided from this information, but 
an indication of the duration range was provided, the authors assigned the LA factor in consensus 
based on scientific literature data.  
For topical spray or eye products it was assumed that ∼3 mL of product would be used per treatment. 
This was based on the assumption that 1 mL will be sprayed per second and the fact that 3 s of spraying 
is the average duration mentioned in the SPCs for topical spray products (Norbrook Laboratories, 2008; 
Intervet Deutschland Gmb, 2009; Ceva Sante, 2010; Eurovet, 2012; Intervet international, 2012a, b; 
Vetoquinol, 2012; Animedica Gmb, 2013; Vetoquinol, 2013; Albrecht Gmb and Novartis Tiergesundheit 
Gmb, 2014; Animedica Gmb, 2014; Intervet, 2014). For two out of three intrauterine products no 
information on the weight of a tablet could be traced. Therefore, these DDDAs were assigned assuming 
administration of one tablet as treatment for an average sow of 220 kg body weight, similar to the 
weights advised by ESVAC (ESVAC et al., 2012). 
The critical importance of a product was also listed, following the guidelines of the WHO (WHO, 2011b) 
and OIE (OIE, 2007) for human and veterinary usage, respectively.  
Assigning DDDAs across countries 
The chapter ‘Assignment of DDDAs and DCDA values’ of the ESVAC reflection paper on collecting data 
on consumption of AM agents for each animal species was used as a guideline to assign DDDAs over 
the four countries.  
An individual product was first categorized based on its AS(s) and subsequently on its administration 
route. Products were also categorized based on whether or not they were LA products. No 
differentiation in DDDA was made for different age categories. Recommended dosages are normally 
not differentiated for different age categories. In the rare cases in which the SPC mentioned different 
dosages for piglets and adult animals we chose to use the recommended dosage for adult animals. This 
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is in accordance with the procedure used in human medicine, where the DDD is assigned based on use 
of a medicinal product by an average adult person (WHO, 2013b). 
The mean, median and mode were calculated for all products within each AS plus administration route 
category. The mean was considered to be the consensus DDDA. The same procedure was used to 
establish the LA factors and treatment duration. Important differences in recommended dosage and 
treatment duration for the individual products compared with the consensus DDDAs and DCDAs were 
identified.  
Data analysis 
Data were managed using Microsoft Excel 2010 and further analysed using IBM SPSS Statistics version 
22. For each product, the difference between its DDDA and the assigned mean consensus DDDA was 
calculated. Differences of >10% from the consensus DDDA in AS plus administration route categories 
with at least two products in two different countries were analysed with a univariate general linear 
model to check for the effects of number of years since first authorization and country. Comparison 
between countries regarding the deviation from the consensus DDDA and treatment duration for each 
administration route was done by using a non-parametric independent samples Kruskal–Wallis test 
with pairwise comparison.  
 
RESULTS 
DDDAs 
There were 159, 240, 281 and 50 AM products licensed in Belgium, France, Germany and Sweden, 
respectively, adding up to a total of 730 products (Table 4). The oldest product was first authorized in 
1955, the newest in 2013. A total of 116 unique categories based on AS, administration route and LA 
factor were identified, for which a DDDA and DCDA were assigned. There were 82 groups of different 
AM ASs or combinations of ASs combined with a similar administration route. Of these 82 AS plus 
administration route categories, 44 (360 products) were authorized for use in feed or water, 51 for 
parenteral administration (326 products), 3 (7 products) for intrauterine use, 11 (21 products) for oral 
non-feed/water use, 6 (15 products) for topical use and 1 (1 product) for use as eye ointment. Fifty-
seven of the ASs were authorized for one administration route, 18 for two, 5 for three and 2 for four 
administration routes. 
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Table 4 Number of antimicrobial products licensed for pigs per country and per administration route, 
including of indication of number of products listed as critically important by WHO (WHO, 2011b) or 
OIE (OIE, 2007) for human or veterinary medicine, respectively. 
ADMINISTRATION ROUTE BELGIUM FRANCE GERMANY SWEDEN TOTAL CRITICALLY 
IMPORTANT 
VETERINARY 
CRITICALLY 
IMPORTANT 
HUMAN 
FEED/WATER 72 138 133 17 360 272 189 
PARENTERAL 81 93 129 23 326 287 223 
PER ORAL NON FEED/WATER  3 3 9 6 21 15 8 
TOPICAL 4 6 4 2 16 16 15 
INTRAUTERINE 0 0 6 1 7 7 7 
EYE OINTMENT 0 0 0 1 1 0 0 
TOTAL 159 240 281 50 730 597 442 
 
The ASs with the most authorized products were colistin (n = 53 products), amoxicillin (n = 49) and 
enrofloxacin (n = 44). The number of authorized products does not necessarily equal the usage of these 
products.  
The list of consensus DDDAs and consensus DCDAs is provided in Table 8.  
For 11 of the 17 ASs with authorization for parenteral administration as well as feed/water 
administration, the mean dosages for parentally administered products were lower in comparison with 
products administered by feed or water having the same AS (Table 5).  
Table 4 shows that 597 of 730 products (81.8%) are refereed by the OIE as critically important for 
veterinary usage, and 442 products (60.5%) by the WHO as critically important for human usage.  
Deviation from consensus DDDA 
The percentage of products deviating >10% from the mean consensus DDDA are listed per category 
based on AS and administration route in Table 8. The number of products within a category showing 
deviation varied from only one (4.9%) to all of the products (100%). Thirty-one out of 82 unique 
combinations showed deviations >10% from the consensus DDDA. The top 20 deviating products are 
listed in Table 6. 
This list includes mainly products containing tylosin, amoxicillin and doxycycline. Fifteen of these top 
20 deviating products were authorized in Germany.   
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Table 5 Differences in feed/water dosage prescription compared to parenteral dosage prescription. A 
positive percentage difference means that the feed/water administration category of this AS had a 
higher mean recommended dosage, a minus means that the parenteral recommended dosage was 
higher. 
ACTIVE SUBSTANCE MEAN DDDA 
FEED/WATER 
N MEAN DDDA 
PARENTERAL 
N DIFFERENCE PERCENTAGE 
DIFFERENCE 
AMOXYCILLIN 20.4 34 11.7 1
3 
8.7 +42.7% 
AMPICILLIN 32.0 7 17.0 3 15.0 +46.9% 
COLISTIN 5.0 41 2.6 8 2.4 +47.7% 
ENROFLOXACIN 1.7 1 2.8 3
8 
-1.1 -62.5% 
LINCOMYCIN 6.7 7 10.5 1
1 
-3.7 -55.1% 
LINCOMYCIN + 
SPECTINOMYCIN 
6.2 13 15.0 6 -8.8 -140.7% 
OXYTETRACYCLINE 35.7 19 8.4 8 27.2 +76.3% 
PAROMOMYCIN 32.5 1 19.3 1 13.3 +40.8% 
SPIRAMYCIN 21.9 2 20.5 3 1.4 +6.3% 
SULFADIMETHOXIN 48.4 2 30.0 1 18.4 +38.0% 
SULFADIMIDIN 77.1 12 86.3 3 -9.2 -11.9% 
TIAMULIN 7.8 29 9.3 7 -1.5 -18.7% 
TRIMETHOPRIM + 
SULFADIAZIN 
29.8 22 18.1 4 11.7 +39.4% 
TRIMETHOPRIM + 
SULFADIMETHOXIN 
26.1 7 22.6 1 3.5 +13.5% 
TRIMETHOPRIM + 
SULFAMETHOXAZOLE 
25.0 2 30.0 2 -5.0 -20.0% 
TRIMETHOPRIM + 
SULFAMETHOXYPYRIDAZIN 
28.2 1 16.0 1 12.2 +43.3% 
TYLOSIN 14.9 33 10.4 9 4.5 +30.2% 
  
Feed/water 
Of the 44 AS categories authorized for feed/water administration, 3 (6.8%) did not deviate from the 
mean consensus DDDA because they had the same SPC dosage recommendation in the different 
countries. These three harmonized feed/water categories were florfenicol (Belgium, France, Germany), 
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trimethoprim/sulfamethoxazole (Belgium, Germany) and valnemulin (Belgium, Germany, Sweden). 
For florfenicol there were two authorized commercial products marketed by two different 
pharmaceutical companies. For trimethoprim/sulfamethoxazole there was one product authorized in 
two countries, first authorized in 2012. Valnemulin was represented by one product in three countries 
and was first authorized in 1999.  
Table 6 Top 20 products deviating from the consensus DDDA. A plus before the percentage deviation 
from the consensus DDDA means that this product had a higher recommended dosage compared to 
the mean consensus DDDA, a minus means that the recommended dosage was lower. 
  AS ADMINISTRA-
TION ROUTE 
COUNTRY PRODUCT NAME % DEVIATION FROM 
CONSENSUS DDDA 
1 Tylosin Feed/Water Belgium Tylosine 75 % Kela +202.4 
2 Oxytetracycline Feed/Water Germany Ursocyclin-Pulver 20% +180.4 
3 Lincomycin Feed/Water Germany Lincomycinhydrochlorid Pulver 50% +122.6 
4 Tylosin Feed/Water Germany Klato lan, 1000 mg/g +101.6 
5 Tylosin Feed/Water Germany Tylogran WSP 1000 mg/g +101.6 
6 Tylosin Feed/Water Germany Tylosintartrat 100% +101.6 
7 Tylosin Feed/Water Germany Tylo-Suscit 100% Kompaktat +101.6 
8 Tylosin Feed/Water Germany Tylo-Suscit 25 +101.6 
9 Amoxicillin Feed/Water Germany Aciphen Kompaktat 1000mg/g +96.0 
10 Amoxicillin Feed/Water Germany Amoxicillin- Trihydrat 100, 100% +96.0 
11 Amoxicillin Feed/Water Germany Amoxin 100 mg/g +96.0 
12 Amoxicillin Feed/Water Belgium Moxapulvis 50 % +96.0 
13 Amoxicillin Feed/Water Germany Triamox 100 W 114,8 mg/g +96.0 
14 Tylosin Parenteral Sweden Tylan  vet. +92.5 
15 Tiamulin Feed/Water France Tiamuval Tiamuline 6,5 Entérite Porc -79.5 
16 Doxycyclin Feed/Water Germany Doxy 50 % (500 mg/g) +73.3 
17 Doxycyclin Feed/Water Germany Pulmodox 500 mg/g +73.3 
18 Doxycyclin Feed/Water France Pulmodox 500 mg/g +73.3 
19 Amoxicillin Parenteral Germany Amoxicillin 15% WDT, 150 mg/ml +71.1 
20 Amoxicillin Parenteral Germany Belamox 200 mg/ml +71.1 
 
One of the feed/water AS categories with large variations between products in recommended dosage 
was tylosin, with a 10-fold difference between the minimum and maximum recommended dosage. 
The product with the minimum dosage and the product with the maximum dosage were both 
authorized in Belgium. Tylosin feed/water products were authorized between 1975 and 2012. The 
authorization date did not explain the deviation from the consensus DDDA (n = 33, P = 0.32), and 
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neither did country (P = 0.36). One Belgian tylosin product has a main indication of dysentery and a 
recommended dose of 45 mg/kg, while the SPC of the other Belgian product mentions dysentery and 
porcine proliferative enteropathy (PHE), with the same recommended dose of 4.5 mg/kg for both 
indications. This shows that for the same indication (here dysentery) the recommended dose varies 
between 4.5 and 45 mg/kg.  
The combination of lincomycin with spectinomycin was also well represented and was a clear example 
of large variation in DDDA (minimum dosage 3.3 mg/kg, maximum dosage 10.0 mg/kg). The 
authorization dates varied between 1975 and 1998 and could not explain the deviation (n = 13, P = 0.81), 
and the country was not decisive either (P = 0.33).  
For some of the other feed/water products with a deviation of >10% from the consensus DDDA, 
country explained the difference: amoxicillin (P = 0.02, Germany > France), chlortetracycline (P < 0.01, 
Germany > Belgium and Sweden), colistin (P < 0.01, Sweden > Belgium, Germany and France), 
neomycin (P < 0.01, France > Germany), sulfadimidine (P = 0.02, Germany > France), tiamulin (P < 0.01, 
Germany > Belgium, Sweden and France) and trimethoprim/sulfadimethoxine (P < 0.01, France > 
Germany). The year of first authorization was only statistically explanatory for feed/water 
sulfadimidine (P = 0.04).  
Table 8 shows the complete list of AS plus administration route categories including differences >10% 
from the consensus DDDA.  
Parenteral 
Of the 51 licensed AS plus administration route categories for parenteral administration, 29 did not 
deviate from the mean consensus DDDA. For 14, this was because there was only one product 
registered for this specific category whereas 15 categories contained several products authorized in 
one or more countries. Looking only at those categories containing multiple products, we found 29.4% 
of parenteral products that had harmonized registration over Belgium, France, Germany and Sweden.  
Parenteral AS plus administration route categories with large recommended dosage variations, such 
as amoxicillin (n = 13, minimum 7 mg/kg, maximum 20 mg/kg) and ampicillin (n = 3, minimum 10 mg/kg, 
maximum 21 mg/kg), were authorized between 1981 and 2005 and between 1983 and 1993, 
respectively. For amoxicillin neither the number of years since first authorization (P = 0.29) nor country 
(P = 0.75) explained the deviation from the consensus DDDA. On the other hand, the LA products of 
amoxicillin also had a long authorization period and no deviation occurred. Also for ampicillin, neither 
the first year of authorization (P = 0.39) nor the country (P = 0.61) was able to explain the deviation.  
ASSIGNING DEFINED DAILY DOSES ANIMAL CHAPTER 3 
84 
 
For parenteral sulfadimidine, country significantly influenced dosage (P = 0.03, France > Germany).  
Year of first authorization (P = 0.04) as well as the country (P = 0.01) were explanatory for differences 
in colistin (P = 0.04). Parenteral colistin products were authorized in Belgium from 1978, while the first 
year of authorization for the French products ranged from 1987 to 1998 and for Germany from 2001 
onwards. The mean recommended dosage was higher in Germany compared with Belgium and France.  
LA ceftiofur is an AS that was first authorized in 2005 and has been granted a central marketing 
authorization by the European Commission (ESVAC, 2013), and thus there was no variation between 
countries. The other products with central marketing authorization were of the ASs tylvalosin, 
tulathromycin, valnemulin and tildipirosin. In the four countries the same product was authorized for 
these specific ASs.  
A general trend for the deviation from the consensus DDDA of feed/water (P = 0.55) or parenteral 
(P = 0.78) products versus their first year of authorization could not be found.  
Intrauterine, oral non-feed/water, topical 
For the 22 AS plus administration route categories authorized for intrauterine, oral non-feed/water or 
topical administration or as eye ointment there was no harmonization of the products. Country or year 
of first authorization did not explain the >10% deviation present.  
Influence of countries on difference in dosage 
There were marked differences between countries regarding recommended dosages [e.g. 
spectinomycin, oral non-feed/water, recommended dose 40 mg/kg in Belgium (n = 1) and 150 mg/kg 
in Germany (n = 1)]. Even within the same country, the differences for some ASs were huge (e.g. 
sulfaguanidine/sulfadimidine in France, n = 2, minimum 38.4 mg/kg, maximum 160 mg/kg; tylosin in 
Belgium, n = 7, minimum 4.5 mg/kg, maximum 45 mg/kg). Some of these AS plus administration route 
categories were unique to some countries (e.g. sulfaguanidine/sulfadimidine for France).  
Comparison between countries showed that the mean recommended dose for feed/water 
administration compared with the consensus DDDA was significantly lower in Germany than in France 
(P = 0.03). For topical products, Sweden had high recommended doses (mean deviation +36%) 
compared with the relatively low recommended doses for Germany (mean deviation −19%), although 
the difference was not significant. The same applied, to a lesser extent, to parenterally administered 
products (mean deviation: Germany −3%, Sweden +12%, difference not significant). For feed/water 
products a non-significant mean deviation of +9% for Germany and −10% for Sweden was seen. A 
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significantly higher recommended dose was observed for parentally administered products in Sweden 
compared with France (P = 0.02) and Germany (P = 0.03). Table 7 shows the deviations from the 
consensus DDDA and the recommended mean duration over countries.  
Table 7 Percentage of the consensus DDDA or the mean treatment duration by country. The consensus 
DDDA and the mean treatment duration are set to be 100%.  The statistical analyses were performed 
using the Kruskal Wallis test with paiwise comparison to check for significance. 
COMPARISON ADMINISTRATION 
ROUTE 
COUNTRY MEAN % OF 
CONSENSUS 
DOSAGE 
SD N SIGNIFICANT 
DIFFERENCE 
FROM 
P-
VALUE 
DDDA Feed/Water Belgium 95.4 37.7 72   
France 95.2 32.0 138 Germany  0.04 
Germany 108.7 41.3 133   
Sweden 89.9 27.7 17   
Parenteral Belgium 100.4 13.4 81   
France 97.0 8.7 93 Sweden <0.01 
Germany 99.5 17.1 129 Sweden 0.02 
Sweden 111.9 23.5 23   
TREATMENT 
DURATION 
Per oral non 
feed/water  
Belgium 77.8 4.8 3 Germany <0.01 
France 86.7 23.1 3   
Germany 10722 10.9 9   
Sweden 95.8 6.5 6   
Duration of treatment 
Analysing deviations from the mean for treatment durations showed the largest variation for 
feed/water-administered products (mean 7.5 days, minimum 3 days, maximum 42 days).  
Products in the oral non-feed/water administration category in Germany had a significantly longer 
treatment duration than in Belgium (P < 0.01). For parenteral products, the variation in treatment 
duration (from 1 to 7 days) was not significantly different between countries.  
 
DISCUSSION 
Data collection, establishment of DDDAs 
Although highly recommended and requested by ESVAC in their latest reports, to date no other 
attempt has been described to establish DDDAs across countries, as far as the authors are aware. Even 
in human medicine only limited publications are available on discrepancies in the DDDs used in human 
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medicine (Kuster et al., 2008; de With et al., 2009). The current paper documents the results of the 
exercise for four EU countries. It may serve as a starting point for an EU-wide DDDA list. However, the 
authors would like to state clearly that the provided list of DDDAs is based on generalizations and 
simplifications and therefore does not necessarily reflect the true use in a herd or a country but rather 
provides a tool to allow comparison between herds or countries. As regards dosing, we argue that it is 
difficult to discuss the concepts of under- and overdosing objectively given the observed huge variety 
in recommended dosages. The DDDA was not specifically developed to describe under- or overdosing 
in the different countries but rather to quantify the amount of exposure of animals to AMs.  
Lists of AM products authorized within countries are subject to regular changes as products are 
updated for their recommended dosages, no longer marketed or new products are authorized. 
Products authorized in February 2013 were taken into account in this paper. Newer products or recent 
changes might not be accounted for. However, since the number of products was substantial in most 
AS categories, the mean consensus DDDA is not expected to be much influenced by possible recent 
changes.  
The mean for all authorized products with the same AS and administration route was considered to be 
the most transparent method of establishing consensus DDDAs. No important difference in the 
number of products deviating >10% from the median or mode was seen compared with using the mean. 
Using the mean implies that there is an impact of the number of products within an AS category 
authorized per country. Countries with a large number of authorized products have a higher impact on 
the consensus DDDA. Mean, median and mode are listed in Table 8. 
The main indications were selected based on available scientific information in the EPAR reports of the 
EMA and SPC and were set by consensus between the authors. However, for some of the products 
authorized in France the chosen main indication was not clearly stated in the SPC. This might partially 
explain the larger deviation from the mean DDDA for French products. No obvious explanation could 
be found for the fact that 75% of the top 20 deviating products were authorized in Germany. However, 
one reason might be that Germany has more authorized products, providing more scope for larger 
deviations.  
Unique combinations licensed for administration via water or feed were analysed together, since there 
are many products that have licenses for both administration routes or are administered by both 
routes under field circumstances. However, there are also products for which the dosage differences 
between the feed and water SPCs are huge. Splitting feed and water administration routes would have 
enabled a more specific analysis of the recommended dosage and treatment duration.  
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LA factors were in some cases established by consensus, e.g. for LA tulathromycin and ceftiofur. 
Because consensus was reached using the scientific literature, this was considered the most 
appropriate approach. However, the EPAR reports on which the consensus was based might not 
provide the most accurate information, since, e.g. duration of activity might differ among individual 
animals, disease indications, pharmacodynamics or environmental conditions, but this uncertainty 
could not be taken into account. For LA products it would be advisable that the SPCs provide more 
detailed information on the expected duration of effect after administration of a dose.  
Assumptions and simplifications 
It was agreed to establish the mean consensus DDDA based on the recommended dosage for usage of 
the product in an adult animal for the main indication. This is in concordance with the definition of the 
DDD, used in human medicine (WHO, 2013b). Since there were products for which the recommended 
dosage differed among several indications, the choice of using the main indication could have 
influenced our results. However, for reasons of simplification and to avoid creation of an exhaustive 
list it was decided to use the recommended dosage for an adult animal and not to consider the other 
indications or the dosage recommendations for young animals.  
The extent to which authorized products are actually marketed and used, and used in concordance 
with the recommendations of the SPC, could not be checked in a scientific way and is highly influenced 
by the individual therapy prescription provided by the veterinarian. Callens et al. (2012a) reported 
recently that correctness of dosing for AM products based on the recommendations of the SPC is being 
circumvented in Belgium. The only certainty is the authorization license of the product. This was 
therefore the basis of this research.  
In this study the number of authorized products was much higher in Germany compared with Sweden. 
A consequence of using the methodology described here is that a country with a larger number of 
products will theoretically have a greater influence on the mean consensus DDDA. This is inevitable in 
the methodology used here, by which we tried to find a consensus DDDA that would fit best the 
available data.  
Some of the necessary assumptions could have been circumvented if more detailed information on 
these matters had been provided in the SPCs. For example, knowledge of the amount of product that 
is applied by using a topical spray can for 1 s would help in the estimation of the total amount of AS 
used per treatment. It is recommended that this information is provided in future registration dossiers.  
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Differences in molecular formulation between products might have influenced variation in the 
recommended dosage in the SPC. To avoid the creation of an almost infinite list with enormous 
complexity it was decided to compromise on this matter by presuming the recommended dosage at 
AS level was the best feasible information.  
Number of products and variation 
For some products, large deviations with respect to the mean consensus DDDA were observed among 
ASs and administration routes and between or within countries. This might influence the outcomes of 
future AMU calculations in the individual countries compared with national data using national DDDAs. 
However, using one harmonized DDDA list is the only feasible way to make a correct cross-country 
comparison.  
That only 6.8% of feed/water and 29.4% of parenteral administration routes were harmonized 
between EU member states indicates the urgent need for EU-wide harmonization. It also strongly 
questions the concept of under- or overdosing for many products since using a half dose (severe 
underdosing) of a specific product from a specific company in one country may constitute overdosing 
with the same active compound according to the registration of another company. Comparison of AM 
consumption data should be conducted transparently and under the same restrictions in all countries. 
A uniform DDDA could be one of the requirements for this. As long as the country-specific DDDAs differ 
largely from the consensus DDDA, however, we should take this into account in analysing comparisons 
of AMU data over countries.  
The hypothesis was that country and number of years since first authorization might influence a 
product's recommended dosage: country might have an effect due to differences in legislation and 
testing requirements, and number of years since first authorization date might have an effect due to 
new insights or techniques.  
The number of years since first authorization explains only some of the variation in recommended 
dosages between groups of ASs and administration routes. The country where the product is 
authorized/marketed also explains some of the deviations from the consensus DDDA. Yet most of the 
deviations of >10% could not be explained by year of first authorization or country. Differences in 
recommended dosage might be influenced by differences in authorization procedures from year to 
year and differences among countries or pharmaceutical companies, although all have to comply with 
the rules set by the EU commission, and hence the EMA (ESVAC, 2013). The authors could not find a 
direct, plausible reason for the large differences in recommended dosages for more recently 
authorized products. Differences in bioavailability of the products might be among the reasons for 
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differences in the recommended doses. However, in our attempt to develop a harmonized DDDA list 
this is the type of complexity that could not be taken into account to prevent the creation of an 
unworkably long list. Country-specific authorization procedures and different solvents, experimental 
circumstances or inoculation methods might explain this variation; however, retrospective validation 
is not possible.  
The lack of distinction between feed- and water-administered products might explain the differences 
in treatment duration for these products as well as some of the deviation from the consensus DDDA. 
In general, products administered through feed have a longer recommended treatment duration 
compared with the same ASs administered via water. In future DDDA-establishing exercises, 
consideration should be given to recording the feed administration route separately from the water 
route.  
Critically important ASs 
It was noticed that the majority of products available in porcine medicine are in the list of critically 
important AMs for either or both WHO and OIE. Their usage in veterinary practice should be greatly 
reduced in the near future, according to current discussions among risk managers and policy makers 
(European Commission, 2013). 
Application of the DDDA list 
The DDDA list described in this article may serve as a starting point for discussion about the 
establishment of DDDAs in EU countries. The DDDAs can be used to make a comparable AMU 
calculation between countries. The description of the approach and the path towards the 
establishment of the DDDA list should help future researchers in their attempt to broaden the list by 
adding more products from other EU countries or animal species.  
 
CONCLUSIONS 
Comparison of authorized AMs for porcine veterinary usage in four EU member states showed large 
variation in the number and types of products as well as differences in recommended dosages. 
Although the process was challenging, a mean consensus DDDA was established for the first time for 
ASs licensed in several EU countries. It enables future comparison of AMU data. Country and number 
of years since first authorization are explanatory for only a small number of ASs plus administration 
route categories that deviate largely from the mean consensus DDDA or the recommended treatment 
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duration. Harmonization of authorization and SPC would strongly improve the comparability of AMU 
data within and between countries.  
We therefore make the following recommendations:  
i. Harmonization. The findings described in this paper could be perceived as indicating a 
lack of knowledge on optimal treatment dosage and duration. The porcine sector, as 
well as other sectors, would benefit from increased European or even international 
harmonization for veterinary medicinal product authorization, for both new and 
existing authorizations.  
ii. Involvement of all member states. Establishment of DDDAs should be performed for 
all EU member states, based on information from the national authorities.  
iii. Accessibility of data. Access (via the World Wide Web) to country-specific databases of 
authorized products is limited due to difficulties in traceability of data sources and 
language barriers. An EU-wide centralized database would ease this process.  
iv. LA factor. The duration of action of an LA product should be established by the 
manufacturer of the product using a procedure similar to that used for the 
recommended dosage and given in the SPC.  
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Table 8 List of the mean consensus DDDAs (defined daily dose animal) per active substance and administration route established with data from four European Union 
countries. The median and mode and minimum and maximum recommended dosages are also provided. The percentage of products that have a DDDA that differs plus 
or minus 10% from the mean consensus DDDA were listed, as well as the difference (in percentage) between the highest and lowest recommended dosage. The last 
column describes the DCDA (defined course dose animal) established using the mean consensus DDDA and the mean consensus treatment duration for the specific active 
substances and administration routes. Topical administration routes consist of topical spray products, eye ointments and intrauterine products. 
Active substance 
(ATCvet code) 
Administration 
route 
Total 
and 
Country 
DDDA 
and 
Long 
acting 
Factor Count 
Mean = 
Consensus 
DDDA Median Mode Min Max 
% 
products 
<90% 
from 
consensus 
DDDA 
% 
products > 
110% 
from 
consensus 
DDDA 
Difference 
highest vs 
lowest 
(%) DCDA 
Amoxicillin 
(QJ01CA04) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feed/Water Total DDDA 34 20.41 20.00 20.00 10.00 40.00 38.2% 17.6% 400.0% 102.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 8 19.13 15.00 15.00 14.00 40.00 62.5% 12.5% 285.7%   
France DDDA 10 14.00 12.50 10.00 10.00 20.00 70.0% 0.0% 200.0%   
Germany DDDA 15 25.40 20.00 20.00 16.00 40.00 6.7% 33.3% 250.0%   
Sweden DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Oral Total DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0% 100.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Parenteral Total DDDA 13 11.69 10.00 10.00 7.00 20.00 61.5% 30.8% 285.7% 35.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 3 11.00 11.00 7.00 7.00 15.00 33.3% 33.3% 214.3%   
France DDDA 2 8.50 8.50 7.00 7.00 10.00 100.0% 0.0% 142.9%   
Germany DDDA 7 12.43 10.00 10.00 7.00 20.00 71.4% 28.6% 285.7%   
Sweden DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 100.0% 100.0%   
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Topical 
Total 
DDDA 1 33.14 33.14 33.14 33.14 33.14 0.0% 0.0% 100.0% 33.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 33.14 33.14 33.14 33.14 33.14 0.0% 0.0% 100.0%  
Amoxicillin + Clavulanic acid 
(QJ51CR02) 
 
 
 
 
Parenteral Total DDDA 1 8.75 8.75 8.75 8.75 8.75 0.0% 0.0% 100.0% 43.8 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 8.75 8.75 8.75 8.75 8.75 0.0% 0.0% 100.0%   
Amoxicillin LA 
(QJ01CA04) 
Intrauterine Total DDDA 5 1.72 1.82 1.82 1.58 1.82 0.0% 0.0% 114.8% 3.45 
LA 
Factor 
  2.00 2.00 2.00 2.00 2.00     100.0%   
Germany DDDA 5 1.72 1.82 1.82 1.58 1.82 0.0% 0.0% 114.8%   
Parenteral Total DDDA 15 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0% 30.0 
LA 
Factor 
  1.80 2.00 2.00 1.00 2.00     0.0%   
Belgium DDDA 5 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
France DDDA 5 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Germany DDDA 4 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Sweden DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Ampicillin 
(QJ01CA01) 
Feed/Water Total DDDA 7 32.04 34.64 20.00 20.00 40.00 28.6% 28.6% 200.0% 160.2 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 20.00 20.00 20.00 20.00 20.00 100.0% 0.0% 100.0%   
Germany DDDA 5 36.86 35.00 34.64 34.64 40.00 0.0% 40.0% 115.5%   
Oral Total DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0% 120.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0%   
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Parenteral 
Total 
DDDA 3 17.00 20.00 10.00 10.00 21.00 33.3% 66.7% 210.0% 51.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 21.00 21.00 21.00 21.00 21.00 0.0% 100.0% 100.0%   
Germany DDDA 2 15.00 15.00 10.00 10.00 20.00 50.0% 50.0% 200.0%   
Ampicillin + Sulfadimethoxine 
(QJ01RA59) 
 
 
 
 
Feed/Water Total DDDA 1 48.00 48.00 48.00 48.00 48.00 0.0% 0.0% 100.0% 144.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 
1 48.00 48.00 48.00 48.00 48.00 0.0% 0.0% 100.0%   
Ampicillin LA 
(QJ01CA01) 
 
 
 
 
 
Parenteral Total DDDA 1 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0% 30.0 
LA 
Factor 
  2.50 2.50 2.50 2.50 2.50     100.0%   
Belgium DDDA 7 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0%   
Apramycin 
(QJ01GB90) 
Feed/Water Total DDDA 7 7.36 6.00 5.00 5.00 10.00 57.1% 42.9% 200.0% 132.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 3 6.00 6.00 6.00 6.00 6.00 100.0% 0.0% 100.0%   
France DDDA 2 6.67 5.00 5.00 5.00 10.00 66.7% 33.3% 200.0%   
Germany DDDA 2 9.75 9.75 9.50 9.50 10.00 0.0% 100.0% 105.3%   
Oral Total DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0% 80.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Benzylpenicillin procaine + 
Neomycin 
(QJ01RA01) 
Parenteral Total DDDA 2 17.00 17.00 16.50 16.50 17.50 0.0% 0.0% 106.1% 51.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 16.50 16.50 16.50 16.50 16.50 0.0% 0.0% 100.0%   
Germany DDDA 1 17.50 17.50 17.50 17.50 17.50 0.0% 0.0% 100.0%   
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Benzylpenicillin + 
Dihydrostreptomycin 
(QJ01RA80) 
Parenteral Total DDDA 1 29.50 29.50 29.50 29.50 29.50 0.0% 0.0% 100.0% 29.5 
LA 
Factor 
  3.00 3.00 3.00 3.00 3.00     100.0%   
France DDDA 1 29.50 29.50 29.50 29.50 29.50 0.0% 0.0% 100.0%   
Benzylpenicillin procaine 
(QJ01RA01) 
Parenteral Total DDDA 8 15.83 17.50 20.00 9.00 20.00 50.0% 37.5% 222.2% 47.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 3 12.53 12.60 10.00 10.00 15.00 100.0% 0.0% 150.0%   
Germany DDDA 3 16.33 20.00 20.00 9.00 20.00 66.7% 33.3% 222.2%   
Sweden DDDA 2 20.00 20.00 20.00 20.00 20.00 0.0% 66.7% 100.0%   
Benzylpenicillin procaine + 
Benzylpenicillin-Benzathine + 
Dihydrostreptomycin 
(QJ01RA97) 
 
Parenteral Total DDDA 1 16.09 16.09 16.09 16.09 16.09 0.0% 0.0% 100.0% 16.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 16.09 16.09 16.09 16.09 16.09 0.0% 0.0% 100.0%   
Benzylpenicillin procaine + 
Benzylpenicillin-Benzathine + 
Dihydrostreptomycin LA 
(QJ01RA97) 
 
 
Parenteral Total DDDA 1 27.25 27.25 27.25 27.25 27.25 0.0% 0.0% 100.0% 54.5 
  LA 
Factor 
  2.00 2.00 2.00 2.00 2.00     100.0%   
Germany DDDA 1 27.25 27.25 27.25 27.25 27.25 0.0% 0.0% 100.0%   
Benzylpenicillin procaine + 
Dexamethasone + 
Dihydrostreptomycine 
(QJ01RV01) 
Parenteral Total DDDA 2 26.27 26.27 25.48 25.48 27.05 0.0% 0.0% 106.2% 105.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 26.27 26.27 25.48 25.48 27.05 0.0% 0.0% 106.2%   
Benzylpenicillin procaine + 
Dihydrostreptomycine 
(QJ01RA01) 
Parenteral Total DDDA 7 36.05 36.61 34.75 22.00 45.00 14.3% 28.6% 204.5% 144.2 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 3 36.25 34.75 34.75 34.75 39.25 0.0% 0.0% 112.9%   
Germany DDDA 2 29.31 29.31 22.00 22.00 36.61 50.0% . 166.4%   
Sweden DDDA 2 42.50 42.50 40.00 40.00 45.00 0.0% 100.0% 112.5%   
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Benzylpenicillin sodium 
(QJ01CE01) 
Parenteral Total DDDA 1 12.00 12.00 12.00 12.00 12.00 0.0% 0.0% 100.0% 36.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 1 12.00 12.00 12.00 12.00 12.00 0.0% 0.0% 100.0%   
Cefquinome 
(QJ01DE90) 
Parenteral Total DDDA 4 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0% 8.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0%   
France DDDA 1 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0%   
Germany DDDA 2 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0%   
Ceftiofur 
(QJ01DD90) 
 
 
 
 
 
 
 
 
 
Parenteral Total DDDA 33 3.00 3.00 3.00 3.00 3.00 0.0% 0.0% 100.0% 9.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 10 3.00 3.00 3.00 3.00 3.00 0.0% 0.0% 100.0%   
France DDDA 9 3.00 3.00 3.00 3.00 3.00 0.0% 0.0% 100.0%   
Germany DDDA 12 3.00 3.00 3.00 3.00 3.00 0.0% 0.0% 100.0%   
Sweden DDDA 2 3.00 3.00 3.00 3.00 3.00 0.0% 0.0% 100.0%  
Ceftiofur LA 
(QJ01DD90) 
 
 
 
 
 
 
 
Parenteral Total DDDA 3 5.00 5.00 5.00 5.00 5.00 0.0% 0.0% 100.0% 5.0 
LA 
Factor 
  5.00 5.00 5.00 5.00 5.00     100.0%   
Belgium DDDA 1 5.00 5.00 5.00 5.00 5.00 0.0% 0.0% 100.0%   
France DDDA 1 5.00 5.00 5.00 5.00 5.00 0.0% 0.0% 100.0%   
Germany DDDA 1 5.00 5.00 5.00 5.00 5.00 0.0% 0.0% 100.0%   
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Chlortetracycline 
(QJ01AA03) 
 
 
 
 
 
 
 
 
 
(QD06AA03) 
 
 
 
 
 
 
 
 
 
 
(S01AA02) 
Feed/Water 
Total 
DDDA 15 51.67 50.00 50.00 15.00 85.00 26.7% 40.0% 566.7% 258.4 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 15.00 15.00 15.00 15.00 15.00 100.0% 0.0% 100.0%   
France DDDA 5 50.00 50.00 50.00 50.00 50.00 0.0% 0.0% 100.0%   
Germany DDDA 7 64.29 60.00 60.00 40.00 85.00 14.3% 85.7% 212.5%   
Sweden DDDA 2 30.00 30.00 25.00 25.00 35.00 100.0% 0.0% 140.0%   
Topical Total DDDA 7 49.67 42.39 33.15 33.15 83.33 71.4% 28.6% 251.4% 99.3 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 2 62.97 62.97 42.60 42.60 83.33 50.0% 50.0% 195.6%   
France DDDA 2 37.77 37.77 33.15 33.15 42.39 100.0% 0.0% 127.9%   
Germany DDDA 2 36.35 36.35 35.66 35.66 37.04 100.0% 0.0% 103.9%   
Sweden DDDA 1 73.50 73.50 73.50 73.50 73.50 0.0% 100.0% 100.0%   
Topical eye Total DDDA 1 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0% 210.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 1 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0%   
Chlortetracycline + 
Sulfamethoxy-pyridazine 
(QJ01DD90) 
Feed/Water Total DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0% 160.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0%   
Chlortetracycline + Sulfanilamide 
(QD06AA52) 
 
 
 
 
Topical Total DDDA 1 380.18 380.18 380.18 380.18 380.18 0.0% 0.0% 100.0% 380.2 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 380.18 380.18 380.18 380.18 380.18 0.0% 0.0% 100.0%   
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Colistin 
(QA07AA10) 
Feed/Water 
Total 
DDDA 41 5.02 5.00 5.00 3.34 7.50 2.4% 2.4% 224.6% 30.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 8 4.99 4.90 4.88 4.88 5.46 0.0% 0.0% 111.9%   
France DDDA 15 4.89 5.00 5.00 3.34 5.00 6.7% 0.0% 149.7%   
Germany DDDA 17 4.99 5.00 5.00 4.88 5.00 0.0% 0.0% 102.5%   
Sweden DDDA 1 7.50 7.50 7.50 7.50 7.50 0.0% 100.0% 100.0%   
Oral Total DDDA 4 5.35 5.00 5.00 5.00 6.40 0.0% 25.0% 128.0% 26.8 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 6.40 6.40 6.40 6.40 6.40 0.0% 100.0% 100.0%   
France DDDA 1 5.00 5.00 5.00 5.00 5.00 100.0% 0.0% 100.0%   
Germany DDDA 2 5.00 5.00 5.00 5.00 5.00 100.0% 0.0% 100.0%   
Parenteral Total DDDA 8 2.63 2.50 2.50 2.50 3.00 0.0% 12.5% 120.0% 13.2 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 2 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0%   
France DDDA 3 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0%   
Germany DDDA 3 2.83 2.75 2.75 2.75 3.00 0.0% 33.3% 109.1%   
Colistin + Amoxicillin 
(QJ01RA01) 
Parenteral Total DDDA 1 11.04 11.04 11.04 11.04 11.04 0.0% 0.0% 100.0% 44.2 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 11.04 11.04 11.04 11.04 11.04 0.0% 0.0% 100.0%   
Colistin + Ampicillin 
(QJ01RV01) 
Parenteral Total DDDA 6 22.50 22.50 22.50 22.50 22.50 0.0% 0.0% 100.0% 67.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 6 22.50 22.50 22.50 22.50 22.50 0.0% 0.0% 100.0%   
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Colistin + Benzylpenicillin 
(QJ01RA01) 
 
 
 
 
 
 
Parenteral Total DDDA 1 34.00 34.00 34.00 34.00 34.00 0.0% 0.0% 100.0% 102.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 34.00 34.00 34.00 34.00 34.00 0.0% 0.0% 100.0%  
Colistin + Dexamethasone + 
Ampicillin 
(QJ01RV01) 
Parenteral Total DDDA 2 21.20 21.20 19.90 19.90 22.50 0.0% 0.0% 113.1% 63.6 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 21.20 21.20 19.90 19.90 22.50 0.0% 0.0% 113.1%   
Colistin + Erythromycin 
(QJ51RF02) 
Feed/Water Total DDDA 2 26.80 26.80 26.80 26.80 26.80 0.0% 0.0% 100.0% 80.4 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 26.80 26.80 26.80 26.80 26.80 0.0% 0.0% 100.0%   
Colistin + Neomycin 
(QA07AA51) 
Feed/Water Total DDDA 1 23.58 23.58 23.58 23.58 23.58 0.0% 0.0% 100.0% 70.7 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 23.58 23.58 23.58 23.58 23.58 0.0% 0.0% 100.0%   
Colistin + Sulfaguanidine 
(QA07AA99) 
Oral Total DDDA 1 62.50 62.50 62.50 62.50 62.50 0.0% 0.0% 100.0% 125.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 62.50 62.50 62.50 62.50 62.50 0.0% 0.0% 100.0%   
Colistin + Trimethoprim 
(QA07AA99) 
Feed/Water Total DDDA 1 14.17 14.17 14.17 14.17 14.17 0.0% 0.0% 100.0% 42.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 14.17 14.17 14.17 14.17 14.17 0.0% 0.0% 100.0%   
Colistin + Zinc oxide 
(QA07AA10) 
Feed/Water Total DDDA 1 101.00 101.00 101.00 101.00 101.00 0.0% 0.0% 100.0% 707.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 101.00 101.00 101.00 101.00 101.00 0.0% 0.0% 100.0%   
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Danofloxacin 
(QJ01MA92) 
 
 
 
 
 
 
 
Parenteral Total DDDA 3 1.25 1.25 1.25 1.25 1.25 0.0% 0.0% 100.0% 3.8 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 1.25 1.25 1.25 1.25 1.25 0.0% 0.0% 100.0%   
France DDDA 1 1.25 1.25 1.25 1.25 1.25 0.0% 0.0% 100.0%   
Germany DDDA 1 1.25 1.25 1.25 1.25 1.25 0.0% 0.0% 100.0%   
Dihydrostreptomycine 
(QA07AA90) 
Feed/Water Total DDDA 2 62.50 62.50 50.00 50.00 75.00 50.0% 50.0% 150.0% 250.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 62.50 62.50 50.00 50.00 75.00 50.0% 50.0% 150.0%   
Oral Total DDDA 1 25.00 25.00 25.00 25.00 25.00 0.0% 0.0% 100.0% 75.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 1 25.00 25.00 25.00 25.00 25.00 0.0% 0.0% 100.0%   
Doxycycline 
(QJ01AA02) 
Feed/Water Total DDDA 32 11.54 10.00 10.00 10.00 20.00 59.4% 9.4% 200.0% 57.7 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 11 10.50 10.00 10.00 10.00 12.50 72.7% 0.0% 125.0%   
France DDDA 11 11.41 10.00 10.00 10.00 20.00 63.6% 9.1% 200.0%   
Germany DDDA 8 13.23 11.65 10.00 10.00 20.00 37.5% 25.0% 200.0%   
Sweden DDDA 2 11.25 11.25 10.00 10.00 12.50 50.0% 0.0% 125.0%   
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Enrofloxacin 
(QJ01MA90) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feed/Water Total DDDA 1 1.70 1.70 1.70 1.70 1.70 0.0% 0.0% 100.0% 5.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 1.70 1.70 1.70 1.70 1.70 0.0% 0.0% 100.0%   
Oral Total DDDA 5 1.85 1.70 1.70 1.70 2.46 0.0% 20.0% 144.7% 7.3 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 2.46 2.46 2.46 2.46 2.46 0.0% 100.0% 100.0%   
Germany DDDA 4 1.70 1.70 1.70 1.70 1.70 0.0% 0.0% 100.0%   
Parenteral Total DDDA 38 2.76 2.50 2.50 2.50 3.75 0.0% 21.1% 150.0% 8.3 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 7 3.39 3.75 3.75 2.50 3.75 0.0% 71.4% 150.0%   
France DDDA 8 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0%   
Germany DDDA 20 2.63 2.50 2.50 2.50 3.75 0.0% 10.0% 150.0%   
Sweden DDDA 3 2.92 2.50 2.50 2.50 3.75 0.0% 33.3% 150.0%   
Enrofloxacin LA 
(QJ01MA90) 
Parenteral Total DDDA 2 7.50 7.50 7.50 7.50 7.50 0.0% 0.0% 100.0% 15.0 
LA 
Factor 
  1.50 1.50 1.50 1.50 1.50     100.0%   
Belgium DDDA 1 7.50 7.50 7.50 7.50 7.50 0.0% 0.0% 100.0%   
Germany DDDA 1 7.50 7.50 7.50 7.50 7.50 0.0% 0.0% 100.0%   
Erythromycin 
(QJ/01/F/A/01) 
Parenteral Total DDDA 2 21.00 21.00 20.00 20.00 22.00 0.0% 0.0% 110.0% 63.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Germany DDDA 1 22.00 22.00 22.00 22.00 22.00 0.0% 0.0% 100.0%   
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Florfenicol 
(QJO1BA90) 
Feed/Water Total DDDA 6 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0% 50.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 3 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
France DDDA 1 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
Germany DDDA 2 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
Florfenicol LA 
(QJO1BA90) 
Parenteral Total DDDA 24 15.31 15.00 15.00 15.00 22.50 0.0% 4.2% 150.0% 30.6 
LA 
Factor 
  2.00 2.00 2.00 2.00 2.00     100.0%   
Belgium DDDA 8 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
France DDDA 8 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Germany DDDA 7 16.07 15.00 15.00 15.00 22.50 0.0% 14.3% 150.0%   
Sweden DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Flumequine 
(QJ01MB07) 
Feed/Water Total DDDA 2 13.50 13.50 12.00 12.00 15.00 50.0% 50.0% 125.0% 54.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 100.0% 100.0%   
France DDDA 1 12.00 12.00 12.00 12.00 12.00 100.0% 0.0% 100.0%   
Formosulfathiazole 
(QA07AB90) 
 
 
 
 
 
Oral Total DDDA 3 141.67 150.00 150.00 125.00 150.00 33.3% 0.0% 120.0% 566.7 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 3 141.67 150.00 150.00 125.00 150.00 33.3% 0.0% 120.0%   
Gentamicin 
(QJ01GB03) 
Parenteral Total DDDA 8 7.65 8.00 8.00 4.00 10.00 25.0% 25.0% 250.0% 30.6 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 10.00 10.00 10.00 10.00 10.00 0.0% 100.0% 100.0%   
Germany DDDA 7 7.31 8.00 8.00 4.00 8.80 28.6% 14.3% 220.0%   
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Kanamycin 
(QJ01GB04) 
Parenteral Total DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0% 45.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Lincomycin 
(QJ01FF02) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feed/Water Total DDDA 7 6.74 5.00 4.75 2.20 15.00 71.4% 28.6% 681.8% 47.2 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 10.00 10.00 10.00 10.00 10.00 0.0% 100.0% 100.0%   
France DDDA 3 4.23 5.00 2.20 2.20 5.50 100.0% 0.0% 250.0%   
Germany DDDA 3 8.17 4.75 4.75 4.75 15.00 66.7% 33.3% 315.8%   
Parenteral Total DDDA 11 10.45 10.00 10.00 10.00 15.00 0.0% 9.1% 150.0% 41.8 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 3 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
France DDDA 1 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
Germany DDDA 6 10.83 10.00 10.00 10.00 15.00 0.0% 16.7% 150.0%   
Sweden DDDA 1 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
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Lincomycin + Spectinomycin 
(QA07AA99) 
Feed/Water Total DDDA 13 6.23 6.24 3.30 3.30 10.00 46.2% 38.5% 303.0% 81.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 5 6.35 6.24 4.00 4.00 10.00 40.0% 40.0% 250.0%   
France DDDA 3 4.40 3.30 3.30 3.30 6.60 66.7% 0.0% 200.0%   
Germany DDDA 5 7.22 7.50 4.40 4.40 9.90 40.0% 60.0% 225.0%   
Parenteral Total DDDA 6 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0% 60.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 3 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
France DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Germany DDDA 2 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Marbofloxacin 
(QJ01MA93) 
Parenteral Total DDDA 21 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0% 6.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 7 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0%   
France DDDA 6 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0%   
Germany DDDA 8 2.00 2.00 2.00 2.00 2.00 0.0% 0.0% 100.0%   
Marbofloxacin LA 
(QJ01MA93) 
 
 
 
Parenteral Total DDDA 1 8.00 8.00 8.00 8.00 8.00 0.0% 0.0% 100.0% 8.0 
LA 
Factor 
  2.00 2.00 2.00 2.00 2.00     100.0%   
France DDDA 1 8.00 8.00 8.00 8.00 8.00 0.0% 0.0% 100.0%   
Neomycin 
(QA07AA01) 
Feed/Water Total DDDA 10 20.31 25.00 10.00 10.00 33.25 40.0% 60.0% 332.5% 81.2 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 6 27.18 26.60 26.60 25.00 33.25 0.0% 100.0% 133.0%   
Germany DDDA 4 10.00 10.00 10.00 10.00 10.00 100.0% 0.0% 100.0%   
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Oral Total DDDA 1 85.00 85.00 85.00 85.00 85.00 0.0% 0.0% 100.0% 255.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 1 85.00 85.00 85.00 85.00 85.00 0.0% 0.0% 100.0%   
Topical Total DDDA 1 14.00 14.00 14.00 14.00 14.00 0.0% 0.0% 100.0% 28.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 14.00 14.00 14.00 14.00 14.00 0.0% 0.0% 100.0%   
Oxolinic acid 
(QJ01MB050 
 
 
 
 
 
 
 
 
 
Feed/Water Total DDDA 2 17.50 17.50 15.00 15.00 20.00 50.0% 50.0% 133.3% 87.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 17.50 17.50 15.00 15.00 20.00 50.0% 50.0% 133.3%   
Oral Total DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0% 80.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0%   
Oxytetracycline 
(QJ01AA06) 
 
 
 
 
 
 
 
 
 
(QG01AA07) 
 
 
 
 
 
 
 
Feed/Water Total DDDA 19 35.66 27.50 20.00 20.00 100.00 57.9% 42.1% 500.0% 214.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 3 35.83 30.00 27.50 27.50 50.00 66.7% 33.3% 181.8%   
France DDDA 14 30.71 20.00 20.00 20.00 50.00 64.3% 35.7% 250.0%   
Germany DDDA 1 100.00 100.00 100.00 100.00 100.00 0.0% 100.0% 100.0%   
Sweden DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 100.0% 100.0%   
Intrauterine 
 
 
 
 
 
 
 
Total DDDA 1 10.91 10.91 10.91 10.91 10.91 0.0% 0.0% 100.0% 32.7 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 
1 10.91 10.91 10.91 10.91 10.91 0.0% 0.0% 100.0%   
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(QJ01AA06) 
 
 
 
 
 
 
 
(QD06AA03) 
Parenteral 
Total 
DDDA 8 8.44 7.50 7.50 7.50 10.00 62.5% 37.5% 133.3% 33.8 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 2 10.00 10.00 10.00 10.00 10.00 100.0% 0.0% 100.0%   
France DDDA 5 7.50 7.50 7.50 7.50 7.50 100.0% 0.0% 100.0%   
Sweden DDDA 1 10.00 10.00 10.00 10.00 10.00 0.0% 100.0% 100.0%   
Topical Total DDDA 4 86.33 84.38 69.45 69.45 107.10 50.0% 25.0% 154.2% 172.7 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 75.00 75.00 75.00 75.00 75.00 100.0% 0.0% 100.0%   
France DDDA 1 93.75 93.75 93.75 93.75 93.75 0.0% 0.0% 100.0%   
Germany DDDA 1 69.45 69.45 69.45 69.45 69.45 100.0% 0.0% 100.0%   
Sweden DDDA 1 107.10 107.10 107.10 107.10 107.10 0.0% 100.0% 100.0%   
Oxytetracycline + Neomycin 
(QA07AA51) 
Feed/Water Total DDDA 2 36.37 36.37 32.73 32.73 40.00 50.0% 0.0% 122.2% 181.9 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 36.37 36.37 32.73 32.73 40.00 50.0% 0.0% 122.2%   
Oxytetracycline + Spiramycin 
(QJ01RA04) 
 
 
 
 
 
Feed/Water Total DDDA 1 35.50 35.50 35.50 35.50 35.50 0.0% 0.0% 100.0% 142.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 35.50 35.50 35.50 35.50 35.50 0.0% 0.0% 100.0%   
Oxytetracycline + Sulfamidine 
(QJ01AA56) 
Feed/Water Total DDDA 1 144.00 144.00 144.00 144.00 144.00 0.0% 0.0% 100.0% 1008.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 144.00 144.00 144.00 144.00 144.00 0.0% 0.0% 100.0%   
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Oxytetracycline LA 
(QA07AA51) 
Intrauterine Total DDDA 1 2.72 2.72 2.72 2.72 2.72 0.0% 0.0% 100.0% 2.72 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 1 2.72 2.72 2.72 2.72 2.72 0.0% 0.0% 100.0%   
Parenteral Total DDDA 25 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0% 20.0 
LA 
Factor 
  2.70 2.70 2.70 2.70 2.70     100.0%   
Belgium DDDA 9 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
France DDDA 6 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Germany DDDA 9 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Sweden DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Paromomycin 
(QA07AA06) 
Feed/Water Total DDDA 1 32.50 32.50 32.50 32.50 32.50 0.0% 0.0% 100.0% 130.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 32.50 32.50 32.50 32.50 32.50 0.0% 0.0% 100.0%   
Parenteral Total DDDA 1 19.25 19.25 19.25 19.25 19.25 0.0% 0.0% 100.0% 77.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 19.25 19.25 19.25 19.25 19.25 0.0% 0.0% 100.0%   
Spectinomycin 
(QJ01XX04) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oral Total DDDA 2 95.00 95.00 40.00 40.00 150.00 50.0% 50.0% 375.0% 380.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 40.00 40.00 40.00 40.00 40.00 100.0% 0.0% 100.0%   
Germany DDDA 1 150.00 150.00 150.00 150.00 150.00 0.0% 100.0% 100.0%   
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Parenteral Total DDDA 3 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0% 120.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0%   
France DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0%   
Germany DDDA 1 40.00 40.00 40.00 40.00 40.00 0.0% 0.0% 100.0%   
Spiramycin 
(QJ01FA02) 
Feed/Water Total DDDA 2 21.88 21.88 12.50 12.50 31.25 50.0% 50.0% 250.0% 196.9 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 21.88 21.88 12.50 12.50 31.25 50.0% 50.0% 250.0%   
Parenteral Total DDDA 3 20.50 23.25 23.25 15.00 23.25 33.3% 66.7% 155.0% 61.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 23.25 23.25 23.25 23.25 23.25 0.0% 100.0% 100.0%   
Sweden DDDA 1 15.00 15.00 15.00 15.00 15.00 100.0% 0.0% 100.0%   
Sulfadimethoxine 
(QJ01EQ09) 
Feed/Water Total DDDA 2 48.35 48.35 46.70 46.70 50.00 0.0% 0.0% 107.1% 338.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 48.35 48.35 46.70 46.70 50.00 0.0% 0.0% 107.1%   
Parenteral Total DDDA 1 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0% 90.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0%   
Sulfadimidine 
(QJ01EQ03) 
Feed/Water Total DDDA 12 77.08 75.00 75.00 50.00 100.00 8.3% 16.7% 200.0% 462.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 50.00 50.00 50.00 50.00 50.00 100.0% 0.0% 100.0%   
Germany DDDA 11 79.55 75.00 75.00 75.00 100.00 0.0% 18.2% 133.3%   
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Parenteral Total DDDA 3 82.10 91.41 62.50 75.00 92.40 33.3% 0.0% 147.8% 328.4 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 91.91 91.91 91.41 91.41 92.40 0.0% 0.0% 101.1%   
Germany DDDA 1 75.00 75.00 75.00 75.00 75.00 100.0% 0.0% 100.0%   
Sulfaguanidine 
(QA07AB20) 
Feed/Water Total DDDA 1 54.00 54.00 54.00 54.00 54.00 0.0% 0.0% 100.0% 216.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 54.00 54.00 54.00 54.00 54.00 0.0% 0.0% 100.0%   
Sulfaguanidind + Sulfadimidine 
(QA07AB20) 
 
 
Feed/Water Total DDDA 2 99.20 99.20 38.40 38.40 160.00 50.0% 50.0% 416.7% 297.6 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 99.20 99.20 38.40 38.40 160.00 50.0% 50.0% 416.7%   
Sulfamethoxypyridazine 
(QJ01EQ15) 
Parenteral Total DDDA 3 59.17 62.50 40.00 40.00 75.00 33.3% 33.3% 187.5% 295.9 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 2 40.00 40.00 40.00 40.00 40.00 100.0% 0.0% 100.0%   
Germany DDDA 1 68.75 68.75 62.50 62.50 75.00 0.0% 50.0% 120.0%   
Tetracycline 
(QJ01AA07) 
Feed/Water Total DDDA 6 52.92 53.75 85.00 20.00 85.00 50.0% 50.0% 425.0% 264.6 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 22.50 22.50 22.50 22.50 22.50 100.0% 0.0% 100.0%   
Germany DDDA 5 59.00 85.00 85.00 20.00 85.00 40.0% 60.0% 425.0%   
Thiamphenicol 
(QD06AX) 
Topical Total DDDA 1 75.00 75.00 75.00 75.00 75.00 0.0% 0.0% 100.0% 150.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 75.00 75.00 75.00 75.00 75.00 0.0% 0.0% 100.0%   
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Tiamulin 
QJ01XQ01) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feed/Water Total DDDA 29 7.80 8.80 8.80 1.60 10.00 20.7% 58.6% 625.0% 78.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 5 7.99 8.80 8.80 4.75 8.80 20.0% 80.0% 185.3%   
France DDDA 9 6.09 6.08 8.80 1.60 8.80 55.6% 22.2% 550.0%   
Germany DDDA 13 8.92 9.00 9.00 7.30 10.00 0.0% 84.6% 137.0%   
Sweden DDDA 2 7.75 7.75 7.50 7.50 8.00 0.0% 0.0% 106.7%   
Parenteral Total DDDA 7 9.26 8.10 8.10 8.00 12.50 57.1% 14.3% 156.3% 18.5 
LA 
Factor 
2 1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 2 8.05 8.05 8.00 8.00 8.10 100.0% 0.0% 101.3%   
France DDDA 2 9.05 9.05 8.10 8.10 10.00 50.0% 0.0% 123.5%   
Germany DDDA 2 10.30 10.30 8.10 8.10 12.50 50.0% 50.0% 154.3%   
Sweden DDDA 1 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
Tildipirosin 
(QJ01FA) 
Parenteral Total DDDA 3 4.00 4.00 4.00 4.00 4.00 0.0% 0.0% 100.0% 4.0 
LA 
Factor 
  9.30 9.30 9.30 9.30 9.30     100.0%   
Belgium DDDA 1 4.00 4.00 4.00 4.00 4.00 0.0% 0.0% 100.0%   
France DDDA 1 4.00 4.00 4.00 4.00 4.00 0.0% 0.0% 100.0%   
Germany DDDA 1 4.00 4.00 4.00 4.00 4.00 0.0% 0.0% 100.0%   
Tilmicosin 
(QJ01FA91) 
Feed/Water Total DDDA 14 14.55 14.85 12.00 12.00 17.50 42.9% 28.6% 145.8% 218.3 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 6 15.17 16.00 12.00 12.00 17.50 33.3% 33.3% 145.8%   
France DDDA 6 14.50 14.00 12.00 12.00 17.50 50.0% 33.3% 145.8%   
Germany DDDA 2 12.85 12.85 12.00 12.00 13.70 50.0% 0.0% 114.2%   
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Trimethoprim + Spiramycin 
(QJ01RA04) 
Feed/Water Total DDDA 1 41.00 41.00 41.00 41.00 41.00 0.0% 0.0% 100.0% 164.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 41.00 41.00 41.00 41.00 41.00 0.0% 0.0% 100.0%   
Trimethoprim + 
Sulfachlorpyridazin natrium 
(QJ01EW12) 
Feed/Water Total DDDA 1 24.00 24.00 24.00 24.00 24.00 0.0% 0.0% 100.0% 96.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 24.00 24.00 24.00 24.00 24.00 0.0% 0.0% 100.0%   
Trimethoprim + Sulfadiazine 
(QJ01EW10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feed/Water Total DDDA 22 29.82 30.00 30.00 22.50 35.00 9.1% 9.1% 155.6% 149.1 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 4 28.13 30.00 30.00 22.50 30.00 25.0% 0.0% 133.3%   
France DDDA 7 31.23 30.00 30.00 30.00 35.00 0.0% 28.6% 116.7%   
Germany DDDA 10 29.50 30.00 30.00 25.00 30.00 10.0% 0.0% 120.0%   
Sweden DDDA 1 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0%   
Parenteral Total DDDA 4 18.09 17.43 15.00 15.00 22.50 50.0% 25.0% 150.0% 90.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 15.00 15.00 15.00 15.00 15.00 100.0% 0.0% 100.0%   
France DDDA 1 16.10 16.10 16.10 16.10 16.10 100.0% 0.0% 100.0%   
Sweden DDDA 2 20.63 20.63 18.75 18.75 22.50 0.0% 50.0% 120.0%   
Trimethoprim + Sulfadimethoxine 
(QJ01EW09) 
Feed/Water Total DDDA 7 26.13 24.90 20.00 20.00 34.02 42.9% 42.9% 170.1% 130.7 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 4 30.74 32.01 34.02 24.90 34.02 0.0% 75.0% 136.6%   
Germany DDDA 3 20.00 20.00 20.00 20.00 20.00 100.0% 0.0% 100.0%   
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Parenteral Total DDDA 1 22.60 22.60 22.60 22.60 22.60 0.0% 0.0% 100.0% 67.8 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 22.60 22.60 22.60 22.60 22.60 0.0% 0.0% 100.0%   
Trimethoprim + Sulfadimidine 
(QJ01EW03) 
Parenteral Total DDDA 6 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0% 80.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Germany DDDA 6 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Trimethoprim + Sulfadoxine 
(QJ01EW13) 
Parenteral Total DDDA 10 17.97 16.10 15.00 15.00 25.00 50.0% 50.0% 166.7% 71.9 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 2 17.50 17.50 15.00 15.00 20.00 50.0% 50.0% 133.3%   
France DDDA 2 16.10 16.10 16.10 16.10 16.10 100.0% 0.0% 100.0%   
Germany DDDA 5 18.00 15.00 15.00 15.00 25.00 60.0% 40.0% 166.7%   
Sweden DDDA 1 22.50 22.50 22.50 22.50 22.50 0.0% 100.0% 100.0%   
Trimethoprim + 
Sulfamethoxazole 
(QJ01EW11) 
 
 
 
 
 
 
 
 
 
 
Feed/Water Total DDDA 2 25.00 25.00 25.00 25.00 25.00 0.0% 0.0% 100.0% 100.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 25.00 25.00 25.00 25.00 25.00 0.0% 0.0% 100.0%   
Germany DDDA 1 25.00 25.00 25.00 25.00 25.00 0.0% 0.0% 100.0%   
Parenteral Total DDDA 2 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0% 120.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 2 30.00 30.00 30.00 30.00 30.00 0.0% 0.0% 100.0%   
Trimethoprim + 
Sulfamethoxypyridazine 
(QJ01EW15) 
Feed/Water Total DDDA 1 28.24 28.24 28.24 28.24 28.24 0.0% 0.0% 100.0% 113.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 28.24 28.24 28.24 28.24 28.24 0.0% 0.0% 100.0%   
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Parenteral Total DDDA 1 16.00 16.00 16.00 16.00 16.00 0.0% 0.0% 100.0% 64.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
France DDDA 1 16.00 16.00 16.00 16.00 16.00 0.0% 0.0% 100.0%   
Tulathromycin LA 
(QJ01FA94) 
Parenteral Total DDDA 4 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0% 2.5 
LA 
Factor 
  7.00 7.00 7.00 7.00 7.00     100.0%   
Belgium DDDA 1 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0%   
France DDDA 1 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0%   
Germany DDDA 1 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0%   
Sweden DDDA 1 2.50 2.50 2.50 2.50 2.50 0.0% 0.0% 100.0%   
Tylosin 
(QJ01FA90) 
Feed/Water Total DDDA 33 14.88 7.50 5.00 4.50 45.00 57.6% 36.4% 1000.0% 163.7 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 7 11.00 5.00 4.50 4.50 45.00 85.7% 14.3% 1000.0%   
France DDDA 10 18.76 25.00 25.00 5.00 25.00 20.0% 60.0% 500.0%   
Germany DDDA 13 15.69 7.50 30.00 5.00 30.00 61.5% 38.5% 600.0%   
Sweden DDDA 3 7.50 7.50 7.50 7.50 7.50 100.0% 0.0% 100.0%   
Parenteral Total DDDA 9 10.39 10.00 10.00 6.00 20.00 22.2% 11.1% 333.3% 52.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 7.50 7.50 7.50 7.50 7.50 100.0% 0.0% 100.0%   
France DDDA 1 6.00 6.00 6.00 6.00 6.00 100.0% 0.0% 100.0%   
Germany DDDA 6 10.00 10.00 10.00 10.00 10.00 0.0% 0.0% 100.0%   
Sweden DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 100.0% 100.0%   
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Tylosin + Oxytetracycline 
(QJ01FA90) 
 
 
 
 
Feed/Water Total DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0% 105.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 15.00 15.00 15.00 15.00 15.00 0.0% 0.0% 100.0%   
Tylosin LA 
(QJ01FA90) 
Parenteral Total DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0% 20.0 
LA 
Factor 
  2.00 2.00 2.00 2.00 2.00     100.0%   
Germany DDDA 1 20.00 20.00 20.00 20.00 20.00 0.0% 0.0% 100.0%   
Tylvalosin 
(QJ01FA92) 
Feed/Water Total DDDA 11 4.10 4.25 4.25 3.19 5.00 27.3% 18.2% 156.7% 36.9 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 2 4.63 4.63 4.25 4.25 5.00 0.0% 50.0% 117.6%   
France DDDA 4 3.64 3.19 3.19 3.19 5.00 75.0% 25.0% 156.7%   
Germany DDDA 3 4.25 4.25 4.25 4.25 4.25 0.0% 0.0% 100.0%   
Sweden DDDA 2 4.25 4.25 4.25 4.25 4.25 0.0% 0.0% 100.0%   
Valnemulin 
(QJ01XQ02) 
Feed/Water Total DDDA 3 3.50 3.50 3.50 3.50 3.50 0.0% 0.0% 100.0% 45.5 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Belgium DDDA 1 3.50 3.50 3.50 3.50 3.50 0.0% 0.0% 100.0%   
Germany DDDA 1 3.50 3.50 3.50 3.50 3.50 0.0% 0.0% 100.0%   
Sweden DDDA 1 3.50 3.50 3.50 3.50 3.50 0.0% 0.0% 100.0%   
Zincoxide 
(QA07XA91) 
Feed/Water Total DDDA 1 2.500.00 2.500.00 2.500.00 2.500.00 2.500.00 0.0% 0.0% 100.0% 35000.0 
LA 
Factor 
  1.00 1.00 1.00 1.00 1.00     100.0%   
Sweden DDDA 1 2.500.00 2.500.00 2.500.00 2.500.00 2.500.00 0.0% 0.0% 100.0%   
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ABSTRACT 
Objectives & Methods 
Nineteen alternatives to antimicrobial (AM) agents were ranked on perceived effectiveness, feasibility 
and return on investment (ROI) from 0 (not effective, not feasible, no ROI) to 10 (fully effective, 
completely feasible, maximum ROI) by 111 pig health experts from Belgium, Denmark, France, 
Germany, Sweden and Switzerland.  
Results 
The top 5 measures in terms of perceived effectiveness were (1) improved internal biosecurity, (2) 
improved external biosecurity, (3) improved climate/environmental conditions, (4) high 
health/Specific Pathogen Free/disease eradication and (5) increased vaccination. The top 5 measures 
in terms of perceived feasibility were (1) increased vaccination, (2) increased use of anti-inflammatory 
products, (3) improved water quality, (4) feed quality/optimization and (5) use of zinc/metals. The top 
5 measures in terms of perceived ROI were (1) improved internal biosecurity, (2) zinc/metals, (3) 
diagnostics/action plan, (4) feed quality/optimization and (5) climate/environmental improvements. 
Univariate linear regression showed that veterinary practitioners rank internal biosecurity, 
vaccination, use of zinc/metals, feed quality optimization and climate/environmental on average 
highest, while researchers and professors focused more on increased use of diagnostics and action 
plans. Financial incentives/penalties ranked low in all countries. Belgian respondents ranked feed 
quality significantly lower compared to the German respondents while reduction of stocking density 
was ranked higher in Belgium compared to Denmark. Categorical principal component analysis applied 
to the average ranking supported the finding that veterinary practitioners had a preference for more 
practical, common and already known alternatives.  
Conclusion 
The results showed that improvements in biosecurity, increased use of vaccination, use of zinc/metals, 
feed quality improvement and regular diagnostic testing combined with a clear action plan were 
perceived to be the most promising alternatives to AMs in industrial pig production based on combined 
effectiveness, feasibility and ROI. 
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INTRODUCTION 
Antimicrobials (AMs) are commonly used in pig production, often to treat important bacterial 
infections caused by for example Escherichia coli, Streptococcus suis, Mycoplasma hyopneumoniae and 
brachyspira, or as a preventive measure against primary or secondary bacterial infections as such 
(Schwarz et al., 2001; Callens et al., 2012b; Callens et al., 2012c; Post, 2012; Varela et al., 2013; Burow 
et al., 2014; van Duijkeren et al., 2014). Reduced AMU in livestock is widely discussed and highly 
promoted in Europe and worldwide as a public health measure to reduce antimicrobial resistance 
(AMR) (ECDC and EMA, 2009; CDC, 2015; ECDC/EFSA/EMA, 2015). However, to assure animal health, 
welfare and economic viability, effective and efficient alternatives are necessary. In the literature, 
many alternatives to AMU have been described. Seal et al. (2013) provided a summary of options 
which include AM peptides, pre- and probiotics, feed additives such as enzymes, phytogenic feed 
additives, immunity stimulants and vaccines. Cheng et al. (2014) recently reviewed the development 
and application of alternatives to antibiotics. 
Pre- and probiotics were tested in broilers with positive results on production performance, while 
increasing at the same time the caecal beneficial bacteria and fatty acids (Mookiah et al., 2014). 
Probiotics proved furthermore capable of altering the presence of pro-inflammatory cytokines and 
chemokines in vitro or the gut microbiota in live pigs (Badia et al., 2012). This subsequently improved 
the gut health and thus served as an alternative to AM agents (Bhandari et al., 2008; Hermes et al., 
2009; Jacela et al., 2010; Badia et al., 2012; Upadrasta et al., 2013). Intestinal bacterial diversity could 
also be improved by using fermented feed (Niba et al., 2009; Tajima et al., 2009). Other feed additives 
that influence the immune response, the microbiome or that show antibacterial effects such as some 
phytotherapeutics are suggested to be alternatives to AM agents as well (Jacela et al., 2010; Ohno et 
al., 2012; Chu et al., 2013). Improved feeding strategies and the use of organic acids related to pig 
health are described by Heo et al. (2012) and Visscher et al. (2008) amongst others. Dietary modulation 
of host defence peptides by short- and medium-chain fatty acids (e.g. butyric acid) is another promising 
feed related alternative to AM agents (Zeng et al., 2013).  
Not only additives to feed or acidification of feed, but also the acidification or disinfection of drinking 
water are potential alternatives to AM agents (Venkitanarayanan et al., 1999). A review by Knoll and 
Mylonakis (2013) and a comment by Henein (2013), as well as Seal et al. (2013) mention the potential 
of bacteriophages as an alternative in the treatment of bacterial infections including multi-drug-
resistant organisms (Heo et al., 2012). Metals such as copper and zinc are mentioned as potential 
alternatives in the literature too. They have been allowed as a (prescription) medicine in piglet feed in 
some European Union countries for several years, while in other EU countries is it not tolerated due to 
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legal differences (Smith et al., 1998; Fard et al., 2010; Pérez et al., 2010; Mavromichalis, 2011; 
European Food Safety Authority (EFSA) panel on Additives Products or Substances used in Animal Feed 
(FEEDAP), 2012; AMCRA, 2014c). Thacker (2013) addresses less traditional alternatives such as rare 
earth elements, clay minerals, AM peptides or essential oils and subsequently highlights the 
inconsistent results and the inferior effectiveness compared to AM agents of the majority of these 
compounds.  
Vaccination can also be seen as an alternative to AM agents, because it should reduce infection 
pressure and increases immunity. Therefore, vaccination may improve the overall health status of the 
pig while lowering the risk of (secondary) infection. Several studies confirm the reduction of AMU after 
vaccination (Adam, 2009; Brockhoff et al., 2009; Aerts and Wertenbroek, 2011; Bak, 2011; Bak et al., 
2011; Coube et al., 2012; Koenders and Wertenbroek, 2012; Tebar et al., 2012). 
Laanen et al. (2013) found a positive association between biosecurity, production parameters and 
AMU. She also described that farmers perceived biosecurity as a tool to reduce disease (Laanen et al., 
2014). 
Hygienic and other general management measures can also play a role in the optimization of the health 
status of a herd, indirectly lowering the necessity of AM agents (Zimmermann et al., 1989). In a similar 
way, disease prevention through optimization of the climate and housing conditions of the pig can lead 
to a lower AMU (Dee et al., 2012).  
Benchmarking and communicative advisory tools can be seen as alternatives to AMU since they 
highlight problem areas at the farm and help farmers in the optimization of the herd together with 
reducing AMU (Bak, 2011; Flipsen and van Eijden, 2011; Bundgaard et al., 2012; Janssen, 2012; Postma 
et al., 2012; Laanen et al., 2013; MARAN et al., 2014). Implementation of financial penalties for high 
AM users is discussed in several countries as a method to reduce AMU (Beemer et al., 2010; 
Boerenbond, 2014; Koeleman, 2014; Veterinary Ireland, 2014).  
Use of genetically enhanced, high-resistance breeds or efforts towards eradication of diseases might 
also play a role in serving as alternatives to high usage of AM agents in pig production (Grol et al., 1990; 
Maes et al., 2007; Doeschl-Wilson et al., 2009; Opriessnig et al., 2009; Lunney and Chen, 2010; Pérez 
et al., 2010). 
However, to achieve practical feasibility in the field, this long list of alternatives should be prioritised 
by experts to be able to focus on a limited number of most promising alternatives. The aim of this 
study was therefore to provide a list of potential alternatives usable in porcine medicine ranked 
according to their effectiveness, feasibility and return on investment by pig health experts. 
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MATERIALS AND METHODS 
Establishing the list of alternatives 
The list of alternatives to AM agents was composed by combined input of all consortium partners in 
the EMIDA Era-net funded MINAPIG project 4. AM agents were defined in this context as veterinary 
medicinal products with an antibacterial effect, excluding phytotherapeutic substances or metals. 
Alternatives were identified from the literature, from previously conducted research and countries’ 
experiences. The proposed alternatives were grouped and combined in order to get a representative 
range of alternatives that are currently being discussed among the scientific community. The final list 
of nineteen alternatives consisted of: (1) acidification of feed or water, (2) age and transfer 
management (e.g. minimized number of movements, less cross-fostering, older age at weaning), (3) 
benchmarking of farmers/veterinarians, (4) communication/unified advice (i.e. improved 
communication between farmer and veterinarian, all herd advisors promote same strategy, (5) 
diagnostics/action plan (i.e. herd specific action plan based on diagnostics and historical data), (6) 
financial/tax (e.g. increased price of pharmaceutical products, incentive/penalty), (7) genetics, (8) high 
health/SPF5/eradication programs, (9) improved climate/environmental conditions, (10) improved 
external biosecurity (External biosecurity: Prevention of pathogens entering a herd), (11) improved 
internal biosecurity (Internal biosecurity: Prevention of pathogens spreading within a herd), (12) 
improved water quality, (13) increased use of anti-inflammatory products, (14) increased vaccination, 
(15) Optimization of feed quality, (16) reduced stocking density, (17) strict euthanasia policy (e.g. 
euthanasia of piglets that are diseased and/or will not grow up to a full grown slaughter pig), (18) use 
of feed additives and (19) use of zinc/metals. 
Some alternatives are more generic, whilst others are more specific towards a certain pathogen. 
However, the nineteen alternatives were selected to cover possible alternatives to the common and 
general, often prophylactic, usage of AMs (mainly antibiotics) in pig production. Reduction of AMU has 
been shown to be part of the solution to put a halt to AMR development or even to force back AMR 
levels (Chantziaras et al., 2014; van Geijlswijk et al., 2014). 
These alternatives were included in a questionnaire that was administered as described below. The 
questionnaire is available as Annex 1 to this paper. 
 
                                                          
4 See; http://www.minapig.eu  
5 SPF = Specific Pathogen Free 
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Selection of experts and data collection 
In each of the collaborating countries (Belgium, France, Germany, Sweden, Denmark and Switzerland) 
the responsible consortium partner identified pig production experts in their respective countries 
based on common knowledge or personal and institutional experience and invited them to participate 
in the written survey between July 2012 and February 2013. In Belgium 44 experts were contacted, in 
Denmark 290, in Germany 18, in France 20, in Sweden 49 and in Switzerland 30. In Belgium, Germany, 
France, Sweden and Switzerland a personal approach was used to invite the experts to participate in 
this study. In Denmark the invitations for participation were send out by mail through the Danish 
Agriculture and Food Council to all pig experts in their database.  
People with a known expertise in porcine medicine and/or AMU and their alternatives were considered 
to have sufficient knowledge to oversee the complexity of alternatives to AMU in pig production and 
therefore selected as experts: veterinary practitioners, scientists active in pig herd medicine 
(professors/teachers, researchers), nutritionists, technical consultants from the pharmaceutical 
industry and veterinary consultants/advisors active in the pig industry. The experts were provided with 
a paper or email version of the list with nineteen alternative measures to AM agents. For every 
alternative category, a short explanation was given to provide extra information to the respondents. 
For example for the alternative benchmarking: “Benchmarking farmers and veterinarians to get 
awareness on the AMU combined with measures if usage limits are exceeded” or for improved internal 
biosecurity: “All measure to prevent the spread of infectious agents within the farm. Based on 
biosecurity assessment and action plan. Consider factors such as: management of diseases, cross-
fostering, all-in-all-out, working lines, etc.”. The experts were also asked to provide their professional 
occupation. The experts did not receive any compensation for completing the questionnaire. The 
criterion of inclusion of the expert’s responses in the dataset was that at least eight out of nineteen 
alternatives should have been scored. 
Scoring 
The experts were asked to score every alternative from 0 to 10 on three parameters: their perceived 
effectiveness to reduce disease incidence and/or AM consumption, the believed feasibility at farm 
level and the expected return on investment for the farmer. A score of zero was explained as 
representing no effectiveness, feasibility or return on investment, while a ten represented full 
effectiveness, maximal feasibility or return on investment. An 11-point scale provides a high gain of 
potential information and a good reliability according to Krosnick and Presser (2010). 
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Data analysis - Categorical Principal Components Analysis 
Results were analysed using descriptive statistics in IBM SPSS Statistics version 22 and data 
management was done using Microsoft Excel. Comparisons between countries and professions per 
alternative and parameter was conducted using an univariate general linear model with Scheffé test 
for post hoc group comparisons. If equality of variance could not be assumed, an appropriate 
transformation of the data was performed. 
The Categorical Principal Component Analysis (CATPCA) was used to graphically visualize the 
relatedness between the perceived effectiveness, feasibility and ROI of the different alternatives. The 
CATPCA was favourite above a standard PCA for the fact that it the alternatives were scored as ordinal 
variables (Linting and van der Kooij, 2011). The CATPCA returns the data as a two dimensional graphical 
presentation where categorical variables were transformed in an optimal scaling process into metric 
variables. The variance accounted for represents the squared distance of the vector tip to the origin. 
To adjust for the fact that zero was amongst the possible answers, the SPSS procedure of discretizing 
the variables by means of multiplying was used. Variables were given an ordinal measurement scale, 
while the two supplementary variables “country” and “profession” were set as “not specified”. The 
number of dimensions was limited to 2, allowing for the two dimensional graphical visualization. 
Missing values were handled by using the standard CATPCA method of imputing the modal category. 
Variable principal normalization was used as an option to optimize the associations between variables. 
 
RESULTS 
Of the 120 experts that responded, 111 rankings were used for further analysis (Belgium n=24, 
Denmark n=30, France n=8, Germany n=17, Sweden n=23, Switzerland n=9). Out of these 111 rankings 
there were 9 respondents who did not rank one of the alternatives, 1 respondent did not rank 3 
alternatives, 1 respondents did not rank 4 alternatives and 1 respondents did not rank 5 out of the 19 
alternatives. The overall response rate over the countries was 26% (120/451). Response rates of the 
contacted experts in the countries ranged from 13% (Denmark) to 94% (Germany). In Denmark the 
procedure used to invite the experts, sending the invitation by email to all email addresses of 
registered pig experts, was inherent to the low response rate. The majority of respondents were 
veterinary practitioners (n=53). The other respondents were: professors/teachers (n=13), (PhD) 
researchers (n=20), nutritionists (n=6), technical consultants of the pharmaceutical industry (n=8) and 
veterinary advisors/consultants (e.g. more specialised advisors) (n=11). The detailed distribution by 
countries and professions is provided in Table 9. 
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Table 9 Respondents to an expert survey conducted to rank alternatives to antimicrobial usage in pig 
production by country and profession. Percentage in column “n total” represents the percentage of 
this specific country within the total number of respondents of 111. The percentages in the other 
columns represent the percentage of respondents in this specific profession profile compared to the 
total number of respondents in that specific country. 
  N TOTAL 
VETERINARY 
PIG 
PRACTITIONER 
PROFESSOR/ 
TEACHER RESEARCHER NUTRITIONIST 
TECHNICAL 
CONSULTAN
T PHARMA 
INDUSTRY 
VETERINARY 
ADVISOR/ 
CONSULTANT 
Belgium 23 (20.7%) 5 (21.7%) 2 (8.7%) 8 (34.8%) 2 (8.7%) 5 (21.7%) 1 (4.3%) 
Denmark 30 (27.0%) 15 (50.0%) 0 (0.0%) 2 (6.7%) 4 (13.3%) 1 (3.3%) 8 (26.7%) 
France 8 (7.2%) 7 (87.5%) 1 (12.5%) 0 (0.0%) 0 (0.0%0 0 (0.0%) 0 (0.0%) 
Germany 17 (15.3%) 7 (41.2%) 7 (41.2%) 1 (5.9%) 0 (0.0%) 1 (5.9%) 1 (5.9%) 
Sweden 24 (21.6%) 11 (45.8%) 3 (12.5%) 8 (33.3%) 0 (0.0%) 1 (4.2%) 1 (4.2%) 
Switzerland 9 (8.1%) 8 (88.9%) 0 (0.0%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Total 111 53 13 20 6 8 11 
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Table 10 Statistics of perceived Effectiveness, Feasibility and Return on investment (ROI) for alternatives to antimicrobial usage as expressed by European 
experts (n=111).  
 ALTERNATIVE AVERAGE OF THE THREE 
PARAMETERS 
EFFECTIVENESS FEASIBILITY ROI 
Mean Rankingb SD Mode Mean Rankingb SD Mode Mean Rankingb SD Mode Mean Rankingb SD Mode 
Internal biosecurity 7.5 1 1.6 8.0 8.2 1 1.9 8.0 6.6 8 1.9 7.0 7.6 1 1.8 8.0 
Increased vaccination 7.2 2 1.4 8.0 7.6 5 1.6 8.0 7.3 1 1.8 8.0 6.8 6 1.9 7.0 
Zinc/metals 7.2 3 1.9 6.0 7.5 8 1.9 8.0 7.1 5 2.9 8.0 7.0 2 2.4 8.0 
Feed quality/optimisation 7.2 4 1.7 8.0 7.5 7 1.9 8.0 7.1 4 2.0 8.0 6.9 4 2.3 8.0 
Diagnostics/action plan 7.0 5 1.6 7.0 7.4 9 1.7 7.0 6.8 7 2.0 8.0 6.9 3 2.1 8.0 
External biosecurity 7.0 6 1.5 8.0 7.8 2 1.8 8.0 6.5 9 1.9 7.0 6.7 7 2.1 7.0 
Climate/environmental 7.0 7 1.4 6.7 7.7 3 1.6 8.0 6.4 12 1.7 5.0 6.9 5 2.0 8.0 
Communication/unified advice 6.6 8 1.7 7.3 7.1 11 2.1 8.0 6.4 13 2.3 5.0 6.2 11 2.5 8.0 
Water quality 6.5 9 1.8 6.0 6.3 14 2.4 7.0 7.2 3 2.1 8.0 6.1 12 2.3 5.0 
Age and transfer management 6.5 10 1.8 7.3 7.2 10 1.8 8.0 5.9 16 2.1 5.0 6.4 9 2.3 8.0 
Strict euthanasia 6.3 11 1.8 5.0 6.4 13 2.3 5.0 6.2 15 2.6 8.0 6.4 10 2.2 7.0 
High health/SPF/eradication 6.3 12 1.7 6.0 7.6 4 2.1 8.0 4.6 18 2.3 5.0 6.6 8 2.5 8.0 
Reduced stocking density 6.3 13 1.9 6.0 7.5 6 2.0 8.0 5.6 17 2.8 5.0 5.7 13 2.5 8.0 
Increased use anti-inflammatory 6.2 14 2.0 6.0 5.9 15 2.4 5.0 7.3 2 2.1 8.0 5.4 16 2.6 5.0 
Benchmarking farmers/vets 6.2 15 1.6 7.0 6.8 12 2.1 8.0 6.4 14 2.1 5.0 5.3 17 2.5 5.0 
Acidification feed/water 6.0 16 1.6 6.0 5.7 17 1.9 6.0 6.8 6 2.2 9.0 5.5 15 2.0 5.0 
Financial/tax 5.3 17 1.8 5.0 5.9 16 2.5 5.0 6.4 11 2.7 5.0 3.6 19 3.0 0.0 
Genetics 5.2 18 1.8 5.0 5.6 18 2.0 5.0 4.5 19 2.4 3.0 5.5 14 2.3 5.0 
Feed additives 5.1 19 1.8 5.0 4.6 19 2.1 5.0 6.4 10 2.4 5.0 4.1 18 2.4 2.0 
b The ranking is provided for each measure and presented in bold for the top 5.
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Top 5 alternatives 
Combining the scores by taking the mean of means for Effectiveness, Feasibility and ROI resulted in 
the following top 5: Improved internal biosecurity (µ=7.5), increased vaccination (µ=7.2), use of 
zinc/metals (µ=7.2), feed quality/optimization (µ=7.2) and diagnostics/action plan (µ=7.0). 
The list of all average scores, the standard deviations and modes over all respondents is provided in 
Table 10. The top 5 is indicated per parameter. 
Preferences by profession 
On average, veterinary practitioners preferred improvement of internal biosecurity, feed quality, 
increased vaccination, use of zinc/metals or climate/environmental improvements if one takes the 
average over all three parameters; effectiveness, feasibility and ROI. Researchers and 
professors/teachers were more focused on increased use of diagnostics and action plans. Practitioners 
however placed diagnostics/action plan on average in sixth position. 
Nutritionists and other advisors, such as pig consultants and veterinary managers, regarded the use of 
zinc/metals as the most important alternative. Those experts focused in general more on the 
alternatives related to feed, water, climate and environment, while professors, teachers and 
consultants from the pharmaceutical industry gave higher rankings to biosecurity measures and 
increased vaccination. Nutritionists and veterinary advisors/consultants gave the lowest average score 
to feed additives. Veterinary practitioners and researchers ranked genetics on average as the least 
interesting alternative. 
Financial/tax as an alternative was in the bottom four ranking for all profession categories. 
Benchmarking of veterinarians and farmers ended up in the middle regions of the ranking for most 
professional categories, except for the practitioners, they placed this alternative fourth last. 
Preferences per country 
The Belgian and German and to a lesser extend the Swedish and French respondents showed a small 
range in their scores and were therefore less distinct in their ranking compared to the Danish and Swiss 
respondents who ranked with a broader range in scores. In Belgium, biosecurity (internal and external) 
improvement is strongly promoted and was therefore perceived as the most promising alternative 
overall. The same applied to Sweden. In Denmark, Germany, France and Switzerland, internal 
biosecurity was on average perceived more favourably than external biosecurity. Use of zinc or other 
metals was perceived as an promising alternative in Belgium and Denmark, while in the other countries, 
ALTERNATIVES TO ANTIMICROBIAL AGENTS CHAPTER 4 
130 
 
it received a mediocre or low ranking. Diagnostics/action plan were perceived as the most promising 
alternative by German experts. Vaccination also scored quite well in Germany. In Switzerland, 
vaccination was ranked first, while in Belgium and Sweden vaccination did not receive a very high score. 
High health/SPF/eradication was the preferred alternative in France, closely followed by 
diagnostics/action plan. In all countries the option financial/tax ranked low in the overall score for 
effectiveness, feasibility and ROI. Interesting differences were observed in the ranking of feed quality 
optimization between Belgium and Germany (average score 6.25 versus 8.12) or the effectiveness of 
reduced stocking density (Belgium 8.32, Denmark 6.40). 
All significant differences per alternative and per scoring parameters effectiveness, feasibility and ROI, 
between countries and professions, can be found in Table 11. 
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Table 11 Results of univariate linear regression analyses of profession and county on the average over the three parameters, perceived effectiveness, feasibility 
and ROI of the alternatives to antimicrobial usage in pig production, based on post-hoc comparisons with Scheffé corrections.c 
DEPENDENT 
VARIABLE 
ALTERNATIVE MEASURE COUNTRY/PROFESSION 
1 
AVERAGE 
SCORE 
COUNTRY/PROFESSION 
2 
AVERAGE 
SCORE 
DIFFERENCE P-VALUE 
Average 
Vaccination Belgium 6.57 Switzerland 8.58 -2.02 0.01 
Age & transfer management 
France 3.79 Germany 6.46 -2.67 0.02 
France 3.79 Sweden 7.43 -3.64 <0.01 
France 3.79 Denmark 6.90 -3.11 <0.01 
France 3.79 Switzerland 6.81 -3.02 0.01 
Feed additives 
Belgium 5.68 Denmark 3.96 +1.73 0.02 
Germany 5.75 Denmark 3.96 +1.79 0.02 
Sweden 4.68 Switzerland 7.00 -2.32 0.05 
Denmark 3.96 Switzerland 7.00 -3.04 <0.01 
Feed quality optimization Belgium 6.25 Denmark 8.12 -1.88 <0.01 
Zinc/metals 
Belgium 6.74 Denmark 8.70 -1.96 <0.01 
Germany 6.14 Denmark 8.70 -2.56 <0.01 
Sweden 7.17 Denmark 8.70 -1.53 0.05 
Denmark 8.70 Switzerland 4.95 +3.75 <0.01 
Effectiveness 
Communication/unified advice Veterinary practitioner 7.40 Technical consultant 
Pharma industry 
4.63 +2.77 0.03 
Researcher 7.68 Technical consultant 
Pharma industry 
4.63 +3.06 0.03 
Vaccination 
Belgium 6.96 Switzerla  9.13 -2.17 0.01 
Sweden 7.09 Switzerland 9.13 -2.04 0.03 
Anti-inflammatory Denmark 6.93 France 3.63 +3.31 0.03 
Age and transfer management 
Germany 7.13 France 4.63 +2.50 0.04 
Sweden 7.74 France 4.63 +3.11 <0.01 
Denmark 7.87 France 4.63 +3.24 0.01 
France 4.63 Switzerland 7.78 -3.15 0.01 
Reduced stocking density Belgium 8.32 Denmark 6.40 +1.02 0.04 
Feed quality optimization Belgium 6.70 Denmark 8.60 -1.96 0.01 
Feed additives 
Sweden 3.96 Switzerland 6.86 -2.90 0.03 
Denmark 3.50 Switzerland 6.86 -3.36 0.01 
Zinc/metals Germany 6.00 Denmark 8.80 -2.80 <0.01 
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Feasibility 
Financial/tax 
Belgium 5.09 Switzerland 9.33 -4.25 0.01 
Germany 5.81 Switzerland 9.33 -3.52 0.03 
Sweden 5.68 Switzerland 9.33 -3.65 0.01 
High health/SPF/eradication Germany 3.71 Denmark 5.97 -2.26 0.05 
France 2.63 Denmark 5.97 -3.34 0.02 
Internal biosecurity Professor/teacher 7.13 Nutritionist 4.00 +3.08 0.04 
 
Age and transfer management 
Belgium 5.41 France 2.75 +2.66 0.05 
Germany 5.81 France 2.75 +3.06 0.02 
Sweden 6.00 France 2.75 +4.21 <0.01 
Denmark 6.96 France 2.75 +3.25 <0.01 
France 2.75 Switzerland 6.44 -3.69 0.01 
Zinc/metals 
Belgium 6.00 Denmark 8.73 -2.73 0.02 
Denmark 8.73 Switzerland 4.00 +4.73 <0.01 
Return on 
investment 
Age and transfer management Sweden 7.44 France 4.00 +3.44 0.01 
Feed quality optimization Belgium 5.57 Denmark  7.83 -2.27 0.02 
Feed additives 
Belgium 5.48 Denmark 2.53 +2.94 <0.01 
Germany 4.81 Denmark 2.53 +2.28 0.04 
Switzerland 5.86 Denmark 2.53 +3.32 0.02 
Zinc/metals 
Germany 6.29 Denmark 8.57 -2.27 0.04 
Switzerland 3.71 Denmark 8.57 -4.85 <0.01 
 
c Only significant results are reported (P < 0.05) because of space limitations. The full table can be requested from the first author. 
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Categorical Principal Component Analysis 
The results of the two-dimensional solution of the CATPCA explained 55.2% of the variance of the 
scores provided by the 111 respondents for the nineteen alternatives. The percentage of variance 
accounted for (PVAF) in the first dimension (38.3%) was more than two times the PVAF in the second 
dimension (16.9%). The model fit, represented by the sum of the percentage of variance accounted 
for was not high, but sufficient. In Figure 13 the biplot of component loadings with the centroid 
coordinates of the multiple nominal category points (country and profession) is shown. In Figure 13 
four groups can be identified, each in a different quadrant. The first dimension reveals the contrast 
between Denmark, Sweden and Switzerland and the other countries as well as between researchers, 
veterinary practitioners and advisors/managers and professors/teachers, technical pharmaceutical 
consultants and nutritionists on the other hand. The second dimension distinguishes between 
researchers versus practitioners and advisors/managers, and between nutritionists and technical 
pharmaceutical consultants and professors/teachers. Furthermore the second dimension splits 
Sweden from Denmark and Switzerland. The upper left quadrant is classified by Belgium, Germany and 
France and professors/teachers and technical pharmaceutical consultants. This quadrant is negatively 
linked to alternatives related to feed and water, vaccination and anti-inflammatory products, financial 
actions, euthanasia and genetics. The scores of the veterinary practitioners and advisors/managers 
and the countries Denmark and Switzerland in the fourth quadrant show a positive relationship with 
these alternatives. The second quadrant with the researchers and Sweden is related to high 
health/SPF/eradication, age and transfer management, reduced stocking density, 
climate/environmental improvements and external biosecurity. Nutritionists are negatively related to 
these alternatives.  
Three (artificial) clusters of alternatives could be identified from Figure 13. One mostly related to SPF 
herds, age and transfer management, water quality, climate and external biosecurity. These 
alternatives could be summarized as a group of alternatives that reduce the risk of introduction of 
disease in the farm/herd and therefore limiting the necessity of AMU. This cluster shows more 
relationship with the Swedish respondents, indicating that these alternatives are more often ranked 
higher by Swedish respondents. The nutritionists scored opposite of this and therefore did not rank 
these alternatives related to the introduction of diseases very high. Another cluster relates more the 
items that reduce the risk of spreading of disease within the herd (e.g. vaccination, increased 
euthanasia, use of anti-inflammatory products). The fact that the vectors of Germany, France and the 
professor/teachers and technical pharmaceutical consultants point in the opposite direction indicates 
that there is a strong negative relationship between these groups of variables. In other words they do 
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not perceive these alternatives as the most promising in the combination of effectiveness, feasibility 
and return on investment.  A last cluster was formed by alternatives related to the feed (feed quality, 
zinc/metals, acidification). Respondents providing high scores to these feed related alternatives were 
more likely to originate from Denmark or Switzerland and to be veterinary practitioners or 
advisors/managers. 
 
Figure 13 Biplot of alternatives to antimicrobial usage in pig production. Biplot of component loadings 
for alternatives to antimicrobial usage in pig production using the combined average score of perceived 
effectiveness, feasibility and ROI combined with multiple nominal category points (country and 
profession). CATPCA analysis based on data collected from European experts (n=111). 
 
DISCUSSION 
Although the numbers of respondents per country were not very high, the authors consider the study 
to have included a relevant group of pig health experts across several European countries.  Some major 
pig producing countries such as Spain or Poland were not included in the study since they do not 
participate in the MINAPIG consortium. Therefore, the conclusion should be interpreted taking into 
account this limitation. The differences in types of respondents (e.g. percentage of professors versus 
practitioners) and their respective numbers in the different participating countries might have 
influenced the results. However, participation to this questionnaire was on a voluntary basis, making 
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it not possible to account for this.  Response bias might be relevant in this type of study, although the 
order of the pre-listed alternatives and the additional explanatory information were carefully designed 
to minimize this risk. The authors put significant effort into the design of the list of alternatives, 
however they do recognize that not all existing alternatives were included. It was attempted to include 
at least those that are supported by scientific evidence of an effect on pig health and/or reduced AM 
consumption necessity. Other alternatives were not included mainly because the authors concluded 
that these were less commonly used or had a lack of evidence of consistent and positive effects. The 
actual effectiveness, feasibility and return on investment of the alternatives to AMs have not been 
studied, but rather the common wisdom of experts on these parameters. Some alternatives might be 
perceived as generally applied production practices. However in the field they are often not properly 
executed and AMs are used instead partially to cover insufficient management. Furthermore one 
should be aware that for some of the respondents a few proposed alternatives were only hypothetical 
of character (e.g. usage of zinc oxide was legally not allowed in Belgium at the time of execution of this 
study). The proposed alternatives were also not equal in their coverage of problems, some were broad-
based while others were more specific. Some may also target more respiratory diseases while others 
are more orientated towards the prevention of gastro-intestinal diseases. Another limitation would be 
that the list of alternatives could be subject to variable interpretation, especially across countries and 
cultures. These limitations might have led to differences in perception and therefore the scoring of the 
proposed alternatives, but this is inherent to this type of study. 
Some countries, such as The Netherlands (Autoriteit Diergeneesmiddelen (SDa), 2014) and Denmark 
(Alban et al., 2013), already have established benchmarking measures in place, combined with a low 
or even obligatory strict reduction of AMU in livestock production. Other countries like Belgium 
(AMCRA, 2014a, b) and Germany (Qualität und Sicherheit GmbH, 2012) have recently started, while 
some countries like France (Ministère de l'agriculture de l'agroalimentaire et de la forêt, 2014) are 
discussing the possibilities. In Sweden the AM consumption is low in spite of a lack of benchmarking 
(European Medicines, 2013). Thus, although already implemented in some EU countries, the 
benchmarking option did not turn out to be the favourite choice amongst the respondents. 
Reservations against comparisons between veterinarians and a possible negative publicity for the 
profession due to this might be an explanation. The same probably applies to financial actions or extra 
taxes imposed by authorities.  
Some EU countries allow the usage of high doses of zinc in weaned piglets as a prescription drug added 
to feed (Mavromichalis, 2011; AMCRA, 2014c). Amongst the countries that do allow the use of zinc 
oxide we find Denmark and Sweden who also participated in this study. During the execution of this 
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study this topic was being discussed in Belgium and since September 2013 the usage of zinc oxide is 
temporarily allowed as prescription in-feed alternative in Belgium as well. In Germany one feed 
additive, that increases the maximum limit of zinc, was allowed of which the amount of usage should 
not be documented. The normal diet just needs to fulfil the requirements stated in directive 
2008/38/EG. These variations might at least partially explain the observed differences found in the 
ranking of zinc oxide as an alternative. The Danish respondents rank it very positive, while for example 
the countries where it is not allowed the respondents to this study perceived more problems and rank 
this alternative lower (e.g. Switzerland). It should also be taken into account that some negative 
characteristics due to the burden on the environment by excretion and to potential selection for 
specific AMR have been described in literature as well (Mavromichalis, 2011; Medardus et al., 2014) 
and might have influenced the opinion of the respondents. Furthermore some authors describe only 
partial effect of zinc oxide or only for a short period, leading to a less positive evaluation (Janczyk et 
al., 2013).  
It will not be of any surprise that alternatives related to the easily feasible administration of products 
(vaccines, anti-inflammatory products) ranked high on feasibility, since limited extra procedures are 
necessary. Alternatives scoring high on ROI are generally low in costs and are perceived to generate a 
positive cost-benefit ratio to the farmer. Both internal and external biosecurity ranked high on all three 
parameters since they were probably perceived as relatively cheap or even free of costs (e.g. washing 
of hands, adjustment of work lines). These measures were perceived as effective and feasible on a 
large number of herds. Laanen et al. (2013; 2014) already indicated that there is room for improvement 
in these areas. The relatively high score for reduced stocking density in Denmark might indicate that 
the respondents see room for improvement in this area, or, they have already seen the beneficial 
influences of these alternatives. 
Another remarkable finding is the fact that for practitioners the range between minimum (5.2) and 
maximum (7.6) in the average scores was small. This indicates that they perceive importance of all 
proposed alternatives and find it hard to make clear distinctions and choices. The fact that the first 
dimension of the CATPCA only includes positive outcome objects might suggest as well that the 
differences between perception of alternatives by the respondents is not very distinctive. 
In the CATPCA, the veterinary practitioners showed an association with the more practical alternatives, 
while the researchers were linked with the more challenging and demanding alternatives. The 
observed differences in relationships of experts in the different countries or with different professions 
towards the ranked alternatives can probably be explained by the differences in the current status and 
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promotion of these alternatives, policy opinions and design of the sector in the different countries. It 
also suggests that acceptance of some alternative measures will be higher in some countries compared 
to others.  
 
CONCLUSIONS 
The results showed that biosecurity improvements, increased vaccination, use of zinc/metals, 
improvement of feed quality and use of regular diagnostics testing and a clear action plan are believed 
to be the most promising alternatives to AMU in industrial pig production based on combined 
effectiveness, feasibility and ROI. 
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ABSTRACT 
Objectives 
Disease prevention through biosecurity measures is believed to be an important factor for 
improvement of the overall health status in animal production. This study aimed at assessing the levels 
of implementation of biosecurity measures in pig production in four European Union (EU) countries 
and to describe possible associations between the biosecurity level and farm and production 
characteristics.  
Methods 
A cross-sectional study was conducted in 232 farrow-to-finish pig herds in Belgium, France, Germany 
and Sweden between December 2012 and December 2013. The biosecurity status in each of these 
herds was described and quantified by using the risk-based scoring tool Biocheck.UGent 
(www.biocheck.ugent.be). Production and management characteristics, obtained from the herd 
management system and by interviewing the farmer, were analysed for their association with the 
biosecurity level. A causal path was designed to study statistical associations. 
Results 
The results showed that there was substantial room for improvement in the biosecurity status on many 
pig farms. Significant differences (p<0.01) both in internal and external biosecurity levels were 
observed between countries. The external biosecurity status, combining all measures taken to prevent 
disease introduction into the herd, was highest in Germany and lowest in France. The internal 
biosecurity status, combining all measures taken to prevent within herd disease transmission, was 
highest in Sweden and lowest, with a large variation, in Belgium. External biosecurity scores were in 
general higher compared to internal biosecurity scores.  
The number of pathogens vaccinated against was significantly associated with internal biosecurity 
status, suggesting an overall more preventive approach towards the risk of disease transmission. A 
higher external biosecurity was associated with more weaned piglets per sow per year. Furthermore 
also the weaning age and the mortality till weaning were highly associated with the number of weaned 
piglets per sow per year. The negative association observed between the biosecurity level and the 
estimated frequency of treatment against certain clinical signs of disease as a proxy for disease 
incidence is consistent with the hypothesis that a higher biosecurity level results in healthier animals. 
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Conclusion 
These findings promote an improved biosecurity status at pig farms and are of relevance in the 
discussion on alternative ways to keep animals healthy with a reduced necessity of AMs; Prevention is 
better than cure! 
 
IMPLICATIONS 
This manuscript could have implications on the future biosecurity status of pig herds. It shows that 
there is still room for improvement in the biosecurity status in the four EU countries studied. 
Furthermore it shows that relevant associations exist between the level of biosecurity and production 
parameters. The found associations are of interest to farmers, since e.g., an improved biosecurity level 
was associated with more weaned piglets per sow per year which is economically beneficial. We also 
show a lower proxy for disease incidence related with a higher biosecurity status. Furthermore with 
these results herd advisors and policy makers will also have tools to inform farmers of the importance 
of a good biosecurity level. 
 
INTRODUCTION 
Biosecurity is the term used in (veterinary) medicine to describe measures to prevent pathogens from 
entering farm premises or a group of animals (external biosecurity) or the spreading of pathogens 
within farm premises or groups of animals (internal biosecurity) (Amass and Clark, 1999).  
The Food and Agriculture Organization of the United Nations (FAO) describes biosecurity to be of direct 
relevance to the sustainability of agriculture, food safety and the protection of the environment (Food 
and Agriculture Organization of the United Nations - Committee on Agriculture, 2003). Biosecurity 
measures are of great importance to prevent or limit the risk of animals becoming infected with 
pathogens (Amass and Clark, 1999; European Commission, 2007; Maes et al., 2008; Fraile et al., 2010; 
Nöremark et al., 2010; Lambert et al., 2012a; Laanen et al., 2013). A reduction in the risk of contracting 
an infection might lead to the reduced necessity of (antimicrobial) treatment of the animals (Laanen 
et al., 2013). Reduced and prudent usage of AMs in livestock production is a hot topic in the media, 
politics and science nowadays, mainly in relation to public health. A reduced need for AMs meets the 
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requests for reduced antimicrobial usage (AMU) (European Commission, 2011b) and mitigated 
antimicrobial resistance (AMR) (Chantziaras et al., 2014). 
The level of biosecurity of a certain herd can be assessed by interviewing the farmer regarding 
biosecurity practices and collecting data by visual inspection. The risk-based weighted biosecurity 
scoring system (Biocheck.UGent™) translates questions regarding biosecurity into a score for a herd 
for its internal, external and overall biosecurity status. This score aims at providing an objective, 
comprehensive and quantitative description of the level of biosecurity and can be used to inform the 
farmer on possible areas for improvements, and to compare their biosecurity level with that of other 
farms/herds. Combining the results of several farms may provide an overall idea of the level of 
biosecurity in a certain region or country (Ghent University, 2010a; Laanen et al., 2010; Laanen et al., 
2013; Backhans et al., 2015). 
Having a good insight into differences and similarities in the biosecurity level of  pig herds is of great 
importance for the advice that can be given and legislation that might be developed in order to 
improve the biosecurity status of pig production in the EU and the subsequent lowered probability of 
introduction and spread of diseases.   
Farmers are likely to be more motivated to implement biosecurity measures if such measures can be 
expected to be beneficial for their farm performance (Casal et al., 2007; Valeeva et al., 2011; Laanen 
et al., 2014), yet there is limited quantitative data available to link biosecurity and production 
parameters (Amass and Clark, 1999; Laanen et al., 2013). Especially studying these relationships on the 
basis of multiple country data has not been done before. 
Therefore, the aim of this study was to gain insight into the biosecurity status of farrow-to-finish herds 
in four European countries and to study associations with production and management characteristics. 
The results of this study will be used by the MINAPIG consortium to study the improved 
implementation of biosecurity measures as an alternative to AMs in pig production. 
 
MATERIALS AND METHODS 
Herd selection 
The study aimed to include 60 farrow-to-finish herds with ≥ 100 sows present at any given time and ≥ 
500 finishers in the four participating countries; Belgium, France, Germany and Sweden. In Belgium an 
email list of pig farmers subscribing to a newsletter issued by the faculty of veterinary medicine of 
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Ghent University was used. Only farms in the Dutch speaking part of the country (Flanders) were 
selected. Flanders represents 90% of the pig production in Belgium (VILT - VLaams Infocentrum Land- 
en Tuinbouw, 2010). In Germany consultancy circles for pig farmers, combined with input from 
veterinary practices was used to select the herds. The herds were located in the regions Mecklenburg-
Vorpommern, Niedersachsen and Nordrhein-Westfalen. These three regions represent approximately 
64% of the total pig production in Germany (Statistisches Bundesamt, 2014b). In France, from a 
database with names and addresses from the French Institute for pig and pork industry (IFIP), farms 
located in the north-west part, representing 75% of the country’s pig production, were randomly 
selected. In Sweden, the database with names and addresses of pig farmers affiliated to the Swedish 
Animal Health Service was used and the farmers were contacted by their herd veterinarian or a 
consortium partner with the request for participation.  
Herd visit and interviews 
The participating herds were visited by one and the same researcher per country in Belgium, France 
and Germany and by a researcher (n=2) or a veterinarian from the Swedish Animal Health Service (n=15) 
in Sweden. All interviewers received training in using a standardized method for data collection. 
Furthermore, the complete protocol was developed in a way that similar methods of data entry could 
be guaranteed. Consultation of and discussion between the project partners assured the completeness 
and accuracy of the herd visit protocol.  
Herds were visited between December 2012 and December 2013. The interviewer completed a farm 
inspection together with the farmer and the questionnaire was also completed during the visit. The 
information on herd management and technical parameters corresponded to the year preceding the 
herd visit. 
Data collection 
The data collected on the farms consisted of technical parameters (e.g., number of weaned piglets per 
sow per year (WSY), mortalities and average daily weight gain (ADG), see Table 9) and herd 
management information (e.g. gender of the responsible person in different age units, farrowing 
rhythm, vaccination protocol, see   
ASSOCIATIONS BIOSECURITY AND PRODUCTION CHAPTER 5 
151  
 
Table 13). The technical parameters were collected from the herd management system if available, 
the herd management information by interviewing the farmer. All information was first collected on 
paper and afterwards entered in an electronic platform. 
The farrowing rhythm of the herds (i.e. the interval, expressed in weeks, between the births of two 
batches of piglets) ranged between a 1-week system (every week a group of sows farrows) and 5-week 
systems for Belgium, France and Germany. In Sweden, farrowing rhythms exceeding 5 weeks were 
common. These were clustered into one category named “>5”.  
The education level of the responsible person was categorised as being “lower” (i.e. basic as in only 
primary school and lower as in minimal secondary education in the protocol), “higher” (i.e. middle or 
higher level secondary education) or having a “university” degree. 
The number of pathogens vaccinated against was obtained by summing the number of the vaccines 
(for all animal categories) used as a preventive measure against a certain pathogen. Combination 
vaccines were calculated separately for the respective pathogens they target.  
Information on estimates of how common treatments against certain disease symptoms were, as a 
proxy for disease incidence, was also collected per animal category. For the sucklers, weaners and 
fatteners there were five predefined disease symptom categories; lameness, gastro-intestinal, 
respiratory, nervous, skin problems. For sows the symptoms mastitis and reproductive disorders were 
added to this list. For each of the symptoms the farmers were asked to assess how common treatments 
(e.g. with AMs, anti-inflammatory products, probiotics, electrolytes, …) were applied to the animals on 
a 5-category-scale, where 1 was equal to never, 2 was rarely, 3 occasionally, 4 regularly and 5 
commonly/always. Guidelines for the interpretation were not provided since the 5-category-scale was 
considered to be self-explanatory. 
Biosecurity quantification  
To quantify the biosecurity status in a reproducible and validated way, we used the publically available 
and previously described biosecurity assessment tool “Biocheck.UGent™”, developed by Ghent 
University, Belgium (Ghent University, 2010a; Laanen et al., 2010; Laanen et al., 2013). This risk-based 
scoring tool, consisting of in total 109, mainly di- or trichotomous (yes, no / always, sometimes, never), 
questions, provides a score for internal and external biosecurity. Both internal and external biosecurity 
are further subdivided into six sub-categories each, with 2-13 questions per sub-category. For internal 
biosecurity these subcategories are; 1) disease management, 2) farrowing and suckling period, 3) 
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nursing unit, 4) fattening unit, 5) measures between compartments, 6) working lines. External 
biosecurity is subdivided into; 1) purchase of breeding pigs, 2) purchase of piglets, 3) artificial 
insemination, 4) transport of animals, 5) feed and water supply, 6) removal of manure and dead 
animals. In the scoring system, every answer is translated into a score with absence of the biosecurity 
measure always resulting in score of 0 and presence of the measure varying in a score between 0.5 
and 10 dependent on the importance of the measure. Furthermore the sub-categories have specific 
weight factors, again depending on their assessed relative importance for disease prevention (see 
supplementary data in Laanen et al. (2013)). Finally the Biocheck.UGent scoring system provides a 
score for each subcategory as well as separate scores for internal and external biosecurity each time 
ranging from a minimum equal to 0 indicating total absence of biosecurity measures and a maximum 
100 indicating full application of all described biosecurity measures. The total biosecurity score of the 
herd is calculated as the average over the internal and external biosecurity score. 
Statistical analysis 
Differences between countries in the overall, internal and external biosecurity score, the 12 sub-
categories of biosecurity and farm characteristics were assessed using ANOVA with Scheffé’s method 
for post hoc comparison. If normal distribution and equality of variance could not be guaranteed, a 
nonparametric, two-sided, independent samples Kruskall Wallis test was performed. Correlation 
between the internal biosecurity score and the external biosecurity score was expressed by using the 
2-way Pearson correlation coefficient.  
For the analyses of associations between the biosecurity scores and the herd characteristics and 
technical results (i.e. from herd management data and questionnaire: number of sows, WSY, ADG 
(g/day), mortality till weaning (%), mortality of finishers (%), farrowing rhythm, weaning age (days), 
years of experience of the farmer, highest education level of the responsible person/farm manager, 
number of pathogens vaccinated against, number of employees and gender), first a causal path was 
designed based on the authors logical reasoning, including all possible associations between two 
variables and centering around both the internal and external biosecurity scores. Based upon the 
potential association described in this causal pathway, univariable analyses were performed with the 
variable where the arrow pointed towards as dependent variable. All analyses were corrected for the 
country effect by adding country as a fixed factor to correct for country specific characteristics.  
Those variables with univariable p-values of < 0.20 were retained for further analysis in a multivariable 
model. Subsequently, with univariable associations that were retained, a multivariable general linear 
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model was constructed using the stepwise backward selection procedure, including testing of two way 
interactions of significant main effects. We checked for confounding effects during modelling by 
evaluating changes in parameter estimates. The association was considered significant if p< 0.05. 
Normal probability tests and plots were examined to check whether the assumptions of normality and 
homoscedasticity of the residuals were fulfilled and no deviations from the assumptions were 
identified besides that a LOG transformation for the number of sows was required. 
To investigate the link between the estimated frequency of treatment against certain disease 
symptoms as a proxy for disease incidence and the biosecurity level, the sum of the scores (never 
equals score 1; commonly/always equals score 5) per animal category was used as the dependent 
variable. Since for the sucklers, weaners and finishers the number of categories of disease symptoms 
was five and a 5-category-scale was used, the possible outcomes of this sum ranged from 5 till 25. For 
the sows seven categories of symptoms were described, leading to a range of 7 till 35. This sum was 
used as a dependent variable in a univariable linear regression model to examine associations between 
this parameter and the biosecurity level of a herd.  
All statistical analyses were performed using SPSS statistics 22 (IBM).  
 
RESULTS 
Farm selection and characteristics 
Finally 52 participating herds in Belgium and 60 in each of the other three countries were included in 
the study, there were no non-responders or drop-offs. Our criterion of ≥100 sows had to be lowered 
to ≥70 sows to reach the maximum of participating herds. Three Belgian herds, six French herds and 
one Swedish herd had a number of sows between 70 and 100. 
The characteristics of the participating herds are described in Table 12 while general information on 
the farrowing rhythm of the participating farms and gender and education information of the farmers 
is provided in   
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Table 13. 
The number of sows present on the farms was skewed to the right and therefore a LOG transformation 
of the data was performed for the statistical analyses. 
The weaning age was on average 27 days (range 19 – 49) for the 232 herds, but this was highly 
influenced by the fact that Sweden showed a higher weaning age (Table 12). The number of WSY 
(number of weaned piglets per sow per year) was comparable in Belgium, France and Germany, but in 
general lower in Sweden. The mortalities showed large variation within the countries.  
The farrowing rhythm showed that a 3 week batch system was most common in France and Germany, 
while in Belgium and Sweden a 4-week system was most common. In Sweden however, a large portion 
of the farms (32%) worked with a batch system >5 weeks. 
The number of pathogens a vaccination was used against ranged from 0 (i.e. no vaccinations at all) till 
11 (i.e. vaccines against 11 pathogens used on the farm). 
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Table 12 General descriptive information of the participating herds regarding technical and 
management parameters. N= number, SD = standard deviation. 
  N MEAN MEDIAN SD MINIMUM MAXIMUM 
Number of sows Belgium 52 333.1 287.5 254.0 70 1750 
France 60 200.3 173.5 114.9 91 695 
Germany 60 396.2 300.0 299.2 100 1510 
Sweden 60 248.9 187.5 188.6 96 1200 
Number of weaned piglets per sow per 
year (WSY, piglets/sow/year) 
Belgium 52 27.4 27.3 2.7 22.2 34.6 
France 58 26.5 26.2 2.3 22.2 32.3 
Germany 60 27.4 27.1 2.3 24.0 32.2 
Sweden 58 23.2 23.5 2.3 14.1 28.3 
Average daily weight gain (ADG, g/day) Belgium 40 703.6 700.0 48.9 623 806 
France 51 795.1 793.0 44.6 683 922 
Germany 38 811.2 800.0 43.8 720 900 
Sweden 38 911.7 900.5 57.1 800 1007 
Feed conversion ratio (FCR, g/g) Belgium 45 2.7 2.7 0.2 2.2 3.0 
France 13 2.8 2.8 0.1 2.5 3.0 
Germany 27 2.8 2.7 0.1 2.4 3.0 
Sweden 21 2.8 2.7 0.3 2.4 3.8 
Mortality till weaning (%) Belgium 51 12.5 12.5 3.0 7.0 19.4 
France 58 19.8 19.9 5.5 4.2 31.2 
Germany 59 15.2 15.3 5.5 3.3 30.4 
Sweden 59 18.2 18.3 4.3 6.1 27.9 
Mortality nursery (%) Belgium 43 2.8 2.3 1.8 0.9 9.0 
France 50 2.2 2.0 1.3 0.5 6.2 
Germany 4 3.9 3.5 2.1 1.8 6.8 
Sweden 52 2.1 1.5 1.8 0.1 8.5 
Mortality finishers (%) Belgium 51 2.8 2.2 1.9 0.3 11.5 
France 51 3.6 3.5 1.3 1.3 8.9 
Germany 4 4.3 4.2 2.1 2.1 6.4 
Sweden 52 1.6 1.3 1.6 0.2 12.0 
Weaning age (days) Belgium 41 23.5 24.0 2.7 19.0 28.0 
France 60 24.0 21.6 3.6 19.5 34.5 
Germany 60 24.4 25.2 3.3 19.3 32.6 
Sweden 58 35.1 35.0 3.7 28.0 49.0 
Years experience Belgium 49 21.7 24 9.1 4 40 
France 58 23.6 22.5 8.3 4 41 
Germany 60 24.9 25 10.2 5 45 
Sweden 59 23.2 22 9.4 5 41 
Number of employees7 Belgium 49 2.0 2 1.0 1 6 
France 60 2.3 2 1.3 1 8 
Germany 58 3.1 2.5i 2.0 1 14 
Sweden 59 4.0 3 2.2 1 15 
Number of pathogens vaccinated against Belgium 52 6.6 7 1.9 2 11 
France 60 6.8 7 1.7 3 10 
Germany 60 7.2 7 1.6 4 11 
Sweden 60 4.0 4 1.5 0 6 
 
  
                                                          
i Employee= person involved in taking care of the pigs. A 0.5 employee was a halftime employee. I.e. 2.5 
employees refers to two fulltime employees and one half time employee. 
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Table 13 General information on the farrowing rhythm of the participating farms and gender and 
education information of the farmers. 
  BELGIUM FRANCE GERMANY SWEDEN 
Farrowing rhythm 1-week system 9 5 16 2 
2-week system 2 3 10 6 
3-week system 12 31 28 11 
4-week system 15 11 5 19 
5-week system 9 9 1 1 
>5-week system 0 0 0 18 
Gender responsible person farrowing unit Male 22 40 44 32 
Female 22 20 12 27 
Gender responsible person nursery unit Male 34 49 56 32 
Female 9 11 3 27 
Gender responsible person fattening unit Male 40 50 59 41 
Female 3 8 1 17 
Highest education responsible person Lower (primary or 
minimal secondary 
school) 
18 22 19 27 
Higher 
(middle/higher 
secondary school) 
20 30 25 10 
University 2 6 16 19 
 
Biosecurity in the different countries 
The biosecurity scores over all four countries showed a total biosecurity of 60.8 (residual standard 
error= 8.9), with a higher score for external biosecurity (65.3, residual standard error= 9.4) compared 
to the internal biosecurity (55.8, residual standard error= 11.3). The boxplots per country for the total, 
external and internal biosecurity showed large variations between and within the countries (Figure 14, 
Figure 15 and Figure 16). 
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Figure 16 Boxplot for the internal biosecurity score per country in farrow-to-finish pig herds. Letters A, B and C 
correspond to post hoc statistical tests. Different letters indicate a statistical significance difference (ANOVA) 
between the countries. 
 
As shown in Figure 17, the internal and external biosecurity were positively correlated (R= 0.43; p< 
0.01).  
Figure 14 Boxplot for the external biosecurity score per 
country in farrow-to-finish pig herds. Letters A, B and C 
correspond to post hoc statistical tests. Different letters 
indicate a statistical significance difference (ANOVA) 
between the countries. 
Figure 15 Boxplot for the total biosecurity score per 
country in farrow-to-finish pig herds. Letters A, B and C 
correspond to post hoc statistical tests. Different letters 
indicate a statistical significance difference (ANOVA) 
between the countries. 
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Figure 17 Link between internal and external biosecurity scores in farrow-to-finish pig herds. The dark 
line represents the fitted line for the association over all combined data. The different countries are 
represented by different markers. 
The external biosecurity subcategory “purchasing policy” scored high with an average score of 84.1 
(range 30 – 100, SD= 14.4), while “supply of fodder, water and equipment” showed the lowest average 
score of 38.5 (range 0 – 90, SD 14.7). Scores for internal biosecurity were more in line with each other, 
with the highest average score for “management of diseases” (x ̄= 60.8, range 0 – 90, SD= 25.4). The 
lowest score was seen for “compartmentalization, working lines and equipment” (x=̄ 45.7, range 0 – 
100, SD= 18.3). Detailed information on the biosecurity scores in general and per country is presented 
in Table 14. “Cleaning and disinfection” was the only subcategory where no significant differences 
between countries were observed. 
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Table 14 Biosecurity scores total and based on external and internal biosecurity and their specific sub-categories in farrow-to-finish herds in four countries. 
Scores generated by using the risk-based Biocheck.UGent™ scoring system (minimum score 0, maximum 100). Similar superscripts (A, B or C) indicate statistical 
equality, while different letters indicate statistical significant differences between countries. P-values are provided for a country comparison based on an 
ANOVA test (superscript I) or Kruskal Wallis test (superscript II) in case equality of variance could not be assumed. 
 
 ALL 4 COUNTRIES BELGIUM FRANCE GERMANY SWEDEN RESIDUAL 
STANDARD 
ERROR 
ANOVAI/ 
KRUSKALL 
WALLISII 
 
 MEAN (SD) MEAN (SD) MEAN (SD) MEAN (SD) MEAN (SD) P-VA UE  
Total biosecurity 60.8 57.8 A 58.6 A,B 63.0 B,C 63.7 C 8.9 <0.01 i  
         
   External biosecurity 65.3 64.0 A,B 59.4 B 70.2 C 68.3 A,C 9.4 <0.01 i  
      Purchasing policy 84.1 85.8 A 72.1 B 88.0 A 91.8 A 12.4 <0.01 i  
      Removing animals, manure, carcasses 65.3 (16.2) 67.4 (13.5) A 61.1 (12.2) A,B 79.1 (10.5) C 54.6 (17.1) B  <0.01 ii  
      Supply fodder, water, equipment 38.5 (14.7) 32.8 (19.3) A 33.1 (9.6) A 46.1 (14.0) B 41.9 (11.5) B  <0.01 ii  
      Access check 64.4 (19.0) 63.4 (14.9) A,B 61.5 (16.4) A 71.3 (15.9) B 62.9 (25.8) A,B  <0.01 ii  
      Vermin, bird control 68.7 61.6 A 64.2 A 70.8 A,B 78.7 B 19.2 <0.01 i  
      Location, environment 56.4 (30.9) 51.7 (29.5) A 53.5 (26.1) A 38.8 (31.3) A,B 81.8 (18.2) C  <0.01 ii  
         
   Internal biosecurity 55.8 51.1 A 57.3 B 55.4 A,B 58.8 B 11.3 <0.01 i  
      Management diseases 60.8 (25.5) 55.4 (21.6) A 53.3 (24.6) A 64.0 (24.7) A,B 69.7 (27.2) B  <0.01 ii  
      Farrowing, suckling period 52.9 46.6 A 53.9 A 52.5 A 57.7 (17.6) B 19.3  0.03 i  
      Nursery period 69.5 57.4 A 67.7 B 72.2 B,C 79.7 C 16.6 <0.01 i  
      Fattening period 73.4 65.8 A 69.1 A,B 78.2 B 79.3 B 20.5 <0.01 i  
      Compartmentalizing, working lines,  
      equipment 
45.7 42.4 A 54.2 B 41.4 A 44.5 A 17.7 <0.01 i  
      Cleaning, disinfection 47.2 49.0 A 50.1 A 44.2 A 45.7 A 19.2  0.32 i  
ASSOCIATIONS BIOSECURITY AND PRODUCTION CHAPTER 5 
160  
 
Link between biosecurity and farm characteristics  
Due to an unbalanced distribution between males and females of the responsible person for the 
nursery and fattening periods (many males and very few females), this variable was not included in the 
analysis. Only the gender of the responsible person in the farrowing unit was tested for its link with 
other relevant parameters.  
The univariable analysis resulted in retaining several variables related with each other.  
The different multivariable models, with outcome variables “number of sows (LOG)”, “number of 
employees”, “gender farrowing”, “education level”, “farrowing rhythm”, “daily weight gain”, “number 
of weaned piglets per sow per year”, “external or internal biosecurity”, number of pathogens 
vaccinated against”, “weaning age”  and “mortality till weaning”, corrected for the country effect, 
finally resulted in a total of thirteen relevant associations linking the biosecurity levels with the before 
mentioned production and management parameters. These thirteen associations are shown in the 
causal path in Figure 18 and in Table 15 significant associations between the before mentioned 
outcome variables and their risk factors are listed. 
The number of sows positively influenced the number of employees (p< 0.01) and number of weaned 
piglets per sow per year (p< 0.01, country interaction). The number of sows and the farrowing rhythm 
were also associated, from a 2-week farrowing rhythm system onwards the number of sows was lower 
(p< 0.01). The farrowing rhythm influenced the weaning age; a 3-week system had a higher weaning 
age. Furthermore herds where the farrowing rhythm was 4 weeks or ≥5 weeks in general had less 
employees (p< 0.01). More employees means as well that there were more often females responsible 
for the farrowing unit (p< 0.01). The external biosecurity was positively influenced by the number of 
employees (p< 0.01). Herds with a higher weaning age also had a lower ADG (p= 0.03) and a lower 
number of weaned piglets per sow per year (p< 0.01). The external biosecurity on the other hand 
positively influenced the WSY (p= 0.02, Figure 19), as did a higher number of sows (country effect), 
while a higher mortality resulted in less WSY. Finally external and internal biosecurity were associated 
with each other (p< 0.01) and a higher internal biosecurity was associated with a higher number of 
pathogens vaccinated against (p= 0.02). 
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Table 15 Statistical results of univariable and multivariable general linear models for internal biosecurity score and herd characteristics in farrow-to-finish pig 
herds. Only associations significant (p< 0.05) in the multivariable model are shown. The reference category for the analysis is indicated with “Ref.” for 
categorical variables. In the multivariable model the p-values which are significant with p≤ 0.05 and p> 0.05 are light gray. Significant interactions are listed 
where applicable. All models were corrected for the country effect by adding country in the model as a fixed variable. 
   UNIVARIABLE  MULTIVARIABLE 
OUTCOME VARIABLE RISK FACTOR N8 Β-COEFFICIENT P-VALUE ADJUSTED R2 Β-COEFFICIENT P-VALUE 
Number sows (LOG)9 Farrowing rhythm 219  <0.01 0.411  <0.01 
 >5 18 -1.126 <0.01  -1.126 <0.01 
 5 20 -0.976 <0.01  -0.976 <0.01 
 4 48 -0.625 <0.01  -0.625 <0.01 
              3 80 -0.831 <0.01  -0.831 <0.01 
 2 21 0.237 0.08  0.237 0.08 
 1 32 Ref. Ref.  Ref. Ref. 
Number employees Farrowing rhythm 213  <0.01 0.352  <0.01 
 >5 18 -3.253 <0.01  -1.092 0.02 
 5 20 -2.355 <0.01  -0.407 0.30 
 4 47 -2.752 <0.01  -1.198 <0.01 
              3 77 -2.231 <0.01  -0.440 0.14 
 2 21 -1.224 <0.01  -0.534 0.12 
 1 30 Ref. Ref.  Ref. Ref. 
 Number sows 221 0.005 <0.01 0.566 0.005 <0.01 
Gender farrowing Number employees 214 0.049 <0.01 0.068 0.049 <0.01 
Farrowing rhythm Number sows 223 0.002 <0.01 0.350 0.002 <0.01 
Daily weight gain (ADG) Weaning age 159 -2.720 0.03 0.675 -2.720 0.03 
External biosecurity 228 0.048 <0.01 0.362 0.017 0.02 
                                                          
8 n= number 
9 LOG= log transformation 
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Number of weaned piglets 
per sow per year (WSY) 
Weaning age 215 -0.166 <0.01 0.367 -0.195 <0.01 
Mortality till weaning 226 -0.180 <0.01 0.423 -0.208 <0.01 
 Number sows 228 0.003 <0.01 0.389 -0.001 0.58 
 Country * Mortality till weaning      <0.01 
 Belgium * Mortality till weaning     0.375 <0.01 
 France * Mortality till weaning     -0.126 0.12 
 Germany * Mortality till weaning     0.175 0.03 
 Sweden * Mortality till weaning     Ref. Ref. 
 Country * Number sows      <0.01 
 Belgium * Number sows     -0.002 0.30 
 France * Number sows     0.005 0.05 
 Germany * Number sows     0.004 0.01 
 Sweden * Number sows     Ref. Ref. 
 Country * Weaning age      0.01 
 Belgium * Weaning age     -0.196 0.17 
 France * Weaning age     0.221 0.03 
 Germany * Weaning age     0.156 0.16 
 Sweden * Weaning age     Ref. Ref. 
Internal biosecurity External biosecurity 232 0.582 <0.01 0.265 0.378 <0.01 
External biosecurity Internal biosecurity 232 0.400 <0.01 0.354 0.378 <0.01 
 Number employees 226 1.477 <0.01 0.214 1.123 <0.01 
Pathogens vaccinated Internal biosecurity 232 0.024 0.02 0.372 0.024 0.02 
Weaning age Farrowing rhythm 212  <0.01 0.738  <0.01 
 >5 18 0.156 0.88  0.199 0.85 
 5 19 0.143 0.88  0.127 0.89 
 4 45 -0.153 0.84  -0.091 0.90 
 3 79 3.177 <0.01  3.211 <0.01 
 2 20 -1.121 0.20  -1.095 0.22 
 1 31 Ref. Ref.  Ref. Ref. 
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Figure 18 Causal pathway with statistical significant associations in the multivariable models between several herd management, production variables and 
internal and external biosecurity scores in farrow-to-finish pig herds. Gender person farrowing= gender of the person responsible for taking care of the pigs 
in the farrowing unit, #= number. Black lines represent the result of a multivariable linear regression analysis based on data from 4 EU countries. The light gray 
dashed line indicates a significant effect between these parameters only through interaction with country. The p-values correspond to the multivariable model. 
All models were corrected for the country effect by placing country as a fixed variable in the model, hence the circle around the figure. 
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Link biosecurity level - frequency of treatment against certain disease symptoms as a proxy for 
disease incidence 
The sum of scores for estimated treatments given against certain disease symptoms was significantly 
associated with the internal biosecurity as well as the external biosecurity score for finishers (p= 0.03; 
p<0.01) and sows (p= 0.02; p = 0.01). For the weaners the score was only significantly (p< 0.01) 
associated with the external biosecurity. The association had a negative coefficient, indicating that a 
higher biosecurity was associated with a lower frequency of treatment for the different categories of 
disease symptoms (Table 16). 
Table 16 Significant (p< 0.05) univariable country corrected general model results for the sum of the 5-point 
Likert scale results (1= never, 5= always) of the frequency of treatment against 5 (weaners, finishers) or 7 (sows) 
symptoms (lameness, gastro-intestinal, respiratory, nervous, skin problems, mastitis, reproductive disorders) per 
porcine animal category. The reference category for the analysis is indicated with “Ref.”. n= number. 
OUTCOME VARIABLE RISK FACTOR N COËFFICIËNT UNIVARIABLE MODEL P-VALUE 
Frequency of 
treatment against 5 
symptoms weaners  
External biosecurity 223 -0.059 <0.01 
Country    <0.01 
Belgium  1.943 <0.01 
France  0.099 0.843 
Germany  4.120 <0.01 
Sweden  Ref. Ref. 
Frequency of 
treatment against 5 
symptoms finishers  
External biosecurity 220 -0.052 <0.01 
Country   <0.01 
Belgium  -0.532 0.18 
France  0.186 0.63 
Germany  1.241 <0.01 
Sweden  Ref. Ref. 
Internal biosecurity 220 -0.028 0.03 
Country   <0.01 
Belgium  -0.500 0.22 
France  0.598 0.11 
Germany  1.023 <0.01 
Sweden   Ref. 
Frequency of 
treatment against 7 
symptoms sows  
External biosecurity 222 -0.044 0.01 
Country   <0.01 
Belgium  0.666 0.16 
France  -0.657 0.15 
Germany  2.125 <0.01 
Sweden  Ref. Ref. 
Internal biosecurity 222 -0.034 0.02 
Country   <0.01 
Belgium  0.605 0.21 
France  -0.311 0.48 
Germany  1.929 <0.01 
 Sweden  Ref. Ref. 
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DISCUSSION 
Farm characteristics and study design 
This study provides a first attempt to study and compare biosecurity practices in pig production in 
several European countries. Yet when interpreting the results, some caution is needed as this study, 
like any observational study, has some limitations. As the willingness to participate and share 
information by the farmer was an important selection criterion, it is likely that the participating farmers 
were representing the better end of the population, resulting in a possible selection bias. Since farmers 
were recruited in slightly different ways in the four countries this might have led to a participation bias 
as well. On the other hand the relative large number of herds included in each country enhances the 
representativeness. 
Although our criterion of including herds with ≥100 sows was not completely met (in total 10 farms 
had <100 sows), we were confident that our study was able to provide results which can be of interest 
for pig production in the participating countries. Participating herds were randomly selected within 
the regions in the four countries where the majority of pig production takes place. In Belgium there 
were +/- 5000 farms with sows in 2005, 34000 in Germany, 11000 in France and 2000 in Sweden 
(EUROSTAT, 2015a). The differences in these numbers indicate that our sample of 52 (Belgium) and 60 
(Germany, France and Sweden) only represents a small portion of total pig production in the four 
countries. The average herd size in our sampled herds (Belgium= 333 sows/herd, France= 200 
sows/herd, Germany= 396 sows/herd, Sweden= 249 sows/herd) suggested that our sample population 
had higher numbers of sows compared to the national average herd sizes in the countries (Belgium= 
210 sows/herd in 2013 (Belgian FPS Economy, 2013), France= 152-257 (depending on type of farm) in 
2011 (SSP-Agreste, 2010), Germany= 145 sows/herd in 2013 (German Federal Statistical Office, 2014) 
and Sweden= 190 in 2013 (Statistics Sweden, 2014)). Via the number of employees a higher number 
of sows was associated with a higher external biosecurity, indicating that our sampled herds might 
represent the better end of the national population. The observation that the number of sows was 
positively correlated with the number of employees at the farm was believed to be a logical 
consequence of the increased workload by an increasing number of sows. Regarding the differences 
in weaning age and ADG we can state that in Sweden it is legally required to wean at 28 days minimum 
(Regeringskansliet Sweden, 1988), while in the other countries the weaning age is often lower. Council 
directive 2008/120/EC mentions an official weaning age of 28 days, but allows weaning at 21 days 
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when certain minimal requirements are met (Council of the European Union, 2008). Furthermore, 
Sweden had a quite high ADG which is consistent with previous reports (Ingvar Eriksson, 2014).  
Biosecurity in the different countries 
The Biocheck.UGent™ system was proved by Laanen et al. (2010) to be a reliable and useful system in 
the comparison and quantification of the biosecurity status in Belgian pig herds. It also allows for 
objective comparisons of the biosecurity level between countries on an overall herd and pathogen 
level, whereas other available systems focus more often on a specific pathogen (e.g. American 
Association of Swine Veterinarians (AASV) (2007) and Wageningen University (2008)). The results of 
this study clearly show that there is still room for improvement in the level of biosecurity in many pig 
herds in Belgium, France, Germany and Sweden. The large variation observed in the majority of the 
biosecurity subcategory scores in the different countries indicates that there were farmers who 
managed to adopt many more biosecurity measures compared to some of their colleague farmers. 
The obtained biosecurity scores for Belgium were comparable to the results described by Laanen et al. 
(2013), who carried out a study in Belgium in 2009-2010 using the same methodology 
(Biocheck.UGent™). For the other participating countries there were no comparable data on the 
biosecurity status available, highlighting the importance of this study to get a first insight in the 
biosecurity level in several countries measured with a common tool.  
The mutual low scoring subcategory for Belgium and France was “supply of fodder, water and 
equipment” for external biosecurity. Often this is related to less structured farmyard logistics and the 
necessity for supplying companies to enter the premises and violating the “clean or herd-specific area”. 
Another important factor in this subcategory is the lack of regular chemical and microbiological testing 
of the water quality.  
Furthermore, the results of the Biocheck.UGent™ scoring system do provide valuable information on 
the possible topics for improvement both at the country specific or overall level. For example, when 
looking at the standard deviation we noticed that mainly in the subcategory “vermin and bird control” 
there was still room for improvement (x=̄ 68.7, SD= 20.1), while for “purchasing policy” there was less 
room for improvement (x=̄ 84.1, SD= 14.4). A difference between countries, which might need country-
specific advice, was for example seen for “management of diseases” which scored low in Belgium (x=̄ 
55.4, SD= 21.6) and higher in Sweden (x=̄ 69.7, SD= 27.2), with for both countries a high SD indicating 
that improvements at herd-level are still possible in both countries. For “location and environment” 
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we also noted a large variation, but this is a subcategory where interventions are generally more 
difficult to implement. For Belgium attention could be paid to the “farrowing and suckling period” since 
the other countries show that higher scores for biosecurity can be obtained. Belgium, Germany and 
Sweden could also try to improve the subcategory “compartmentalization, working lines and 
equipment”, since results from the French herds show that this is possible. An interesting difference 
was also seen in the score for the “nursery period”, where Sweden was scoring higher and Germany 
also scored higher. The subcategory “nursery period” is largely influenced by the high weight factor for 
the score for the maximum pig stocking density (Supplementary data in Laanen et al. (2013)), which is 
lower in Sweden because of Swedish legislation (Regeringskansliet Sweden, 1988). The same applies, 
to a lesser extent, to the fattening period.  
The higher external biosecurity score compared to the internal score could be explained by the idea 
that it is easier for a farmer to impose rules upon external visitors which are more related to external 
biosecurity in comparison to altering their own habits which are more related to internal biosecurity, 
which is in line with findings of Gunn et al. (2008) and Laanen et al. (2013). Another reason might be 
that farmers may be more aware of the risk of introduction of disease/pathogens from other herds or 
sources (Visschers et al., 2015). However, the findings of this study suggest that improvement in both 
internal and external biosecurity was still possible in all countries since we observed a large range. The 
internal biosecurity might offer the best starting point for an improvement of the biosecurity status. 
(Laanen et al., 2013).  
Link between biosecurity and farm characteristics 
We identified and quantified associations between the level of biosecurity and farm characteristics 
and production parameters, but it should be stressed that these results were obtained in a cross-
sectional study, which does not allow to identify causal relationships. However, by designing a likely 
causal path before executing the statistical analysis we tried to overcome part of this limitation. Since 
differences per country were likely to occur due to differences in cultures and habits, regulations, pig 
production structure, disease prevalence and external factors such as e.g. the presence of wild boars 
it was decided upon to include country as a fixed variable in all models to ensure correction for these 
effects. 
The implementation of biosecurity measures can be considered as a proxy of overall herd 
management, therefore the observed associations could also be related to other herd factors as 
mentioned above. Although the information gathered on the production parameters and herd 
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management were collected for the preceding year and the biosecurity status was measured at the 
moment of the herd visit, to our belief this did not influence the quality of the collected data. 
Figure 18 shows that the internal biosecurity level associates with the level of vaccination (against how 
many pathogens was being vaccinated). This indicates that herds with a possible better understanding 
of the risks of transmission of disease within the herd tend to take more preventive measures such as 
improving their biosecurity status and ensure a good immunity status of the animals by vaccinating 
against a large number of pathogens.  
The external biosecurity was linked to the number of weaned piglets per sow per year; a 10 point 
higher external biosecurity score resulted in our study in 0.2 piglets extra weaned in the multivariable 
model (Figure 19).  
 
Figure 19 Link between the external biosecurity score in farrow-to-finish pig herds and the number of 
weaned piglets per sow per year. The dark line represents the fitted line for the association over all 
combined data. The different countries are represented by different markers. 
Link between frequency of treatment against certain disease symptoms, as a proxy for disease 
incidence and biosecurity level 
The estimated frequency of treatment against prelisted categories of disease symptoms was used as a 
proxy for the disease incidence in the studied herds. It should be noted however that this is a rough 
and subjective unit of measurement. However, the negative association found between the used 
parameter as a proxy for disease incidence and the level of biosecurity does suggest a lower level of 
disease in herds with better biosecurity indicating that indeed biosecurity could be seen as a tool for 
disease prevention as suggested before (Amass and Clark, 1999; Maes et al., 2004; Casal et al., 2007; 
European Commission, 2007; Maes et al., 2007; Gunn et al., 2008; Brockhoff et al., 2009; Brennan and 
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Christley, 2012). The association was seen in relation with the internal biosecurity, which could be 
explained by the fact that part of the pre-listed symptoms, e.g. lameness and skin problems, might be 
associated with management and pig-to-pig transmissible diseases by the farmer. On the other hand, 
the association with the external biosecurity could be explained by the reduced risk of introduction of 
disease, for example in the case of respiratory pathogens. A more thorough analysis of more detailed 
information on actual disease incidence or AMU might provide more clear insights on these 
associations. 
 
CONCLUSIONS 
This cross-sectional study on 232 selected pig herds in Belgium, France, Germany and Sweden showed 
that there is substantial room for improvement in the biosecurity status in many herds. Belgium 
showed the lowest total and internal biosecurity score and France had the lowest external biosecurity 
score. Sweden had the highest scores for total and internal biosecurity and Germany the highest 
external biosecurity score.  
Both the internal and external biosecurity scores were significantly associated with the country and 
each other.  
Herds with more sows and subsequently more employees were likely to have a higher external 
biosecurity score. A higher external biosecurity score positively influenced the number of weaned 
piglets per sow per year and the internal biosecurity score. Other paths were also found relevant in 
the associations between herd management, production and biosecurity. 
These results may be relevant in guiding pig farmers towards better biosecurity levels as a tool to 
achieve improved animal health and production.   
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ABSTRACT 
Background 
High antimicrobial usage (AMU) and the threat of antimicrobial resistance (AMR) highlighted the need 
for reduced AMU in pig production. Prevention of disease however, is necessary to obtain a reduced 
need for AM treatment. This study aimed at assessing possible associations between the biosecurity 
level, AMU and farm and production characteristics in order to advice on best practices for a low AMU 
and maximum animal health and production. 
A cross-sectional study was conducted in 227 farrow-to-finish pig herds in Belgium, France, Germany 
and Sweden between December 2012 and December 2013. Associations between biosecurity status, 
AMU, and production parameters were evaluated with multivariable general linear models, according 
to an assumed causal pathway. 
Results 
The results showed that higher AMU in sows tended to be associated with higher AMU from birth until 
slaughter (p= 0.06). The AMU from birth until slaughter was positively associated with the number of 
pathogens vaccinated against (p< 0.01). A shorter farrowing rhythm (p< 0.01) and a younger weaning 
age (p= 0.06) tended to be also associated with a higher AMU from birth until slaughter whereas a 
better external biosecurity (p< 0.01) was related with a lower AMU from birth until slaughter. 
Conclusion 
Management practices such as weaning age and biosecurity measures may be important factors 
indirectly impacting on AMU. We therefore promote a holistic approach when assessing the potential 
to reduce the need for antimicrobial (AM) treatments. 
 
 
INTRODUCTION 
In many countries of the European Union (EU) pig production is amongst one of the sectors using the 
most AM agents in animal production as reported in detail for some EU countries (Callens et al., 2012a; 
Filippitzi et al., 2014; MARAN et al., 2014). After the discovery of penicillin by Fleming in 1928 and its 
subsequent usage around World War II antimicrobials (AMs) became very important to cure bacterial 
infections in both humans and animals. Unfortunately however, bacteria are capable of developing 
resistance mechanisms against the AMs used, either by genetic mutations or by taking up resistance 
genes from other bacteria (WHO, 2015b). This resistance selection is mainly triggered by the use of 
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AMs (Callens et al., 2015 submitted). EU countries with a high AMU rank also high in their resistance 
levels (Chantziaras et al., 2014). Therefore, reduced and prudent AMU in animals became of high 
interest in recent years, mainly due to the public health threat of antimicrobial resistance (AMR) 
development and possible transmission from the animal to the human population (Wegener, 2012; 
Delia Grace, 2015; Dorado-García et al., 2015; European Food Safety Authority (EFSA) and European 
Centre for Disease Prevention and Control (ECDC), 2015). The first efforts in some EU countries show 
that a reduced usage of AMs results in reduction of resistance levels as well (MARAN et al., 2014; 
Aarestrup, 2015), which is the main focus of the international fight against AMR in animal production 
(European Commission, 2011a). 
To be able to reduce AMU, it is important to ensure healthier animals and therefore reduce the 
necessity for AM treatment. Some authors have suggested a broad range of possible alternatives (Seal 
et al., 2013; Cheng et al., 2014; Postma et al., 2015b), for example the increased use of vaccines to 
make animals less sensitive to infections (Adam, 2009; Bak and Rathkjen, 2009; Brockhoff et al., 2009; 
Aerts and Wertenbroek, 2011) or an improved management and increased biosecurity level (Laanen 
et al., 2013; Postma et al., 2016b). However, several of these suggested alternatives are based upon 
clinical observations or rational deduction rather than quantitative observations making them prone 
to critics due to insufficient scientific bases of their efficacy for the replacement of AMs.   
Therefore, a good insight in the associations between preventive measures, management factors, 
production parameters, biosecurity status and AMU is of critical importance to better understand the 
value of the different alternatives and to help herd advisors and farmers in the optimization of their 
farm management. Knowing whether such associations exist provides researchers, farmers, herd 
advisors (e.g. veterinarian, feed advisor, climate specialist) and policy makers with potential tools to 
improve herd production combined with reduced necessity of AM products.  
This study aimed at studying and visualizing associations between management characteristics, 
production parameters, biosecurity status and AMU data from four EU countries. The results of this 
study will be used by the MINAPIG consortium to study the implementation of high biosecurity, 
vaccines and herd health management measures as potential drivers for reduced AMU in pig 
production. 
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METHODS 
Herd selection 
This study was performed in four EU countries with a medium to highly intensive pig production 
(Marquer et al., 2014) namely Belgium, France, Germany and Sweden. Per country the aim was to 
include 60 farrow-to-finish herds with ≥ 100 sows and ≥ 500 finishers. For Belgium an email list of pig 
farmers who subscribed to a newsletter issued by the faculty of veterinary medicine of Ghent 
University was used to select the herds based on willingness to participate. Only the Dutch speaking 
part of Belgium, Flanders, which represents 90% of pig production in Belgium (VILT - VLaams 
Infocentrum Land- en Tuinbouw, 2010), was included in the study due to logistic reasons. Herds in the 
north-western part of France, representing 75% of the country’s pig production, were randomly 
selected from a database of the Institute for pig and pork industry. In Germany the herds were selected 
from consultancy circles and with veterinarians’ input in the three regions with the largest pig 
production, Niedersachsen, Nordrhein-Westfalen and Mecklenburg-Vorpommern (64% of total 
German production) (Statistisches Bundesamt, 2014a). A request for participation by their herd 
veterinarian or a consortium partner was used to reach the 60 participating pig farmers in Sweden. 
Finally in Belgium 52 herds participated in this retrospective study and in the other three countries 
there were 60 participants. For five Belgian herds the information on the AMU was not complete, 
resulting in a total of 47 herds used in the analyses for Belgium and a total of 227 herds in the study. 
Our criterion of including herds with ≥100 sows had to be lowered to ≥70 sows to reach the maximum 
of participating herds. Three Belgian herds, six French herds and one Swedish herd had a number of 
sows between 70 and 100.  
Herd visit 
A strict protocol was used to visit and interview the participating herds, guaranteeing a similar 
collection and entry of data over the countries. Interviewers received a training to standardize the 
method for data collection. Furthermore, the participating herds were visited by one 
veterinarian/researcher in Belgium, one in France and one in Germany and by two 
veterinarians/researchers or a veterinarian from the Swedish Animal Health Service (n=15) in Sweden. 
Agreement between the project partners on the completeness and accuracy of the herd visit protocol 
was reached by consultation, discussion and consensus. 
Herds were visited once on a convenient day in the period between December 2012 and December 
2013. A farm inspection in combination with the completion of the questionnaire was performed by 
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the interviewer during the herd visit. The collected herd management and technical parameter 
information corresponded to the year preceding the herd visit. 
Data collection 
Technical parameters (e.g. number of weaned piglets per sow per year (WSY)) and herd management 
characteristics (e.g. farrowing rhythm) were collected, together with information on the biosecurity 
status of the herd using the risk-based scoring system Biocheck.UGent™ (www.Biocheck.UGent.be). 
The technical parameters were collected from the herd management system if available or by 
interviewing the farmer.  
The farrowing rhythm refers to the interval, expressed in weeks, between the birth of two batches of 
piglets. In this study this ranged between a 1-week system and a 5-week system for Belgium, France 
and Germany, while in Sweden systems with a farrowing rhythm of over 5-weeks were also used. The 
latter were coded for analysis as >5-week systems. The number of weaned piglets per sow per year 
was calculated as the number of litters per year times the number of liveborn piglets per sow minus 
the mortality until weaning. The weaning age was expressed as the average duration, in days, from the 
birth of a piglet until it was weaned. The number of pathogens vaccinated against was created by 
summing up all vaccinations used in a herd, either for sows, boars, gilts or piglets on the date of the 
herd visit, except the vaccine used for immune-castration of male animals. For combination vaccines 
every single pathogen they have activity against was accounted for separately. Anti-inflammatory, 
anti-coccidial and zinc-oxide usage was expressed as being applied yes or no. A more detailed 
description of the other variables mentioned in Table 17, such as the gender and education level, can 
be found in (Postma et al., 2016b). The questionnaire can be obtained upon request from the first 
author. 
Biosecurity quantification 
The biosecurity status of the participating farms was quantified by using the risk-based tool 
Biocheck.UGent™ (Ghent University, 2010a). This assessment tool makes comparison of the 
biosecurity status of herds within and between countries possible by returning 109, mainly 
dichotomous and trichotomous, questions into a score from 0 to 100 for both external and internal 
biosecurity, where zero means absolute lack of any biosecurity measures and 100 means declaration 
of full application of all assessed biosecurity measures. The Biocheck.UGent™ consists of 6 
subcategories for internal biosecurity (1. disease management, 2. farrowing and suckling period, 3. 
nursing unit, 4. fattening unit, 5. measures between compartments, 6. working lines) and 6 for external 
biosecurity (1. purchase of breeding pigs, 2. purchase of piglets, 3. artificial insemination, 4. transport 
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of animals, 5. feed and water supply, 6. removal of manure and dead animals). The Biocheck.UGent™ 
system is described in more detail in Laanen et al. (Laanen et al., 2010; Laanen et al., 2013), Backhans 
et al. (Backhans et al., 2015) and Postma et al. (2016b) in which it has shown to be a comprehensive, 
repeatable scoring system with a predictive and discriminating validity. 
Antimicrobial usage quantification 
Information on the AMU for the preceding year in Belgium, Germany and Sweden, and the last batch 
in France, was collected at in point in time. Invoices from the veterinarian and feed company combined 
with information from the farmer were used in Belgium. In France this information came from the 
journal of treatment of and interview with the farmer. While in Germany the delivery and treatment 
forms from the prescribing veterinarian were used. In Sweden paper copies derived from treatment 
records, which are mandatory and inspected by the county administration board, were used. 
From the collected information the product name including details such as formulation and 
concentration, amount purchased/used and the animal category in which it was used were registered. 
If the animal category in which the product was used was not explicitly mentioned on the invoice, the 
farmer was asked to provide more information. 
Herd level AMU data were used to calculate the “treatment incidence” (TI) per herd and age category 
by the formula described below and as described and used before in several publications (Timmerman 
et al., 2006; Callens et al., 2012a; Laanen et al., 2013; Sjölund et al., 2015). 
TI =
Total amount of antimicrobials administered (mg)
DDDA (
mg
kg ) ∗ number of days at risk ∗ kg animal at risk
∗ 1000 pigs at risk 
The TI is a technical unit of measurement that quantifies how many animals out of a theoretical group 
of 1000 animals received daily an AM treatment. Or, if one animal would live for a theoretical period 
of 1000 days, how many of these days it would have been treated with an AM. Divided by 10 this gives 
the percentage of the lifespan an average animal on this herd was treated with a daily dose of AMs. 
Combined TI’s were calculated for sows, gilts and boars (TI Breeding) and over a standardized period 
at risk of 200 days for the lifespan of a pig from birth until slaughter (TI 200). The 200 days, as the 
standard duration between birth and slaughter, was agreed upon based on consensus between the 
project partners from the participating countries. This TI 200 days makes it easier to compare the usage 
over countries, since the period at risk is standardized between these countries. For sows the period 
at risk was set to one year. 
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To be able to compare the usage over countries a standardised assumed weight at treatment was set 
for the different age categories; suckling piglet = 2 kg, weaner = 7 kg, finisher = 35 kg, sow = 220 kg. 
Furthermore, to be able to compare the different products and their concentrations within similar AM 
classes used in the different countries, a consensus defined daily dose animal (DDDA) per AM class, 
including consensus long acting factors, were established. The procedure used to come to these 
consensus DDDAs was extensively described in Postma et al. (Postma et al., 2015a). 
Data processing 
A LOG transformation of the data for the number of sows as an outcome variable (data not shown) in 
the regression models was needed to correct for the right skewedness of this variable. 
Outcomes for TI 200 and TI breeding were also LOG transformed using SPSS statistics 22 (IBM), after 
adding one to the original outcome to adjust for zero values in the data.  
Biocheck.UGent™ is a webbased scoring system using Limesurvey. 
Statistical analysis 
Initially all possible causal routes linking AMU, biosecurity status, herd characteristics and technical 
parameters (e.g. number of sows, WSY, average daily weigh gain (ADG, g/day), mortalities (%)) were 
identified based on logical reasoning with the main focus on parameters influencing the AMU or the 
ones being influenced by the AMU. Subsequently each of the identified possible associations was 
assessed using a regression model with the specific predictor always in combination with country as a 
second predictor variable to account for country specific characteristics. 
All associations that showed a univariable p-value of < 0.20 were retained for the  multivariable analysis. 
The multivariable general linear model was constructed using the stepwise backward selection 
procedure, including testing of two-way interactions of significant main effects. Confounding effects 
were evaluated during the modelling process by checking changes in parameter estimates. The 
association in the multivariable linear regression model was considered significant if p< 0.05 and a p-
value between 0.05 and 0.10 was considered nearly significant and relevant to describe. Normal 
probability tests and plots were examined to check whether the assumptions of normality and 
homoscedasticity of residuals were fulfilled. 
All statistical analyses were performed using SPSS statistics 22 (IBM). All tested variables can be found 
in Table 17. 
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RESULTS 
Farm characteristics 
A 3-week farrowing rhythm system was most commonly used (80/227 herds). Followed by a 4 week 
system (48/227), a 1-week system (32/227), a 2-week system (21/227), a 5-week system (20/227) and 
a >5-week system (18/227). The mean weaning age was highest in Sweden (35 days) and lowest in 
Belgium (23.5 days). The mean number of piglets weaned per sow per year was comparable in Belgium 
(27.2, SD= 2.6), France (26.5, SD= 2.3) and Germany (27.4, SD= 2.3), but lower in Sweden (23.2, SD= 
2.3). In Belgium, France and Germany the number of pathogens vaccinated against had a median of 7, 
while in Sweden this was 4. Out of 227 herds, 71 reported to use anti-inflammatory products in the 
weaners, while 90 out of 227 used anti-coccidial products in the suckling piglets.  
Other herd characteristics of interest were described in more detail in the publication of Postma et al. 
(2016b).  
Biosecurity status 
The external biosecurity level (65.5, range 43-93) was overall higher compared to the internal 
biosecurity level (55.7, range 6-88). External biosecurity was highest in Germany (70.2) and lowest in 
France (59.4), while the internal biosecurity level was highest in Sweden (58.8) and lowest in Belgium 
(50.3). In Postma et al. (2016b) results of the biosecurity quantification in the herds in the four 
participating countries and the link with production characteristics were described in detail. Since five 
Belgian herds were lacking information on AMU they were removed from analysis in this study, 
resulting in slightly different results compared to the ones published in Postma et al. (2016b). 
Antimicrobial usage 
Average AMU in the breeding animals (23.0) was lower compared to the usage from birth until 
slaughter (TI 200) in the growing pigs (128.3). For both the TI 200 days (Sweden= 22.7; Germany= 
242.8) and the TI breeding animals (Sweden= 10.9, Germany= 42.0) Sweden was the lowest using 
country and Germany the highest.  
The quantification of the AMU and the results in the four countries is described in detail in Sjölund et 
al. (Sjölund et al., 2016, submitted).  
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Associations between antimicrobial usage, biosecurity level and farm characteristics  
The country corrected univariable analysis resulted in retaining several variables related with the AMU 
or with each other (Table 17). The associations that remained significant in the multivariable models 
are shown in the causal path in Figure 20. 
The multivariable model for the LOG TI Breeding, corrected for the country effect showed significant 
associations with the LOG TI 200 (p< 0.01). A higher AMU in the breeders was associated with a higher 
antimicrobial usage in the growing pigs (LOG TI 200). 
The LOG TI Breeders was positively associated with the number of WSY (p= 0.06), meaning that farms 
with a higher AMU in the breeding animals on average weaned slightly more piglets, however, the ß-
value was low. 
For the LOG TI 200 the multivariable model showed, after correction for a possible country effect, 
three variables that were directly associated with the AMU from birth until slaughter and one that was 
nearly significant.  
The LOG TI 200 was associated with the weaning age (p= 0.06); herds with a higher weaning age 
showed a lower TI 200. A significant (p< 0.01) lower TI 200 was observed for 5-week or >5-week 
systems in comparison to 1-week system. Also for 2-, 3- and 4-week systems a non-significant trend 
towards a lower TI 200 was observed in comparison to a one week system. Herds with a higher score 
on their external biosecurity status also showed a lower TI 200 (p< 0.01). While herds vaccinating 
against more pathogens showed a higher TI 200 (p< 0.01). 
It should be noted that parameters such as the internal biosecurity level, number of sows or employees, 
gender of the responsible person in the farrowing unit, the education level of the responsible person 
or the use of products like zinc oxide were not retained in any of the multivariable models associated 
with AMU. The level of AMU furthermore was not significantly associated with production parameters 
such as the ADG or the mortality until weaning. 
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Table 17 Results of univariable and multivariable general linear regression models. LOG = log 
transformation. Light gray values in the univariable model indicate that these factors were not 
significant (p < 0.20) in the univariable model. In the multivariable model p-values which are significant 
with p< 0.05 are black and bold, 0.05<p<0.10 are black and p> 0.10 are light gray. Significant 
interactions are listed where applicable. All models were corrected for the country effect by adding 
country in the model as a fixed variable. Only relevant variables are listed. 
   
COUNTRY CORRECTED 
UNIVARIABLE 
COUNTRY CORRECTED 
MULTIVARIABLE 
OUTCOME 
VARIABLE 
RISK FACTOR N 
Β-
COEFFICIENT 
P-
VALUE 
ADJUSTED 
R2 
Β-
COEFFICIENT 
P-VALUE 
LOG TI 
Breeding 
TI 200 227 <0.01 <0.01 0.148 <0.01 0.01 
 Internal biosecurity 227 0.22 0.36 0.073   
 External biosecurity 227 0.51 0.08 0.083   
 Years experience 221 -0.07 0.81 0.071   
 Pathogens vaccinated 227 2.35 0.14 0.079   
 # sows 227 0.01 0.33 0.074   
 # employees 221 0.43 0.78 0.066   
 Gender 214  0.60 0.071   
 Male 137 3.14 0.60    
 Female 77 Ref. Ref.    
 Education 210  0.11 0.082   
 Lower 84 -15.47 0.05    
 Higher 84 -15.77 0.06    
 University 42 Ref.  Ref.    
 Farrowing rhythm (cat) 219  0.76 0.060   
 >5 18 -0.81 0.95    
 5 20 2.76 0.82    
 4 48 -1.34 0.89    
 3 80 4.33 0.62    
 2 21 14.94 0.20    
 1 32 Ref. Ref.    
LOG TI 200 TI Breeding 227 <0.01 <0.01 0.332 <0.01 <0.01 
 Internal biosecurity 227 -0.01 0.11 0.325   
 External biosecurity 227 -0.02 0.01 0.353 -0.03 <0.01 
 Weaning age 216 -0.05 0.05 0.335 -0.05 0.06 
 Years experience 221 <0.01 0.28 0.324   
 Pathogens vaccinated 227 0.18 <0.01 0.355 0.14 <0.01 
 # sows 227 <0.01 0.01 0.346   
 # employees 221 0.05 0.32 0.315   
 Gender 214  0.51 0.313   
 Male 137 0.11 0.51    
 Female 77 Ref. Ref.    
 Education 210  0.39 0.331   
 Lower 84 0.07 0.77    
 Higher 84 0.28 0.24    
 University 42 Ref. Ref.    
 Zinc oxide 205  0.29 0.310   
 Yes 39 0.25 0.29    
 No 166 Ref. Ref.    
 
Anti-inflammatory 
weaners 
227  0.05 0.338   
 Yes 71 0.37 0.05    
 No 156 Ref. Ref.    
EVALUATION  BIOSECURITY, PRODUCTION & AMU CHAPTER 6 
184  
 
   
COUNTRY 
CORRECTED 
UNIVARIABLE 
COUNTRY 
CORRECTED 
MULTIVARIABLE 
   
OUTCOME 
VARIABLE 
RISK FACTOR N 
Β-
COEFFICIENT 
P-VALUE 
OUTCOME 
VARIABLE 
RISK 
FACTOR 
N 
        
 Anti-coccidial 214  0.10 0.313   
 Yes 90 0.28 0.10    
 No 124 Ref. Ref.    
 Farrowing rhythm 219  <0.01 0.360  <0.01 
 >5 18 -0.78 0.05  -0.88 0.02 
 5 20 -1.15 <0.01  -1.10 <0.01 
 4 48 -0.51 0.07  -0.44 0.11 
 3 80 -0.38 0.12  -0.21 0.42 
 2 21 0.10 0.75  -0.06 0.85 
 1 32 Ref. Ref.  Ref. Ref. 
Number of 
weaned 
piglets per 
sow per year 
(WSY) 
Years experience 217 -0.02 0.27 0.354   
External biosecurity 223 0.05 <0.01 0.362   
Internal biosecurity 223 0.03 0.06 
0.349 
  
 Weaning age 212 -0.17 <0.01 0.367 -0.19 <0.01 
 Pathogens vaccinated 223 0.18 0.06 0.349   
 Mortality till weaning 222 -0.18 <0.01 0.423 -0.21 <0.01 
 #sows 223 <0.01 <0.01 0.391   
 #employees 217 0.22 0.02 0.359   
 TI Breeding 223 0.01 <0.01 0.362 0.01 0.06 
 TI 200 223 <0.01 0.71 0.339   
 
Anti-inflammatory 
sucklers  
223      
 Yes 122 0.43 0.39 0.340   
 No 105 Ref. Ref.    
 
Anti-inflammatory 
weaners  
223      
 Yes 71 0.57 0.13 0.345   
 No 156 Ref. Ref.    
 
Anti-inflammatory 
sows  
215      
 Yes 217 1.18 0.49 0.343   
 No 2 Ref. Ref.    
 Anti-coccidial  211      
 Yes 90 0.08 0.82 0.337   
 No 124 Ref. Ref.    
 Zinc oxide  201      
 Yes 39 0.86 0.06 0.363   
 No 166 Ref. Ref.    
 
Country * Weaning 
age 
     0.02 
 
Belgium * Weaning 
age 
    -0.20 0.18 
 France * Weaning age     0.21 0.04 
 
Germany * Weaning 
age 
    0.15 0.18 
 
Sweden * Weaning 
age 
    Ref. Ref. 
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Figure 20 Causal pathway associations for TI 200 days and TI Breeding. Causal pathway with statistically significant associations in the multivariable models 
for the TI 200 days and the TI Breeding associated with production, management or biosecurity variables. TI= treatment incidence (antimicrobial usage 
quantification), WSY= number of weaned piglets per sow per year. Black lines represent the result of a multivariable linear regression analysis based on data 
from 4 EU countries. The light gray line indicates 0.05<p<0.10. The p-values and β-values correspond to the multivariable model. All models were corrected 
for the country effect by placing country as a fixed variable in the model, hence the circle around the figure. 
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DISCUSSION 
By showing associations between a higher level of biosecurity, a longer farrowing rhythm or weaning 
at an older age and a reduced AMU the aim of this study was met and the results of this paper have 
the potential to advise on best practices.  
Associations between antimicrobial usage, biosecurity level and farm characteristics  
To overcome national differences in cultures, habits, regulations, pig production structure, disease 
prevalence and other external factors all models were corrected for country by adding country as a 
fixed factor in all models. The obtained associations are therefore corrected for the country effect and 
interaction with country was tested as well. 
In Figure 20 the causal pathway shows an association (p= 0.06) between the TI Breeding and the 
number of weaned piglets (WSY). Improved piglet survival might be the result of a more active 
presence in the farrowing unit by the farmer during the farrowing period, which is the most likely 
period of AM treatment for sows. When better attention is paid during the farrowing process piglet 
survival might improve, resulting in more weaned piglets per sow per year (Kirkden et al., 2013; 
Kraeling and Webel, 2015). Another possible explanation for the positive association between the TI 
Breeding and the WSY could be the increase in the farrowing index due to a positive effect of the AMU 
in the reduced incidence of mastitis and endometritis problems in the sows. A healthy sow might also 
nurse her piglets better, resulting in a more optimal transmission of maternal antibodies. Although we 
assumed in the causal pathway that treatment of breeders could have an effect on the number of 
weaned piglets per sow per year, it may also be possible that in fact the association could be reversed 
and that high productive sows are more sensitive to diseases and require more AM treatments, in 
which case the higher productivity would lead to a higher TI Breeding. Other unmeasured factors might 
have also influenced this outcome. In all cases we should keep in mind that the association we found 
was only minor, with a low ß-coefficient and should therefore not be used as an excuse to increase 
AMU in breeding animals. Furthermore, AMU in the sow was recently negative associated with the 
bacterial gut flora and AMR levels of the piglet (Callens et al., 2014). 
The link between the level of usage in the breeding animals with the level of usage in pigs from birth 
to slaughter was expected, as a high overall disease pressure in a herd may explain the high usage in 
both breeding animals and the animals from birth until slaughter. A limited number of herds 
concentrated the majority of AM treatments and a certain attitude/behaviour of the farmer towards 
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regular usage of medicines might be another explanation for the association between usage in 
breeding animals and growers (Visschers et al., 2015). 
Vaccines are used to improve the immunity status of the animals which should result in a reduced risk 
for animals to become diseased and subsequently leading to a reduced need for AM treatment. 
Therefore vaccines are often suggested as a suitable alternative for AMU (McEwen and Fedorka-Cray, 
2002; Andrew Potter et al., 2008; Allen et al., 2013; Allen et al., 2014; Aarestrup, 2015; Postma et al., 
2015b). This is an apparent contradiction with the observed positive association between the number 
of pathogens vaccinated against and the TI 200 in the present study, although this was also observed 
by Temtem et al. (Temtem et al., 2015). This association might be due to a high disease pressure on 
these herds which has not (yet) been brought under control through vaccination, due to insufficient 
detection of disease, or it might again be an indication of a certain attitude of the farmer and/or his 
veterinarian, i.e. using/prescribing a lot of veterinary medicinal products as an insurance against 
disease (Speksnijder et al., 2015a; Visschers et al., 2015). This association could be further explored by 
looking at vaccination details, disease pressure and AM treatment indications. 
The association we found between the weaning age (p= 0.06) and TI 200 suggests that a higher 
weaning age results in healthier, more robust animals who have a reduced necessity for AMs. This is 
in agreement with the idea that stronger animals, for example when weaned at a later age, are also 
more likely to have better coping abilities against possible (pathogenic) threats (The Pig Site; Thomson 
and Friendship, 2012b).  
For the farrowing rhythm we found that a 5-week and ≥ 5-week system were significantly associated 
with a lower AMU. Also for 2-, 3- and 4-week systems a non-significant trend towards a lower TI 200 
was observed in comparison to a one week system. We did furthermore see that the herds with a 3-
week system had on average a higher weaning age, while for example a 4-week system had lower 
average weaning ages in Belgium, France and Germany (Postma et al., 2016b). However, since both 
variables were included in the multivariable model this indirect effect was already accounted for and 
the single effects of the farrowing rhythm and the weaning age on the TI 200 both hold strong. One 
explanation for the lower TI 200 in longer farrowing rhythms might be that a longer period in-between 
two batches guarantees a better separation between the age groups and allows for more cleaning and 
disinfection time, resulting in less risk of transmission of pathogens between them. For example 
Nathues et al. (Nathues et al., 2013) showed that piglets within a herd with a 3-week system were less 
likely to be infected with Mycoplasma hyopneumoniae compared to a 2-week system. His findings did 
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not hold true for a 4-week system, but more pathogens and factors most likely influence our finding 
and not only M. hyopneumoniae, resulting in a positive effect in general for the longer farrowing 
rhythms. 
Both the better results related to a longer farrowing rhythm and even more important the finding that 
a higher weaning age lead to a lower TI 200 might be of great relevance in future advising of pig farmers 
to reduce their AMU. Further research should investigate this association in more detail and determine 
whether this trend can be confirmed. If so, it would be possible to reduce AMU by developing more 
strict regulation and legislation on the weaning age. 
A last important finding was the association between the level of external biosecurity and the TI 200 
(p< 0.01). External biosecurity controls the risk of entrance and exit of pathogens into a herd. 
Introduction of pathogens from an outside source poses the largest risk for disease onset in pig 
production (Ribbens et al., 2009; Ghent University, 2010a; Lambert et al., 2012a; Lewerin et al., 2015). 
When we would be able to reduce this risk it is also likely that less AMs would be needed (European 
Commission, 2007, 2011b). Moreover, external and internal biosecurity are shown to be highly 
correlated to each other (Postma et al., 2016b). Due to this association internal biosecurity 
improvement might also have an effect on the AMU from birth until slaughter. Laanen et al. (Laanen 
et al., 2013) showed this association between internal biosecurity and TI in her study performed in 
Belgium in 2009-2010. Since improvement of the internal biosecurity level could be a rather simple 
intervention (e.g. strict hygiene protocols, correct use of working lines) at herd level, this might be an 
important consideration in the reduction of AMU. 
We should also stress that no significant positive associations were found between a higher usage and 
better production results such as ADG or mortality, as also supported by a paper of van der Fels-Klerx 
et al. (van der Fels-Klerx et al., 2011). Although it is sometimes suggested that the use of AMs results 
in heavier pigs, as also stimulated in earlier years by the use of AM growth promotors in the feed, we 
did not find a significant link in this study. In the EU the use of AM growth promotors in feed was 
banned since 2006 (European commission, 2005). The use of zinc oxide also showed no association 
with AMU, although often it is promoted as an alternative in the reduction of AMU (Wierup, 2001; 
Postma et al., 2015b). Unknown however, was how long the herds already used zinc oxide and whether 
this could already have affected their AMU. Improved health of the pigs might result in a better ADG 
and lower mortality, however, no significant direct association between these and the AMU was found 
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and most likely more factors were of importance in the herds’ ADG and mortality results. Results 
suggest that administering AMs did not improve technical results. 
Future studies should try to confirm the above presented findings so that they could be validated as 
successful actions in the reduction of AMU.  
Study design and limitations 
Only a limited number of studies have investigated the associations between production parameters, 
other herd characteristics and AMU (Laanen et al., 2013). A recent review of Aarestrup (Aarestrup, 
2015) emphasizes the need for research on effects of interventions. The current study attempts to 
provide a first overview of the associations between production parameters, preventive measures 
such as high biosecurity status and vaccination level and herd and management characteristics with 
the level of AMU. Knowledge on these associations might be used as input for future intervention 
studies. 
We should however, be aware that this study is likely influenced by the fact that the participating 
farmers resembled the better end of the population since their selection was based on willingness to 
participate (except in France where random sampling was used, by selecting herds from the database 
of Institute for pig and pork industry including on average 53% of herds located in North-West France 
with >49 sows) and interest in the topic, resulting in a selection bias. Variability between researchers 
was minimized by providing all interviewers with the same training in execution of the questionnaire 
form, however, it might have caused some random noise as well. In France information on AMU was 
collected from the last batch whereas for the other countries the year preceding the herd visit was 
used. This could have led to a limited bias due to difference in disease prevalence in combination with 
seasonal influences. Recall bias was considered to be of minimal importance since the majority of 
collected information was checked using visual inspection and/or documentation. We should also 
stress that the obtained associations were the result of a cross-sectional study design, not allowing to 
make direct causal conclusions. By designing the causal pathway however, we tried to give a clear 
overview of obtained associations. 
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CONCLUSIONS 
This cross-sectional study on 227 pig herds in Belgium, France, Germany and Sweden showed that the 
AMU in breeding animals tends to be positively associated with the number of weaned piglets per sow 
per year and the AMU from birth to slaughter (TI 200) in growing pigs. The TI 200 was shown to be 
lower in herds with a farrowing rhythm ≥5-weeks, a higher biosecurity status and tended to be lower 
with weaning of the piglets at an older age. Policy makers, herd advisors and farmers should benefit 
from this knowledge in order to reduce the AMU on pig herds. 
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ABSTRACT  
Antimicrobial usage (AMU) has been described to be high in pig production. Although farmers and 
veterinarians are aware of the high usage, little is known about intervention to improve the situation. 
The present study evaluated the extent to which AMU could be reduced in pig production by the 
optimization of herd management, biosecurity status, vaccination strategy, anthelmintic therapy and 
advice on prudent AMU. Furthermore, the effects of these interventions on the herd production 
results were explored.  
This intervention study was conducted on 61 Flemish pig herds and included three visits per herd. 
During the initial visit, information was gathered on herd management, biosecurity status (quantified 
by means of the Biocheck.UGent™ risk based scoring system), vaccination strategy, anthelmintic 
therapy and AMU. This info was then translated into a herd specific action plan which was discussed 
with the farmer and herd veterinarian/other advisors during the second visit. In the final herd visit (+/- 
8 months later), comparable data was obtained to evaluate the progress. Overall, a significant 
improvement of 2.4 points external and 7 points internal biosecurity on the herdsw as obtained, 
combined with additional vaccination, anthelmintic therapy and prudent AMU. This was accompanied 
by a significant reduction of the AMU with a decrease of 52% for the pigs from birth till slaughter and 
32% for breeding animals, based on treatment incidences (TIs) and included an important reduction in 
the use of critically important AMs. More importantly, the increased biosecurity levels and decreased 
AMU were combined with significantly improved technical results such as the number of weaned 
piglets per sow per year (+1.1), daily weight gain (+5.9 g/day) and mortality in the finisher period (-
0.6%). 
Guided interventions as a team effort of farmer and herd veterinarian/other advisors have shown to 
be a promising method in the reduction of AMU in pig production.  
  
IMPACTS  
- A promising route of action to achieve the reduction of AMU is the optimization of herd 
management, improvement of the biosecurity level and guidance on prudent AMU.  
- Implementation of these improvements as a team effort of the farmer in collaboration with 
experts, resulted in a significant reduction of 52% in AMU from birth till slaughter, and a further 
reduction of 32% in breeding animals. 
- On average, the production results were improved during the intervention period.   
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INTRODUCTION 
International organizations, such as the World Health Organization (WHO), as well as national and local 
organizations are requesting action to stop the development and expansion of resistance (AMR) 
(European Commission, 2011b; AMCRA, 2014d; FAO, 2015; OIE, 2015a; WHO, 2015a, c). Efforts need 
to be made in human medicine as well as in veterinary medicine to reduce AMU. Indeed, the usage of 
AMs in animal husbandry is high (McKenna, 2010; Landers et al., 2012). Usage in animals, might pose 
a risk to public health (Marshall and Levy, 2011; Aarestrup, 2015) through the selection of AMR 
(Lipsitch and Samore, 2002; McEwen and Fedorka-Cray, 2002; Chantziaras et al., 2014; Callens et al., 
2014). 
Reduced and prudent use of AMs in animal production might lead to a halt in the selection of resistant 
bacteria and could ultimately result in a reversion to susceptibility. The possibility of this reversion was 
recently shown in the Dutch report on AMR, where a remarkable decline in the resistance in 
commensal E. coli is observed since the strong reduction in AMU in animals has been  achieved 
(Speksnijder et al., 2015c; Van Geijlswijk et al., 2015). Similar patterns were observed in Denmark and 
Sweden (DANMAP, 2015; Swedres-Svarm, 2015). 
Within the animal production sector, pig production is one of the top sectors using AMs (Callens et al., 
2012a; Filippitzi et al., 2014; MARAN et al., 2014; Van Boeckel et al., 2015) and therefore a substantial 
decrease in the unnecessary use in pig production is required. To be able to achieve this reduction, it 
is important to assist and guide farmers in this process, since they are generally aware of the problems 
and risks, but not sufficiently knowledgeable on the implications  on herd level (Visschers et al., 2015). 
They are generally also willing to reduce their AMU but are insufficiently familiar with alternative 
solutions such as biosecurity improvements (Laanen et al., 2014; Postma et al., 2016a; Postma et al., 
2016b) and improved immunization through vaccination against infections such as ileitis (Adam, 2009; 
Coube et al., 2012), porcine proliferative enteropathy (Bak and Rathkjen, 2009), porcine circovirus 
(Brockhoff et al., 2009; Aerts and Wertenbroek, 2011; Coube et al., 2012; Koenders and Wertenbroek, 
2012), and Actinobacillus pleuropneumoniae (Del Pozo Sacristán et al., 2014).  
To provide farmers as well as veterinarians and other advisors on farms with good information on 
these alternatives, it is required that effects of aforementioned alternatives are illustrated under field 
conditions.  
Previous studies have provided information on the association between herd characteristics, disease 
problems and AMU (Hybschmann et al., 2011; Laanen et al., 2013; Fertner et al., 2015). The EU study 
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of the minapig consortium (Postma et al., 2016a; Postma et al., 2016b) indicated associations between 
biosecurity, improved production results (e.g. number of weaned piglets/sow/year) and reduced AMU. 
Information on national reduction and the related influence on productivity and evolution of diseases 
is also substantiated (DANMAP, 2015; MARAN, 2015; Swedres-Svarm, 2015). However, herd specific 
information on the possible reduction in AMU in a longitudinal intervention study over a relatively 
short period of time at herd level combined with a follow-up of the herds’ productivity was not yet 
available. 
The present study therefore aimed at evaluating the potential reduction of AMU and looking at the 
effect on performance characteristics, by promoting prudent usage combined with farm management 
optimization through the guidance of farmers. 
 
MATERIALS AND METHODS 
Herd selection 
Motivated farmers with a farrow to finish herd with minimum 150 sows located in Flanders that had 
sufficiently detailed technical/bookkeeping data were selected. Flanders represents 95% of produced 
pigs in Belgium (Statistics Belgium, 2015b). A call for farmers interested in collaboration was sent out 
through letters issued by the two initiating parties (Belpork vzw, 2015; Boerenbond, 2015), by means 
of publishing a request for expression of interest in participation in farmers magazines in Flanders and 
via an email newsletter issued by Ghent University. Upon expression of interest by the farmer or herd 
veterinarian, the details of the study were explained. After obtaining consent from both the farmer 
and the herd veterinarian, a date for the first herd visit was determined. Participants were independent 
farmers, not integrated within large pig production companies. 
First herd visit 
During the first herd visit, information was gathered on herd characteristics, management and 
technical performances of the herd. In addition, a biosecurity audit was performed by means of the 
Biocheck.UGentTM (Ghent University, 2010a) system. The farmer was notified that a tour around the 
farm would form part of the visit. The visits to all herds were performed by one and the same 
researcher. The herd veterinarian was asked to provide information on the purchased AMs, more 
specifically the exact product and volume, over the past year. A visit took on average 2 hours and 
consisted of, firstly, a visit to the stables where the normal routine and walking line of the farmer was 
followed, and secondly, an interview consisting to aid in data collection.  
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Follow up herd visits 
Based on the collected information, a herd specific action plan was prepared focusing on biosecurity 
interventions and preventive measures including vaccination and the prudent use of AMs. The 
proposed action plan  was first sent to the herd veterinarian for review. After approval the plan was 
discussed with the farmer, herd veterinarian and other advisors when applicable during a second herd 
visit. Interventions that were estimated to be feasible by the farmer and herd veterinarian were agreed 
upon to be implemented in the following months. These final agreements were listed and sent to the 
farmer and veterinarian by email in a summary document highlighting the action points for the 
forthcoming months. 
The current study was a longitudinal prospective study. The “initial situation” was considered to be the 
situation before the second herd visit. On average eight months after the second visit the herds were 
visited for a third time, the “situation after implementation”. The third visit was conducted using the 
same methodology as the first visit to estimate the impact of implementation between the initial 
situation and the situation after implementation. Implementation was assured by checking invoices 
and diagnostic results. 
Data collection 
Data was collected by means of a visual herd inspection during the visit of the herd and a paper and 
pencil questionnaire about the production results and herd management characteristics. 
The following information was collected: Name and contact information of the farmer and veterinarian, 
type of herd, herd management information including farrowing rhythm (week system) and, numbers 
of animals and duration of production rounds, information on the employees and buildings, the aim of 
the farmer in the next 5-10 years to enable tailor-made advice, technical parameters, information on 
(routine) prophylactic and curative AM treatments in the year preceding the first visit (product, age of 
treatment, weight at treatment, duration and dose and indication), motivation for AMU and reason to 
participate in the study, vaccination and anthelmintic treatment scheme (product, moment of 
treatment, duration), diagnostics results (date, type of test, result, action), and results of slaughter 
findings (date, number of animals, condemnation rate and reason). The original questionnaire form 
can be obtained from the first author, who collected the data and performed all herds visits. 
Technical parameters were retrieved from the herd management programme or bookkeeping data 
and included the following information: the number of weaned piglets per sow per year, growth 
performance (g/day) for the finisher period, mortality till weaning, mortality in the nursery, mortality 
in the finisher period and feed conversion rate (FCR) of the year preceding the visit. Availability of at 
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least two of these parameters was required as part of the selection criteria, although farmers turned 
out to be highly motivated to present all data. 
The level of biosecurity was quantified by means of the Biocheck.UGent™ risk based scoring system 
(Ghent University, 2010a). This tool has proven to be a reproducible, validated and comprehensive 
quantification tool for assessing biosecurity in pig herds (Laanen et al., 2010; Laanen et al., 2013; 
Backhans et al., 2015; Postma et al., 2016b). The scoring system provides a score for internal and 
external biosecurity, each in turn subdivided into 6 subcategories. The minimal final score is 0, 
indicating total absence of biosecurity measures and the maximal score is 100, indicating application 
of all described biosecurity measures. The Biocheck.UGent™ can be used for different herd types (e.g. 
farrow to finish; fattening and breeding) since the calculation of the scores is adapted to the animal 
categories present in the herd.  
Quantification of antimicrobial usage  
By using invoices obtained from the herd veterinarian and feed company (for medicated feed), 
information was gained on the purchased amounts of AMs (product name, formulation and 
concentration) in the year preceding the first herd visit. The farmer provided information on (routine) 
prophylactic treatments, which are AM treatments that are systematically provided at certain 
production stages/ages (e.g. castration or weaning). Specific information was furthermore gathered 
concerning the curative treatments and the animal categories these were applied for. With this 
information the AMU was quantified by calculating the “treatment incidence” (TI) per herd and per 
age category as described by Timmerman et al. (2006). 
The TI quantifies how many animals from a theoretical group of 1000 animals daily receive an AM 
treatment. A TI for standard treatment was calculated for the breeding animals (sows, gilts, boars), 
suckling piglets, weaned piglets and finishers. Furthermore, the AMU from birth till slaughter was 
quantified over a standardized lifespan period of 205 days (TI205) for those herds where all age 
categories from birth till slaughter were present. In the calculation of the TI for on (routine) 
prophylactic treatment a standardized assumed weight at treatment was used for different age 
categories; suckling piglets = 4 kg, weaners = 12 kg, finishers = 50 kg, sows = 220 kg, breeding gilts = 60 
kg, boars = 275 kg, adapted based upon the proposed standard weights at treatment by ESVAC (ESVAC 
et al., 2013).  
For curative usage, no detailed information was available whether the purchased AMs were used for 
suckling piglets or weaners, as this information is typically not included in invoices. Therefore, curative 
treatments for suckling piglets and weaners were combined into a category “suckling + weaned 
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piglets”. This combined category was given an assumed weight of 8 kg, being the average of the 
weights of the two age categories.  
In order to take into account the potency and concentrations of different products a defined daily dose 
animal (DDDA) per product was established, including a long acting factor (value that represents the 
duration of activity of a long-acting product). These DDDAs were established via the method described 
in Postma et al. (2015a), except that for this analysis national product (Summary of Product 
Characteristics) data was used and DDDAs were assigned per product instead of per AM class and 
administration route. Information on active substances was used to report on the frequency of use of 
specific active substances. Especially the 3rd and 4th generation cephalosporins and (fluor)quinolones, 
the most critically important AMs as defined by WHO and OIE, were highlighted. 
Statistical analysis 
Descriptive statistics were performed for relevant variables (e.g. TIs, biosecurity scores, production 
results). Normal probability tests and plots were examined to check whether assumptions of normality 
and homoscedasticity were fulfilled. AMU per active substance/AM class was expressed in TIs based 
on the (routine) prophylactic AMU and as a percentage of the total (routine) prophylactic AMU for a 
specific age category. 
Paired samples t-test with analysis by analysis exclusion was used to compare the results on AMU and 
biosecurity per herd between the initial situation and the situation after implementation of the 
proposed interventions. A p-value of ≤ 0.05 was considered to represent a significant finding.  
With an univariable linear regression model the level of initial AMU, expressed as ranks (low use; 
medium use; and high use) was used to gain information on the possible degree of reduction per age 
category over the intervention period. Herds that were initially not using (routine) prophylactic 
therapies were excluded from this analysis. The ranking was based on the 33% and 66% percentile of 
the (routine) prophylactic AMU over all herds. The difference in the (routine) prophylactic AMU for 
piglets, finishers or sows (AMU visit 3 to AMU visit 1) served as the outcome variable. Since there were 
too many missing values for curative usage only the difference in (routine) prophylactic usage was 
considered in this analysis. 
All statistics were performed using IBM SPSS version 23 (IMB Corp., 2014). Stacked-clustered bar charts 
were prepared using Microsoft Excel following the method described by Blakeston (2013). 
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RESULTS 
Herd characteristics & herd visits 
This study was performed on 65 pig farms in Flanders. Four herds dropped out during the course of 
the study due to personal situations or unforeseen circumstances, resulting in 61 herds included in the 
intervention period. Herd visits were performed between December 2010 and May 2014. On average 
8 months passed between the 2nd and 3rd visit (x=̄ 8.20, SD= 3.8).  
Forty-one herds were farrow to finish herds (closed or semi-closed), nine were multisite herds, seven 
were finisher herds of which one had specific pathogen free (SPF) status, three were multiplying herds 
of which one had SPF status and one herd only had nursery piglets. In total 52 herds housed sows, 54 
housed piglets and 57 housed finishers. 
When asking for the motivation to participate in the project, the majority of the farmers responded 
positively towards increasing their insight and understanding in herd management and AMU (n= 47). 
Participation resulting from the increased awareness of the threat of AMR was only mentioned by a 
minority (n= 19) of the farmers. The hope to improve the financial situation when improving overall 
management was also often (n= 23) one of the main reasons for participation. Three farmers indicated 
to participate to be an example for colleagues. 
The participating farmers had on average 22.6 years of experience (minimum 5 years, maximum 50 
years) and employed on average 1.8 employees (including the farmer himself) with a minimum of 1 
(farmer himself) and maximum 6. 
The average size of the participating herds is provided in Table 18. Sow genetics on the herds were 
Topigs (n= 19), Hypor (n= 10), Danbred (n= 6), PIC (n= 3) and Landrace crossings (n= 14). The majority 
of the herds worked in a 3-week (n= 17) or 4-week (n= 16) farrowing rhythm, ten worked in a 1-week 
system, seven in a 5-week system and two in a 2-week system.  
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Table 18 Average numbers of animals and production results over all farms for visit 1 and visit 3. 
Significant p-values (p≤ 0.05) for the paired samples t-test are presented in bold font. 
 VISIT # N FARMS MEAN SD MINIMUM MAXIMUM 
P-
VALUE 
Number of sows 1 52 320.7 252.2 85 1750 
0.15 
 3 52 328.3 263.1 85 1750 
Number of finisher places 1 57 1456.6 759.8 500 3915 
0.57 
 3 57 1469.8 772.4 500 3915 
Number of weaned piglets per sow per year 1 49 26.4 2.4 22.2 33.2 
<0.01 
 3 48 27.5 2.8 22.1 34.6 
Mortality till weaning (%) 1 49 12.8 3.5 6.3 21.1 
0.68 
 3 48 12.6 3.3 6.7 19.1 
Weaning age (days) 1 50 23.1 2.6 19.0 28.0 
0.02 
 3 47 22.6 2.5 18.9 28.0 
Feed conversion ratio finishers 1 47 2.7 0.2 2.3 3.4 
0.01 
 3 36 2.6 0.3 1.5 3.1 
Daily weight gain (g/day) finishers 1 49 667.5 77.7 456.0 782.0 
0.01 
 3 33 675.2 83.2 487.0 801.8 
Mortality in finisher period (%)  1 54 3.2 2.0 0.8 11.5 
0.04 
 3 39 2.6 1.8 0.8 7.6 
 
Initial production parameters and preventive measures 
The main production characteristics are described in Table 18. On average 2.6 anthelmintic therapies 
were applied per year to sows (range 0 (n= 2) - 7.4). Piglets received anthelmintic therapy (including 
anti-coccidial treatment) on 24 herds (24/53 herds with piglets, 1 unknown) with a minimum of 1 
therapy per nursery group and a maximum of 3. Fatteners received on average 2 anthelmintic 
therapies per round (range 0 (n=2) - 3.5, 1 unknown). The average number of pathogens vaccinated 
against was 5.4 (range 3 - 10) for sows (52/52 herds) and 1.3 (range 0 - 3) for piglets (46/54 herds) 
(Table 19). Only 2 herds vaccinated finishers, both only against one pathogen. 
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Table 19 Number of herds vaccinating against pathogens for visits 1 and 3. Additional or removed vaccinations per age category visualized with a “+” before 
a number (relates to the number of herds who started vaccinating against this pathogen during the intervention period) or a “-“ before a number (refers to 
the number of herds who stopped with this specific vaccination during the intervention period). The rotavirus vaccine was off-label use of the ruminant vaccine. 
  APP ATROFIC RHINITIS CLOSTRIDIUM E.COLI ERYSIPELOTHRIX GLÄSSER INFLUENZA LAWSONIA M._HYO PARVO PCV2 PRRSV 
ROTA/CORONA  
(OFF-LABEL) 
Sucklers Visit 1      1  3 44  13 4  
 Visit 3      2   43  19 5  
 Changes      +2 / -1   +2 / -3  +8 / -2 +2 / -1  
Weaners Visit 1       2  2  1   
 Visit 3     1  2  2  1 1  
 Changes     +1   0  0  0 +1   
Finishers Visit 1       2       
 Visit 3       0       
 Changes       -2       
Sows Visit 1 2 24 2 35 50 7 19 1 5 51 10 40 1 
 Visit 3 2 34 2 38 47 12 20 1 4 46 12 39 2 
 Changes  +12 / -2 0 +10 / -7 +3 / -6 +7 / -2 +6 / -5 0 +1 / -2 +2 / -7 +3 / -1 +3 / -4 +1  
Gilts Visit 1 2 31 2 32 46 5 17  2 47 8 40 1 
 Visit 3 4 31 2 33 45 11 23  5 44 12 41 2 
 Changes +3 / -1 +5 / -5 +1 / -1 +4 / -3 +3 / -4 +7 / -1 +7 / -1  +3  +1 / -4 +5 / -1 +4 / -3 +1  
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The internal biosecurity status at the initial herd visit was on average 49 (range 25 - 84), external 
biosecurity was higher with a score of 63.5 (range 43 - 95) (Table 20). The highest score was obtained 
for “purchasing policy” (x=̄ 85), the lowest for “supply of fodder, water and equipment” (x=̄ 34). 
Table 20 Scores for the biosecurity status of the participating herds for visit 1 and after the intervention 
period (visit 3). Obtained by using the biosecurity risk based scoring system Biocheck.ugent™. 
Significant p-values (p≤ 0.05) of the paired samples t-test are presented in bold font. 
 VISIT # COUNT MEAN SD MINIMUM MAXIMUM P-VALUE 
External biosecurity 1 61 63.7 9.8 43.0 95.0 
<0.01 
 3 61 66.1 9.7 46.0 93.0 
     Purchasing policy 1 61 85.0 13.6 43.0 100.0 
0.01 
 3 61 88.1 9.8 56.0 100.0 
     Removing animals. manure carcasses 1 61 66.8 15.6 17.0 100.0 
<0.01 
 3 61 71.0 11.7 41.0 100.0 
     Supply fodder. water and equipment 1 61 34.0 21.5 0.0 90.0 
0.56 
 3 61 35.1 20.4 0.0 100.0 
     Access check 1 61 62.3 17.0 18.0 100.0 
0.16 
 3 61 64.1 18.6 18.0 100.0 
     Vermin and bird control 1 61 58.9 21.3 20.0 100.0 
0.05 
 3 61 62.6 19.8 20.0 100.0 
     Location and environment 1 61 55.0 26.0 10.0 100.0 
0.21 
 3 61 52.3 26.8 10.0 100.0 
Internal biosecurity 1 61 49.2 13.6 25.0 84.0 
<0.01 
 3 61 56.2 15.4 26.0 88.0 
     Management of diseases 1 61 48.2 24.1 0.0 100.0 
<0.01 
 3 61 58.4 27.7 0.0 100.0 
     Farrowing and suckling period 1 52 43.0 22.2 0.0 86.0 
<0.01 
 3 54 49.2 22.3 0.0 86.0 
     Nursery period 1 54 60.4 19.5 21.0 100.0 
0.05 
 3 56 61.8 22.2 0.0 100.0 
     Fattening period 1 59 62.9 27.3 7.0 93.0 
<0.01 
 3 57 70.5 23.5 7.0 93.0 
     Compartmentalizing working lines and equipment 1 61 39.4 18.7 11.0 93.0 
<0.01 
 3 61 46.8 21.8 11.0 100.0 
     Cleaning and disinfection 1 61 46.8 21.4 0.0 95.0 
<0.01 
 3 61 55.5 24.3 15.0 95.0 
 
Initial antimicrobial usage 
The average TI205 for (routine) prophylactic treatments was 121.16 (SD= 120.63, n= 53), implying that 
on average over these farms 121 out of 1000 finisher pigs received a daily dose of AMs for (routine) 
prophylactic treatment purpose, or an average finisher pig on these farms was treated with AMs in the 
framework of (routine) prophylactic treatments during 12% of their lifespan from birth till slaughter. 
The usage in the different age categories is described in Table 21.  
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Table 21 Antimicrobial usage quantification, expressed as treatment incidence (TI; number of animals 
out of a 1000 at risk who received a daily dose of antimicrobials). P-values from the paired samples t-
test are also provided in the last column. Significant p-values (p≤ 0.05) are presented in bold font. For 
curative treatment no distinction could be made between usage in suckling piglets or weaners, 
therefor only the combined TI for curative usage over these age categories is presented. For 
completeness this TI suckling + weaned piglets is also provided for the (routine) prophylactic treatment. 
  VISIT # N MEAN SD MINIMUM MAXIMUM 
P-VALUE 
TI(routine) prophylactic. DDDA Sows 1 54 41.92 85.73 0.00 442.42 
0.06 
3 51 18.90 46.53 0.00 192.50 
TIcurative. DDDA Sows 1 48 40.29 77.29 0.00 368.23 
0.71 
3 27 35.89 58.97 0.00 222.43 
TI(routine) prophylactic. DDDA Suckling piglets 1 54 241.71 210.82 0.00 950.00 
<0.01 
3 51 78.51 93.49 0.00 312.50 
TI(routine) prophylactic. DDDA Weaned piglets 1 56 335.23 342.16 0.00 1304.78 
0.02 
3 54 172.25 347.53 0.00 1895.92 
TI(routine) prophylactic. DDDA Suckling + Weaned piglets 1 55 313.76 261.57 0.00 999.05 
<0.01 
3 53 134.72 241.16 0.00 1322.67 
TIcurative. DDDA Suckling + Weaned piglets 1 48 201.26 346.13 0.77 1680.05 
0.42 
3 27 139.13 162.01 0.00 646.74 
TI(routine) prophylactic. DDDA Finishers 1 59 37.55 150.74 0.00 939.13 
0.09 
3 57 3.71 15.16 0.00 98.64 
TIcurative. DDDA Finishers 1 50 65.22 143.24 0.00 986.02 
0.07 
3 29 14.70 20.25 0.00 75.71 
TI(routine) prophylactic . DDDA 205 days Birth - Slaughter 1 53 121.16 120.63 0.00 706.76 
<0.01 
3 51 50.09 90.40 0.00 483.90 
TI(routine) prophylactic. DDDA 205 days Birth - Slaughter 1 46 101.10 142.41 0.29 631.05 
0.20 
3 26 60.60 58.90 0.00 255.66 
 
REDUCING AM USAGE: A TEAM EFFORT  CHAPTER 7 
210  
 
Interventions 
For biosecurity and herd management a total of 39 different interventions were defined (Table 22). On 
average over the herds 12 biosecurity/management interventions were deemed to be feasible and 
eventually on average 8 (range 0 – 15) of the interventions were implemented (Table 22). For 
vaccination, anthelmintic therapy and preventive measures, on average 6 advices were deemed 
feasible and 5 were implemented (range 0 – 12), out of 38 interventions given across all farms (Table 
23).  Out of 38 herds where the advice was given, 25 altered their vaccination scheme. This included 
mainly additional vaccination against atrophic rhinitis, E. coli, Glässers disease, influenza and porcine 
circovirus 2 (Table 19), and was often combined with additional diagnostic testing (n= 38 out of 56 
where the advice was given). Over all farms, 15 different interventions were given for prudent AM 
treatment; on average 4 advices were perceived to be feasible and 3 (range 0 – 7) were eventually 
implemented (Table 24).  
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Table 22 Proposed interventions (n= 39 in total) to the participating 61 farmers on biosecurity and herd 
management measures. The column “advice” shows on what percentage of the farms the advice was 
given, “feasible” shows how many of the farms where the advice was given assumed the 
implementation to be feasible (herd visit 2) and “implemented” shows which percentage of the herds 
where the advice was given actually performed the intervention at the follow up of the herd (herd visit 
3). A percentage >100% relates to an additional interest by a farmer to perform a certain intervention 
in visit 2 an/or actual implementation in visit 3, while not initially advised. AM = antimicrobial, AMU = 
antimicrobial usage. 
  % ADVISED % FEASIBLE % IMPLEMENTED 
Registration symptoms & moment mortality for analysis 95 98 66 
Hand hygiene, change coverall and clean boots 86 88 59 
Change needles often 85 82 62 
Hygiene lock per animal/age category 76 58 7 
Make and use sick bay correctly 75 59 45 
Use strict euthanasia policy 71 90 81 
Wash sow before farrowing crate 68 45 20 
Analysis drink water 1x/year well/pipes 68 98 80 
Clean carcass storage 66 87 44 
Iron oral administration 61 19 3 
Limit cross fostering 59 49 40 
Check/analyse feed & water sows 56 55 52 
Clean & disinfect everything per round/loading 56 61 48 
Use 2 blades for castration, work hygienically 54 97 69 
Clean and disinfect treatment material per round 54 56 44 
Watch injury, cold, feed changes during transport 53 32 29 
Keep dog/cat out of the stable 49 34 21 
Keep birds out of the stable 47 39 21 
Limit manipulation suckling piglets 47 61 54 
Perform hygienogram 46 93 19 
Respect empty period after cleaning & disinfection 44 19 19 
AI / AO, do not return to younger age group 41 54 33 
Manipulate carcasses with gloves/wash hands 39 78 52 
Place materials according to walking route 34 70 40 
Clean & disinfect material after use 32 79 74 
Respect clean & dirty road when loading animals 32 95 63 
Optimize stocking density 27 69 44 
Respect correct walking route 25 80 60 
Ensure good climate & ventilation 20 92 75 
Use dirty road for transport of manure 20 100 75 
Quarantine stable and sufficient period 19 73 27 
Limit purchase of breeding material 19 82 55 
Physical barrier animal/age categories 15 11 0 
Functional carcass storage in dirty area 15 89 56 
Change wooden boards for plastic boards 10 67 83 
Proper vermin control 10 83 67 
Respect clean & dirty road for material delivery 8 40 40 
Keep the farmyard clean 5 33 0 
Respect clean & dirty road with feed delivery 5 33 33 
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Table 23 Proposed interventions (n= 38 in total) to the participating 61 farmers on vaccination, 
anthelmintic therapy, general prevention and analysis measures. The column “advice” shows on what 
percentage of the farms the advice was given, “feasible” shows how many of the farms where the 
advice was given assumed the implementation to be feasible (herd visit 2) and “implemented” shows 
which percentage of the herds where the advice was given actually performed the intervention at the 
follow up of the herd (herd visit 3). A percentage >100% relates to an additional interest by a farmer 
to perform a certain intervention in visit 2 an/or actual implementation in visit 3, while not initially 
advised. AM = antimicrobial, AMU = antimicrobial usage. 
   % ADVISED % FEASIBLE % IMPLEMENTED 
Request slaughter findings for analysis   75 59 57 
More diagnostic testing   77 99 81 
Send in clinical represents for post mortem 
analysis 
  72 95 79 
Additional vaccinations in general   51 94 81 
Additional specific vaccinations     
 PCVs 16 103 62 
  PRRSv 10 81 49 
  Influenza virus 6 85 85 
  APP 4 76 38 
  Glässers disease 4 76 76 
  Lawsonia 
intracellularis 
3 57 57 
  E. coli 40 114 114 
  Rot virus 1 114 114 
  PCV2 1 114 114 
  M. 
hyopneumoniae 
1 114 114 
  Parvo / 
Erysipelothrix 
1 114 114 
Maintain anthelmintic therapy   40 114 109 
Adjust anthelmintic therapy    39 105 84 
Check serology titres in general   33 95 90 
Check serology titres specific pathogens     
  PRRSv 44 89 81 
  PCV2 11 71 43 
  Influenza virus 10 100 100 
  APP 4 114 114 
  Lawsonia 
intracellularis 
3 100 100 
  E. coli 3 100 100 
  Glässers disease 3 114 114 
  M. 
hyopneumoniae 
2 0 0 
  Artrofic rhinitis 2 100 100 
Adjustment of vaccination scheme general  21 0 62 
Adjustment of vaccination scheme specific 
vaccines 
    
 PRRSv 30 0 61 
 E. coli 20 0 58 
  M. 
hyopneumoniae 
18 73 82 
  Parvo / 
Erysipelothrix 
11 0 71 
  Artrofic rhinitis 8 100 80 
  Influenza vi us 7 100 100 
  PCV2 5 100 67 
  Glässers disease 2 100 100 
Check influence of housing and climate (e.g. 
lung problems) 
  6 114 28 
Be aware of risk of infectious transmission 
between herds 
 4 114 114 
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Table 24 Proposed interventions (n= 15 in total) to the participating 61 farmers on prudent and 
reduced antimicrobial usage. The column “advice” shows on what percentage of the farms the advice 
was given, “feasible” shows how many of the farms where the advice was given assumed the 
implementation to be feasible (herd visit 2) and “implemented” shows which percentage of the herds 
where the advice was given actually performed the intervention at the follow up of the herd (herd visit 
3). A percentage >100% relates to an additional interest by a farmer to perform a certain intervention 
in visit 2 and/or actual implementation in visit 3, while not initially advised. AM = antimicrobial, AMU 
= antimicrobial usage. 
  % ADVISED % FEASIBLE % IMPLEMENTED 
Restrictive use of potent AM 92 72 45 
Stop (routine) prophylactic treatment from birth till slaughter 88 69 59 
Use correct dosing and duration for AM treatment 66 78 57 
Herd optimization instead of AMU 5 88 70 
Use small spectrum AM instead of broad spectrum 49 98 62 
Stop use of tulathromycin in iron injection sucklers 25 105 77 
Stop prophylactic treatment in sows 24 90 83 
Try alternative strategies/products against diarrhea in weaners 19 86 10 
Parenteral AM treatment instead of per oral 14 66 40 
Stop use of AM around castration 12 105 60 
Ask for resistance profile/sensitivity testing 7 79 0 
Maintain individual treatment 3 105 105 
Treat at correct moment with AM 3 53 0 
Treat in (small) age groups for a specific disease and unique 
problem 
2 105 105 
Use AM via drench against diarrhea in sucklers 2 105 105 
 
Visit 1 versus visit 3 
The numbers of sows and finisher placed in the participating herds did not change significantly during 
the course of the intervention period. The mortality till weaning reduced slightly between the initial 
situation and visit 3, but this was not significant. On the other hand the average number of weaned 
piglets per sow per year increased significantly with 1.1 piglet. Significant beneficiary changes were 
also observed in the feed conversion rate (FCR) (-0.1), daily weight gain (+5.9 g/day) and mortality in 
the finisher period (-0.4%) in paired samples. Furthermore, the weaning age reduced significantly with 
0.4 days (Table 18). 
Biosecurity levels improved in general. On average, external biosecurity improved significantly with 
2.4 points, mainly consisting of significant improvements of its subcategories “purchasing policy” (+3.5), 
“removing animals, manure and carcasses” (+4.0) and “vermin and bird control” (+4.4) (Table 20). The 
internal biosecurity improved substantially with an overall average increase of 7.0 points. Considering 
the latter, improvement was noted in all six subcategories (Table 20). 
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AMU reduced on average over the herds in all age categories (Table 21). The reductions in the (routine) 
prophylactic use were all significant or nearly significant (0.05<p< 0.09). For curative usage also 
reductions were also observed, being nearly significant for finishers. The combination of (routine) 
prophylactic and curative usage (total usage) led to a reduction of on average 31.7% for breeding 
animals, 45.8% for piglets and 81.6% for finishers. For the overall period from birth till slaughter, the 
reduction was 52.0% (95% confidence interval in reduction in TI = -76.9 (upper bound), -191.3 (lower 
bound)) (Figure 21). 
 
 
Figure 21 Graphical visualization of the AMU reduction in breeding animals (sows), piglets, finishers or 
over the total period from birth till slaughter after advices were given to 61 herds to improve herd 
management, biosecurity and to use AM more prudently. The values in the bars represent the AMU 
for prophylactic usage (red) or curative usage (green) and lighter colors represent the results of the 
AMU after implementation of the interventions. The percentage above the bars represent the percent 
reduction in AMU that was achieved over all participating herds. Standard = (routine) prophylactic 
AMU. 
 
A linear regression model for the association between the reduction in AMU (visit 3 minus visit 1) and 
the rank of initial AMU showed that high users in piglets, finishers and breeding animals were able to 
reduce AMU significantly more compared to initially low-users (Table 25). Production and herd 
characteristic variables did not yield significant results in a linear regression model (data not shown).  
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Table 25 Univariable linear regression model results for the association between the observed 
reduction achieved in this study in an age category and different levels of initial antimicrobial usage. 
Significant p-values (p≤ 0.05) are in bold font. High users: ≥66% percentile; ≤ medium users between 
66% percentile and 33% percentile ≤; low users < 33% percentile, of the standard AMU over all herds. 
OUTCOME VARIABLE AMU RANK N Β-VALUE P-VALUE 
TIDDDA, (routine) prophylactic sows visit 3 – visit 1   24   <0.01 
  High users 8 -212.9 <0.01 
  Medium users 9 -32.5 0.38 
  Low users 7 Ref. Ref. 
TIDDDA, (routine) prophylactic piglets visit 3 – visit 1   49   <0.01 
  High users 18 -507.4 <0.01 
  Medium users 15 -168.1 0.13 
  Low users 16 Ref. Ref. 
TIDDDA, (routine) prophylactic finishers visit 3 – visit 1   13   0.03 
  High users 4 -454.6 0.02 
  Medium users 5 -39.3 0.81 
  Low users 4 Ref. Ref. 
 
Active substances 
The use of critically important AMs, was largely reduced (Table 26). For example the (routine) 
prophylactic usage of ceftiofur long acting in sucklers was reduced by 83%, expressed as percentage 
of the TI visit 3 minus TI visit 1 (Table S4). Although the total use was reduced for all age categories, a 
limited increase in use was observed for some active substances such as chlortetracycline (sucklers, 
sows), aminopenicillins (sucklers, weaners), the macrolides tylosin, lincomycin + spectinomycin and 
tiamulin (finishers), and oxytetracyclin, flumequine and procain benzylpenicillin (sows). 
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Table 26 Top 5 used antimicrobial classes (active substance level) per age category for visit 1 expressed as total treatment incidence (TI) over all herds per age 
category and in percentage of the total usage over all participating herds for the specific age category. For the same active substances also the usage at visit 
3 is provided and the difference between visit 1 and visit 3. 
  
VISIT 1 TI 
% OF TOTAL 
AMU AGE 
CATEGORY 
VISIT 3 TI 
% OF TOTAL 
AMU AGE 
CATEGORY 
DIFFERENCE 
TI (VISIT 3 – 
VISIT 1) 
DIFFERENCE  
IN % 
Sucklers Top 5 Ceftiofur long acting parenteral 1898 40.0% Ceftiofur long acting parenteral 317 25.6% -1581 -83% 
Tulathromycin parenteral 1713 36.1% Tulathromycin parenteral 327 26.5% -1386 -81% 
Amoxicillin long acting parenteral 379 8.0% Amoxicillin long acting parenteral 205 16.6% -174 -46% 
Colistin feed/water 238 5.0% Colistin feed/water 16 1.3% -223 -93% 
Amoxicillin feed/water 229 4.8% Amoxicillin feed/water 0 0% -229 -100% 
Other 
Critically 
important 
Ceftiofur parenteral 228 4.8% Ceftiofur parenteral 225 18.2% -3 -2% 
Danofloxacin parenteral 21 0.5% Danofloxacin parenteral 0 0% -21 -100% 
Enrofloxacin parenteral 20 0.4% Enrofloxacin parenteral 0 0% -20 -100% 
Cefquinome parenteral 3 0.1% Cefquinome parenteral 0 0% -3 -100% 
Weaners Top 5 Colistin feed/water 5368 44.2% Colistin feed/water 1635 23.7% -3733 -70% 
Amoxicillin feed/water 3030 25.0% Amoxicillin feed/water 1466 21.2% -1564 -52% 
Trimethoprim + sulfonamides feed/water 2469 20.3% Trimethoprim + sulfonamides feed/water 2161 31.3% -308 -12% 
Doxycyclin feed/water 355 2.9% Doxycyclin feed/water 354 5.1% -1 -0% 
Oxytetracyclin feed/water 301 2.5% Oxytetracyclin feed/water 0 0% -301 -100% 
Other 
Critically 
important 
Flumequine feed/water 48 0.4% Flumequine feed/water 0 0% -48 -100% 
Finishers Top 5 Doxycyclin feed/water 978 40.0% Doxycyclin feed/water 71 40.7% -907 -93% 
Colistin feed/water 544 22.3% Colistin feed/water 0 0% -544 -100% 
Lincomycine + spectinomycin feed/water 419 17.1% Lincomycine + spectinomycin feed/water 0 0% -419 -100% 
Tylosin feed/water 226 9.2% Tylosin feed/water 0 0% -226 -100% 
Trimethoprim + sulfonamides feed/water 131 5.4% Trimethoprim + sulfonamides feed/water 81 46.2% -50 -38% 
Other 
Critically  
important 
Marbofloxacin parenteral 25 1.0% Marbofloxacin parenteral 0 0% -25 -100% 
Sows Top 5 Trimethoprim + sulfonamides feed/water 803 50.3% Trimethoprim + sulfonamides feed/water 116 15.1% -688 -86% 
Lincomycine + spectinomycin feed/water 181 11.3% Lincomycine + spectinomycin feed/water 200 26.0% +19 +10% 
Amoxicillin feed/water 143 9.0% Amoxicillin feed/water 30 4.0% -113 -79% 
Lincomycin feed/water 127 7.9% Lincomycin feed/water 0 0% -127 -100% 
Colistin feed/water 82 5.1% Colistin feed/water 82 10.6% 0 0% 
Other 
Critically  
important 
Marbofloxacin parenteral 59 3.7% Marbofloxacin parenteral 179 10.74% +76 +75% 
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DISCUSSION 
In this study, it was attempted to demonstrate the efficacy of counselling farmers towards the 
reduction of AMU without jeopardizing production results. At the start of the study, the recruitment 
of herds was difficult, despite the efforts made to promote this study and the possibility for farmers to 
collaborate free of charge. This might be illustrative of a general reluctance amongst farmers and 
veterinarians to change their existing AM treatment practices due to the belief that this will hamper 
their production results. It may also indicate a certain conviction amongst farmers that it is outside 
their professional abilities to change the situation. Given these difficulties we decided to reduce the 
stringency of our original selection criteria. As a result, nine herds had no sows and seven farrow to 
finish herds did not have the minimum required 150 sows. Nonetheless, the average number of sows 
(n= 326) in the participating farrow to finish herds were still higher than the average herd size 
expressed in number of sows (n= 210) in Belgium for 2013 (Belgian FPS Economy, 2013). Combined 
with the fact that the selection of herds was based on willingness of farmers to participate this likely 
has led to a sample only representative of professional Flemish farms with an interest in the topic of 
AMR. Abandoning the initial selection criteria and the absence of some animal categories in a few 
herds was not problematic since the majority of the comparisons were done for each age category, 
and the overall biosecurity measurement system provided corrected scores for those situations where 
some age categories were lacking. It is expected that the results were only marginally influenced by 
the variation in duration between the second and third visit, as the obtained technical results were 
always compared to the results obtained in the year preceding the visit. 
A critical limitation of the study is the partial lack of data on curative AMU for the third herd visit. In 
general veterinarians appeared reluctant to provide this information on a second occasion (visit 3). For 
the (routine) prophylactic treatments, this was less of a problem, since this information was received 
directly from the farmers where no reduction on motivation to participate and provide data was 
observed. However, given the fact that, for those herds where complete data on (routine) prophylactic 
and curative treatments was available, a reduction in use was seen in both categories. It can therefore 
be concluded that in the herds where data on curative treatments from herd visit 3 was lacking, it is 
unlikely that there would have been a shift from (routine) prophylactic to curative use. Moreover, the 
reduction percentages presented in this study were average TIs over those herds for which the 
required data (either (routine) prophylactic or curative usage) were available, therefore correcting for 
the missing data.  
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Throughout the study, the suggested interventions were inspired by the specific problems/pathogens 
and diagnostic results each herd faced. It therefore makes little sense to attempt defining universal 
best practices for all pig herds, nor is it possible to make an overall list to rank the effectiveness of 
specific interventions. The observed result in this study is noted as the effect of the intervention 
globally, and cannot be further extrapolated to the effect of one or more successful interventions. 
Other potential unspecified confounding factors might have influenced the results, but due to the 
holistic approach of the study, the effect is considered to be negligible. It is, however, noteworthy that 
the management and biosecurity interventions that seemed most feasible and were subsequently 
executed by the farmers were generally the more simple management strategies. They related to 
changing the working habits and routines of the farmer himself (e.g. changing of needles, hand and 
personal hygiene, analysis of water quality). Interventions incurring high costs and/or more 
pronounced changes, such as introducing a new hygiene lock to change clothes/boots and wash hands, 
were implemented less frequently. An important focus of the suggested advice was a good and early 
registration of disease symptoms in order to be able to take proper and timely control measures (e.g. 
biosecurity, vaccination, climate changes) and to create awareness of the importance of the 
“prevention is better than cure” principle. A sufficient vaccination, based on relevant diagnostic testing, 
is also related to this prevention principle. Pathogens for which changes in vaccination policy 
implementation were advised were most often E. coli, PCV2 and to a lesser extent PRRSv in both sows 
and piglets. The change from (routine) prophylactic treatment towards curative treatment and the 
restricted use of potent AM was the main advice in proposed interventions on prudent and reduced 
AMU. The marked reduction in AMU of critically important AM products indicated that a routine could 
be broken when specific guidance is provided to reduce the usage of these types of products. This 
change in mentality should also be seen as one of the key success factors of this study. The application 
of other preventive measures instead of a (routine) prophylactic AM treatment with highly potent 
products was feasible and the change towards curative use and less critically important AM products 
indicated no direct detrimental effects during the study period. However, effects over multiple years 
were not measured in this study.  
The observed substantial reduction (52% in AMU from birth till slaughter in the finisher pigs and 32% 
in the breeding animals) is, to our knowledge, the first of this kind to be described in detail. The current 
study supports the positive combination of an improved biosecurity status and herd management 
optimization with a subsequent improvement in production results and a reduction in AMU and 
demonstrates that the associations found in cross-sectional studies (Hybschmann et al., 2011; Laanen 
et al., 2013; Fertner et al., 2015; Postma et al., 2016a; Postma et al., 2016b) can be confirmed in this 
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type of longitudinal studies. A limitation of the study is that no control farms were included. During 
the study period (2011-2014) the total AMU in veterinary medicine in Belgium (all animal species) 
showed a reduction of around 12% expressed in mg active substance per kg biomass produced (Dewulf 
et al., 2015). Due to a lack of species specificity, it cannot be determined where and how this reduction 
was achieved.  
The results furthermore mainly suggest that in the initially high using farms, a substantial portion of 
the AMU was unnecessary and that most likely relative simple additions in biosecurity or vaccination 
assured animal health when omitting these therapies out. The observed effect that the higher using 
herds were able to reduce significantly more (reduction in percentage of TI on average 62.9% for initial 
high users in piglets (n= 18) and 97.2% in finishers (n= 4)) ensures us that this is a group of farmers 
where this guided reduction strategy is able to generate the largest effect. Medium and low users 
could also still be targeted for intervention studies since reduction in the AMU was also feasible in 
these groups (36.3% in medium users piglets (n= 15), 69.9% in low users piglets (n=16) and 61.5% in 
medium users finishers (n=5) respectively). 
An important success factor of the current study was the order of action: “Check, Improve and Reduce”. 
This implies that the herd counselling always started with a thorough evaluation of the herd 
management, biosecurity and health situation followed by tailored advice with specific suggestions for 
improvement. In this process it is important that an advisor/coach helps the farmer with explaining 
what he/she could be improving and what the risk is when certain practices are not performed 
correctly. In addition, follow up and feedback on the agreed and executed improvements is of high 
importance to retain levels of motivation. Only after implementation of these improvements, changes 
and reductions in AMU may be suggested. Using this approach, farmers keep control over the health 
situation and are less reluctant to change certain AMU treatment procedures. 
The herd veterinarian is generally seen as the designated advisor to execute the important role of 
coaching the farmer towards a reduced use of AM in his/her herd. However, in some cases this system 
is not well functioning, as the veterinarian has often already been the advisor for years resulting in the 
loss of motivation due to e.g. persistent disease problems, perceived lack of follow up by the farmer,  
miscommunications or time constraints. In these cases temporary assistance by an external coach / 
veterinarian may be helpful. The role of the veterinarian as a coach and the constraints herein, as 
described above, have been described in ruminant veterinary medicine (Lindberg and Houe, 2005; 
Smith and Hollis, 2007; Derks et al., 2011; Hakansson et al., 2011) and to a lesser extent in porcine 
veterinary medicine (Alarcon et al., 2014). The coach in this study was not paid by the farmer. It can 
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be anticipated that in cases where the farmer has to pay for the advice of a specialist, this may result 
in an additional hurdle to engage in such a process. To this extent, extra motivation could originate 
from an economic evaluation of the efficacy of similar interventions. Therefore, a study by Rojo-
Gimeno C. and Postma M. et al., (2015 submitted) has shown, based on the results of the current study, 
and including labour costs of all persons involved (coach, veterinarian, farmer, etc.), that on average 
the participating herds achieved a financial gain or overall benefit from partaking in this “team effort” 
approach. The latter therefore proves a very promising tool in AM reduction in pig production. 
 
CONCLUSION 
A significant reduction of 52% in AMU from birth till slaughter in the finisher pigs and 32% in the 
breeding animals was achieved together with improved production results. Breaking routines, through 
motivation and guidance of farmers on general herd management, improved biosecurity, optimized 
vaccination and a prudent use of AMU, as a team effort, has shown that the much needed reduction 
of AMU in pig production is possible. The presented approach could be used by veterinarians and other 
herd advisors when guiding farmers in the reduction of the AMU in their herds and the subsequent 
active participation in the fight against AMR.  
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ANTIMICROBIAL USAGE IN PIG PRODUCTION:  
BELGIUM VERSUS EU 
 
A recent comparison of  AMU in pig production with AMU in other food-producing species in Belgium 
showed that the use in pigs could be ranked as second highest, after veal calves (Filippitzi et al., 2014). 
For the other major pig producing countries in the EU (Denmark, France, Germany, Spain and the 
Netherlands) currently only detailed information on AMU on a larger scale is available for Denmark 
and the Netherlands. Bos et al. (2013) used 2011 national data from the Netherlands to make an 
estimation on the distribution of AMU amongst food-producing species. They found that the mean 
AMU, expressed as animal defined daily doses per year (ADDD/Y), was 35.6 for white veal calves, 16.9 
in pig breeding production, 5.2 for pig finisher farms and 23.8 for broilers (in animal treatment 
days/year). The porcine data used in Filippitzi et al. (2014) were based on the paper of Callens et al. 
(2012a) and included the AMU on pigs from birth till slaughter whereas the Dutch data reports finishers 
separately, and the sows and piglets combined (Bos et al., 2013) which makes them difficult to 
compare. Data from Denmark, showed that in 2012 the mean AMU in pigs in general was 30 DAPD 
(the number of defined animal daily doses per 1000 animals per day) (DANMAP, 2012). Due to 
differences in age categories, assumed weight at treatment and DDDAs comparison between the 
Danish, Dutch and Belgian data is impossible. This clearly illustrates the variety of AMU quantification 
systems available and the difficulties in comparing the obtained results, as was previously already 
highlighted by Bondt et al. (2013). The results presented in CHAPTER 6, as well as the full AMU data of 
this project described by Sjölund et al. (2016, submitted), are therefore unique in the sense that they 
allow, for the first time, to compare AMU data in pigs in four European countries (France, Germany, 
Sweden and Belgium) that was collected and analysed in a standardized manner. The study showed 
that from birth till slaughter the mean TI was highest in Germany (243), followed by Belgium (143) and 
France (108) and was lowest in Sweden (23). For breeding animals, again the TI was highest in Germany 
(42) followed by France (22), Belgium (16) and finally Sweden (11). Based on these data one can 
conclude that there were surprisingly large differences between the countries.  
In general, weaned piglets received the most treatments, followed by suckling piglets. Within herds it 
was furthermore observed that AMU was significantly associated across age categories indicating that 
high users in the piglets also used more in the finishers. This may, among other things, be explained by 
farmers’ habits and behaviour. The differences in AMU between countries, but also between herds, 
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might be related to the differences in disease prevalence or differences in the level of biosecurity as 
described in CHAPTER VI including the differences in pig density. In the publication of Sjölund et al. 
(2016, submitted) it was furthermore highlighted that AMs in Belgium, France and Germany were most 
often applied via water or feed and in Sweden parenteral treatments were the most frequent. This 
difference in the route of administration can for a substantial extend explain the lower use in Sweden 
as well. Third and fourth generation cephalosporin usage (10.8%) and to a lesser extend 
fluoroquinolone usage was significantly higher in Belgium in comparison to the other countries. 
Although already in 2006 this high use of critically important AMs in pig production in Belgium was 
identified and warned for (Timmerman et al., 2006) Callens et al. (2012a) described an further 
increasing trend in the use of these AM classes between 2004 and 2010. The national AM consumption 
reports also showed an increase of the use of these classes over the years (Dewulf et al., 2015). This 
trend is worrisome since the use of these classes is associated with the  selection of broad spectrum 
resistance mechanisms such as extended-spectrum-beta-lactamases (ESBLs) with a potential huge 
impact in human and veterinary medicine (Callens et al., 2014).   
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THE WAY FORWARD: 
ANTIMICROBIAL USAGE QUANTIFICATION 
 
Based upon the above described variety in available quantification systems and the related  difficulties 
in comparison of results, Collineau et al. (2016, submitted) suggests to use a standardized method of 
quantification of AMU for comparison between countries (given a similar selection procedure of herds), 
as well as individual herds, based on defined daily doses. The TI formula described in CHAPTER 1 is a 
known quantification method based on these daily doses and has been used in several publications 
quantifying AMU in pigs (Timmerman et al., 2006; Callens et al., 2012a; Laanen et al., 2013; Sjölund et 
al., 2015; Sjölund et al., 2016, submitted). The studies presented in CHAPTER 6 and 7 of this dissertation 
make use of the TI formula as well. 
When analysing the formula in detail, we can identify four major components: 1) amount of active 
substance used, 2) defined daily dose animal, 3) period at risk and 4) weight of the animals at treatment. 
When using this formula to compare usages between countries or even herds it is important to be 
attentive for a number of possible sources of confusion or even errors in each of the components which 
might look as details but which may have substantial impact on the outcome.  
In the numerator, the amount of AMs used/purchased, recalculated into the amount of active 
substance (AS) of AM, generally causes the least difficulties. One point of attention is that it should 
always be expressed in milligrams of AS. If the concentration of a product is given in International Units 
(e.g. polymixines) it is of importance that the same conversion factors are used. 
In the denominators there are three important components that may all lead to deviations in the 
obtained TI. 
1. DDDA or DCDA 
The Defined Daily Dose Animal (DDDA) represents the assumed average dose for a specific product per 
kg animal per species per day (ESVAC, 2015b) and is used to make the amount of AS administered 
relative to the advised dose. By doing so the huge differences in molecular weight between different 
AMs is corrected for. Using a higher assumed dosage in one country in comparison to another country 
(different DDDAs for the same product) will result in a lower TI in the first country for the same amount 
of AS used. Therefore, to allow for comparisons between herds and countries a standardized set of 
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DDDA is of utmost importance. The Defined Daily Course Dose (DCDA) is comparable to the DDDA but 
is used to count the number of complete courses of an AM treatment. As for the DDDA also for the 
DCDA a standardized list, including standardized dosing regimens and treatment lengths, is needed. 
Both in human (Kuster et al., 2008; de With et al., 2009; Gravatt and Pakyz, 2013; Bruyndonckx et al., 
2014; Gagliotti et al., 2014) and veterinary medicine (Merle et al., 2014; Collineau et al., 2016, 
submitted), there has been discussion on the correctness of using DDDs or DDDAs and the possible 
alternatives. However, both WHO (WHO, 2011a) for human medicine as well as ESVAC in Europe for 
veterinary medicine recommend the use of DDDs and DDDAs, respectively. The established DDDs by 
WHO in human medicine (WHO, 2016) are readily used for quantification and benchmarking of human 
AMU (Dumartin et al., 2011; Bozkurt et al., 2013; Bajis et al., 2014; Chandy et al., 2014; Sharma et al., 
2015). In veterinary medicine however, there are not yet established DDDA lists available. As a 
consequence, all countries who quantify AMU as an expression of the number of treatment days (or 
similar expressions) work with different DDDAs which renders the results incomparable as explained 
above. When we started performing multi country studies, there was a clear need for the 
establishment of a common DDDA and DCDA list. Therefore we established a methodology as 
described in CHAPTER 3 to determine “consensus” DDDAs and DCDAs which subsequently were used 
to describe AMU in pig production in the four concerned countries (Sjölund et al., 2016, submitted) 
and to study the associations between AMU, biosecurity and production results as described in 
CHAPTER 6.  
When performing this DDDA and DCDA establishment exercise some remarkable discoveries were 
made. Marked differences, up to ten-fold, in the recommended dosage for products with a similar AS 
and administration route between countries and sometimes even within countries were observed.. 
Although differences were expected, they were not expected to be so large and had never been 
described in detail before. Such differences on the one hand make it difficult for veterinarians to 
determine the optimal treatment dose but on the other hand also, when not accounted for, will result 
in very large differences in the obtained TI. One should be aware that the situation described in 
CHAPTER 3 reflects the situation in 2013. Since then evolution in the described recommended dosages 
has occured. For example the Belgian product with the ten-fold difference was withdrawn from the 
marketed for usage in pig production. Moreover, in the calculation of the DDDAs no corrections were 
made for formulation, composition (e.g. solvents), the chemical form, etc. Which may also, partially, 
explain variability in dosing between products. Similar problems were observed for the prescribed 
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duration of treatment. It is therefore highly advisable that, especially for those products where 
substantial variation was observed, a standardization of the summary of product characteristics (SPC) 
across products and countries is performed. To achieve this, it is advisable that the same protocols are 
used by every pharmaceutical company for registration studies and that the results are interpreted in 
a standardized manner by the National Competent Authorities . Moerover, the pharmaceutical 
companies should be stimulated to suggest and provide argumentation for the DDDA (and LA-factor) 
of a new product.  
Another important finding from CHAPTER 3 is the fact that information on the LA-factor of products is 
not easily available and no standard procedures seem to be in place to establish the duration of action 
of such a LA-product. Information on how the LA effect was determined should be freely available and 
harmonized over countries and pharmaceutical companies. A more accessible database, where all 
products licensed in the EU could be found, is therefore highly recommended. In 2015 ESVAC published 
a reflection paper on the principles of assigning DDDAs and DCDAs (ESVAC, 2015b). These 
recommendations follow the approach used in human medicine where WHO defines DDDs (WHO, 
2011a) and are largely in line with the methodology described and used in CHAPTER 3. 
2. Standard weights 
The TI, calculated according to the formula described in CHAPTER 1, represents the number of animals 
out of a group of 1000 treated with a daily dose of an AM. Prescription of the administrable dose is 
normally provided in mg AS per kg of live weight. Therefore the weight of the animal at treatment 
should be taken into account when quantifying AMU to allow for comparison between age categories 
and species with very different weights within and between herds and countries. ESVAC et al. (2013) 
has proposed standard weights per species and per age category that are advised to be used. These 
weights were established by ESVAC using input from the EU member states and are meant to reflect 
the average weights at treatment per age category (ESVAC et al., 2013). This average weight at 
treatment is often a bit lower than the actual average weight in a certain age category as animals are 
more frequently treated in the start of the production period rather than towards the end. Previously 
on country level or in research projects different weights were used in the quantification of AMU as 
presented in Table 27. 
It is obvious Table 27 that there is a huge variation in weights of pigs used to quantify AMU in different 
countries and studies. In the paper of Pardon et al. (2012), on the quantification of AMU in veal calves, 
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it was very clearly demonstrated that simply by using a different assumed weight at treatment, a very 
substantial different TI was obtained. They found a TI of 414 when using the actual live weight of the 
calves at treatment, while the TI was over 2.5 times lower (TI= 164) when using the standard weight 
of 164 kg of live weight for a veal calve as used in the Dutch MARAN report (MARAN et al., 2011). Bondt 
et al. (2013) also described this problem and the influence of using different weights in the 
quantification of AMU when comparing usage data from the Netherlands and Denmark.  
Since ESVAC is the leading EU body involved in the quantification of AMU over EU countries, it is 
advisable that the standard weights proposed by ESVAC (ESVAC et al., 2013) should be used for 
harmonization.  
Table 27 Standard weights used for the quantification of AMU in several EU countries or research 
projects. 
INSTITUTION/ 
PROJECT 
REFERENCE YEAR 
COUNTRY/ 
REGION 
SOW BOAR GILT 
SUCKLING 
PIGLET 
WEANED 
PIGLET 
FINISHER 
ESVAC DDDA 
reflection paper 
ESVAC (2015c) 2013 EU 220 220  4 12 50 
ESVAC report 
(mg/PCU) 
ESVAC (2015b) 2015 EU 240     6511  
AB Register 
Belpork vzw 
AB Register (2014) 2014 Belgium 220 220  4 12 50 
MARAN 
 
MARAN et al. (2011) 2009 
The 
Netherlands 
220   1012 70 
SDa 
 
Stichting Autoriteit 
Diergeneesmiddelen 
(SDa) (2013) 
2013 
The 
Netherlands 
22013 350 107  17.5 70 
DANMAP DANMAP (2015) 2012 Denmark 20013 200   19 70 
Minapig Postma et al. (2016a) 2015 
Belgium, 
France, 
Germany, 
Sweden 
220 275 60 2 7 35 
RED AB Postma et al. (2016c) 2015 Belgium 220 275 60 4 12 50 
                                                          
11 Slaughtered weight. 
12 Only piglets < 20 kg defined. 
13 Sows and suckling piglets combined. 
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3. Period at risk 
The period at risk refers to the number of days the group of animals concerned (for which the mg of 
active substances are collected) are present and can potentially be treated with an AM. Preferably this 
period at risk refers to specific production stages or age categories such as suckling piglets (birth – 
weaning), nursery period (weaning – start finisher period) and finisher period (start finisher period – 
slaughter). For each of these production stages an assumed weight at treatment also needs to be 
established (see above). By using this specific period at risk, adequate follow up of the evolution in the 
herd can be made and adjustments in the interventions on e.g. vaccination and management can be 
suggested timely. Again using different age-category periods or different periods at risk may influence 
the TI outcomes. In the Netherlands (MARAN, 2015) suckling piglets and sows are combined in the 
quantification of AMU. In the Danish DANMAP reports piglets and sows are also combined (DANMAP, 
2015). When combining these two age categories one excludes or at least markedly reduces the effect 
of AMU in suckling piglets. Calculating usage in suckling piglets based on the sow weight of 220 kg, 
instead of an average standard weight at treatment of 4 kg according to ESVAC, will hugely reduce the 
TI since the denominator increases. The same applies to the period at risk. As mentioned for sows a 
period at risk of one year or one cycle would be preferable. However, the suckling piglet period 
normally ranges between 21 and 28 days. Quantifying AMU over the period from birth till weaning will 
allow to specifically draw conclusions for the suckling piglet period. Whereas including the suckling 
piglets in the calculation of the sows, with a much longer period at risk, will increase again the 
denominator and decrease the TI. As Callens et al. (2012a) described in her study 33% (68/206) of the 
treatments were administered to the suckling piglets and 57% (118/206) in weaners. In the results of 
CHAPTER 6, described in detail in Sjölund et al. (2016, submitted), AMU in suckling piglets was second 
highest among age categories in Belgium, France and Germany and the highest in Sweden. A similar 
pattern was seen for the Belgian data presented in CHAPTER 7. Therefore, combining sows and suckling 
piglets will result in a loss of detail in AMU quantification and will completely ignore the relative 
substantial usage in suckling piglets. It is therefore advisable to make sufficient different age categories, 
with their related average weights at treatment and periods at risk, to be able to accurately describe 
the usage in the different phases of the production. Especially those age categories with substantial 
use (young animals) should be described separately and not be merged with other age categories.  
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THE WAY FORWARD: 
BIOSECURITY & HERD MANAGEMENT 
Porcine health experts from Belgium, Denmark, France, Germany, Sweden and Switzerland perceived 
an improved (internal and external) biosecurity to be among the most effective alternatives to AMU, 
with internal biosecurity also scoring number one for the expected return on investment (ROI), as 
described in CHAPTER 6. Not only experts, but also farmers themselves do perceive biosecurity to be 
an important strategy in animal health improvement (Casal et al., 2007; Valeeva et al., 2011; Laanen 
et al., 2014). 
1. Current biosecurity status 
The results on biosecurity described in CHAPTER 5 illustrated that for all four countries included some 
aspects of biosecurity were already well implemented whereas others need substantial improvements. 
In general, for every biosecurity aspect, the variation within the countries was larger than the variation 
between the countries. In Germany especially a good external biosecurity with a good purchasing 
policy and access check was observed, whereas the location and environment generally scored low 
due to the high pig density in the area under investigation. The biosecurity level on the participating 
Swedish pig herds was good, although there was substantial room for improvement in the systems for 
animal transport, hygienic measures between compartments and the working procedures between 
age groups (Backhans et al. (2015)). The French herds were best in cleaning and disinfection and 
compartmentalizing and the use of working lines. Their average scores for management of diseases 
and access check on the other hand were rather poor. In Belgium some external biosecurity 
parameters scored relatively well (purchasing policy, removing animals, manure, carcasses and access 
check), while especially the supply of fodder, water and equipment and vermin and bird control 
showed room for improvement. Laanen et al. (2013) found similar results for Belgian herds in her study 
performed in 2009-2010. And, the results from Belgian herds in CHAPTER 7 give similar patterns in the 
level of biosecurity. 
Although not exactly comparable, some studies describing the level of implementation of biosecurity 
measures in other countries are available. At the European level we can find a pattern indicating that 
biosecurity levels in general are more rigorously implemented in the northern countries and in major 
pig producing countries compared to southern countries and minor pig producing countries. Olofsson 
et al. (2014) reported that in Sweden professionals visiting Swedish farms pose the greatest risk for 
the spread of infectious animal diseases. This was confirmed in the score for access check in our study 
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(CHAPTER 5) which was the second lowest for Swedish herds in comparison to the other countries. In 
internal biosecurity on the other hand, Sweden clearly scored better compared to the other countries, 
especially related to the youngest age groups (farrowing and suckling period and nursery period) 
(CHAPTER 5). Finnish pig farmers had implemented more biosecurity measures compared to cattle and 
sheep farmers and report to be satisfied of their own biosecurity levels although improvements were 
still possible (Sahlström et al., 2014). In Danish fattening herds several biosecurity measures were 
already correctly implemented in 1999-2000, such as the purchase of piglets from one herd of origin 
and the use of entry rooms to change clothes and boots (Boklund et al., 2004). In Germany main risk 
factors for Salmonella-infections in pigs were related to some poorly executed biosecurity measures 
in the contact between animals in the finisher period (Gotter et al., 2012). In the study in CHAPTER 5 
however the German herds scored relatively high for the subcategory fattening period. In Polish farrow 
to finish herds principles of all-in / all-out were only implemented and adhered to in a small percentage 
of herds enrolled in the study of Dors et al. (2013). In the United Kingdom differences in the level of 
biosecurity, especially related to the disinfection of footwear and vehicles and the sharing of 
equipment between farms, were reported by Twomey et al. (2010). Ribbens et al. (2008) classified the 
biosecurity status of pig herds in Belgium in 2005 to be acceptable, but measures related to personal 
hygiene and access of visitors was only performed in a limited percentage of participating herds, 
something which was still observed in the results described in CHAPTER 5. Medium-sized to large 
Spanish pig farmers located in high pig density regions reported their biosecurity measures to be higher 
compared to small herds in pig dense areas (Simon-Grifé et al., 2013). Somewhat earlier Casal et al. 
(2007) reported a relatively good implementation of measures to reduce the risk of infection through 
people and other animals, but a lack of measures related to replacement stock in Spain.   
In other parts of the world, the level of biosecurity in pig herds is reported as variable. In Canada the 
biosecurity status is comparable to the situation in Western Europe (Lambert et al., 2012b; Arruda et 
al., 2015). Major pig producers in Australia maintain closed herds and implement good biosecurity 
measures (East et al., 2014), but smaller producers need to improve the level of biosecurity (Schembri 
et al., 2015). South American countries showed a wide variation in the adoption of preventive 
measures (Julio Pinto and Santiago Urcelay, 2003). Biosecurity levels in pig production in African 
(Nantima et al., 2015) or Asian (Leslie et al., 2015) countries in general is considered to be minimal, 
although (Zhang et al., 2013) reported a great variability in biosecurity scores in Chinese herds with 
some herds having a sufficient biosecurity status. 
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2. The importance of biosecurity in animal health 
In CHAPTER 1 several mechanisms have been described through which biosecurity can reduce the 
introduction or spread of pathogens in a herd. Moreover several cross-sectional studies were listed 
that have found associations between biosecurity and the risk of pathogen transmission. Based on the 
observation that a higher biosecurity status was associated with a lower frequency of treatment as a 
proxy for disease incidence as described in CHAPTER 5, the hypothesis that an improvement in the 
level of biosecurity results in healthier animals is further supported in this thesis. For weaners an 
association between biosecurity and health was only found for external biosecurity, while for finishers 
and sows both internal and external biosecurity were significantly associated with the frequency of 
treatment. Spread of respiratory diseases important in finishers and sows such as Mycoplasma 
hyopneumoniae, PRRSv or swine influenza can occur via airborne transmission between herds (Table 
1), highlighting the risk of these diseases in high pig dens areas such as Flanders (Maes et al., 2000; 
Otake et al., 2010; Desrosiers, 2011). Internal biosecurity is mainly of importance in the circulation of 
disease between age groups as a result of insufficient separation of age groups, cleaning and 
disinfection of compartments, materials and a lack of personal hygiene, as well as the transmission of 
disease via direct contact. Yet only a few intervention studies used biosecurity measures, whether or 
not combined with other strategies, to reduce or even eliminate specific pathogens or disease from a 
pig herd (PRRSv: Štukelj et al. (2015), Swine influenza: Mughini-Gras et al. (2015), porcine circovirus: 
Patterson et al. (2011a), Salmonella: Taker and Bilkei (2007)). The intervention study of CHAPTER 7 did 
not study specific diseases and their evolution in association with the interventions. However, it did 
provide information on the improvements in production parameters on the herds (see next paragraph).  
3. The importance of biosecurity in animal productivity 
Besides the repeatedly observed association between herd size and biosecurity (Laanen et al., 2013; 
Simon-Grifé et al., 2013; Sahlström et al., 2014) few data are available on the association with other 
herd characteristics and production parameters under field conditions.  
The only study which previously analysed comparable relations was Laanen et al. (2013) which 
demonstrated a positive association between biosecurity and daily weight gain and a negative 
association with feed conversion rate. Although these specific associations were not retained in the 
final multivariable causal path described in CHAPTER 5, some comparable and related associations 
were found.  
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A higher external biosecurity was found to be associated with a higher number of weaned piglets per 
sow per year which suggests a relation between biosecurity and productivity. External and internal 
biosecurity were also strongly associated with each other, possibly suggesting an indirect link between 
the other parameters associated with one of the both. This result is in agreement with the study of 
Dors et al. (2013) who describes a higher number of pigs born per sow per year and sold per year in 
herds with a proper biosecurity. The biosecurity in this study however mainly focused on the all-in / 
all-out principle and not on other aspects of biosecurity. Yet, one needs to remain cautious as these 
associations do not prove any causal relationship and other possibly related factors such as overall 
herd management, genetics, feeding, etc. may have influenced the observed association. 
Studies describing interventions that focus on biosecurity in relation to livestock productivity as was 
done in CHAPTER 7 are even more rare. Nevrkla et al. (2014) found that repopulation of a sow herd 
with minimum disease gilts in a decontaminated stable resulted in higher numbers of piglets produced. 
In poultry and duck production, one study was published that evaluated the effectiveness of practical 
and affordable biosecurity interventions in Cambodia. This study was not able to obtain a reduction in 
mortality rates in poultry and duck flocks and concluded that the spread of infectious diseases in 
backyard poultry flocks in Cambodia could not be limited (Conan et al., 2013). Our intervention study 
(CHAPTER 7) however resulted in very positive outcomes for the farmer. Advice on the improvement 
of the biosecurity status resulted in a significant increase of the Biocheck.UGent™ score with 3.8% and 
14.2% for external and internal biosecurity respectively. At the same time the number of weaned 
piglets per sow, the mortality in the finishers and the daily weight improved significantly. Interestingly 
the biosecurity variables that were, significantly associated with the daily weight gain in the study of 
Laanen et al. (2013) (i.e. removal of animals, manure, cadavers, vermin/bird control, fattening unit and 
cleaning and disinfection) were also significantly improved in the study of CHAPTER 7.  
Although more interventions were performed in CHAPTER 7 besides the improvement of biosecurity, 
the findings further support the hypothesis that better biosecurity is indeed related to better 
production results.  
4. The importance of biosecurity in the reduction of AMU 
In CHAPTER 6 the associations between production, biosecurity and AMU were described based on 
results of a cross-sectional study performed in four EU countries. An association was found between 
the level of external biosecurity and the TI from birth till slaughter. The only other study describing a 
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direct association between the level of biosecurity and the AMU is the study of Laanen et al. (2013). 
She found that mainly a higher internal biosecurity score was associated with a lower AMU. This finding 
was not confirmed in CHAPTER 6 for internal biosecurity but it was for external biosecurity and as 
previously mentioned internal and external biosecurity scores were highly correlated to each other. A 
remark should be made that Laanen et al. (2013) only included prophylactic treatments from birth till 
slaughter. By consequence association between the AMU in breeding animals and the level of 
biosecurity could not be evaluated in that study. Furthermore the results of CHAPTER 6 also included 
curative usage and the use of TI based on DDDA, not based on UDDAs as by Laanen et al. (2013). In the 
results described in CHAPTER 6, a significant association between productivity and TI was also found 
in the form of more weaned piglets per sow per year in relation to a higher TI in the sows. However, 
the beta value of this association was rather low, questioning the importance of this finding. As 
mentioned in CHAPTER 6 it might also be that high productive sows in general receive more AM 
treatments as a result of their higher productivity. Taking in consideration the comments on prudent 
AMU as listed in CHAPTER 1, the structural use of AM in breeding animals to improve production 
should of course not be promoted. 
Based on the different available cross-sectional studies it was hypothesized that improving biosecurity 
should result in a reduction in AMU.  
CHAPTER 7 described an intervention study in which optimization of the biosecurity level was a very 
important intervention in improvement of animal health. The subsequent achieved reduction in AMU 
was very substantial. Although these results were based on a combination of interventions related to 
vaccination, herd management, prudent AMU and biosecurity they again add to the idea that there is 
a true link between biosecurity an AMU.   
5. The importance of herd management in animal health, productivity and reduced 
AMU  
The results described in CHAPTER 4 suggest that especially veterinary practitioners believed that  
besides biosecurity, other measures such as improved feed quality, increased vaccination, use of 
zinc/metals and climate/environmental improvements are efficient, feasible and gaining a good return 
on investment. In general a trend was observed in the results of CHAPTER 4 regarding the rank for a 
certain alternative for its effectiveness, feasibility and ROI. The Spearman’s rho correlation coefficient 
was low for the relation effectiveness – feasibility (rs = 0.035, p= 0.89), medium for the association 
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feasibility – ROI (rs = 0.240, p= 0.32) and high for the association effectiveness – ROI (rs = 0.784, p< 
0.01). 
From the cross-sectional study described in CHAPTER 5 we learned that herds with more sows were 
managed with more employees, and when more employees were working on the farm, also more of 
them were females responsible for the farrowing unit. This management factor could have contributed 
to the significant association between the number of employees and the external biosecurity. 
Knowledge and awareness on risks of introduction of pathogens is most likely higher when foreign 
personnel is working on the farm, since the specific risks are dealt with on a daily basis as personnel 
has to come from outside into the herd every day. Another benefit of working with employees might 
be that specific personnel is assigned to a specific age category which will improve internal biosecurity 
since it will reduce the risk of transmission of pathogens between age categories by people as well as 
by materials. No direct association was found between a higher biosecurity level and more weeks 
between two consecutive farrowing groups of sows as might have been expected since these longer 
farrowing rhythms normally allow a better separation of age categories. However, in CHAPTER 6 we 
did see a significant association between a longer farrowing rhythm and a lower TI200, indicating a 
beneficial influence of more length between two farrowing groups. Furthermore an older weaning age 
was associated with a lower AMU from birth till slaughter in CHAPTER 6. Therefore, farmers and herd 
advisors should certainly keep in mind that changes in the weaning age will have their effect on animal 
health and AMU. In the study in CHAPTER 5 it was shown that the average weaning age in Belgium was 
the lowest (23.5 days) in comparison to France (24.0 days), Germany (24.4 days) and Sweden (35.1). 
Legally the weaning age should be at least 28 days, but it is allowed to wean earlier when minimal 
requirements for the nursery pigs are met (Council of the European Union, 2008). In light of the above, 
an older weaning age should be promoted or even a compulsory increase of the weaning age should 
be investigated in relation to animal health and AMU. 
The use of vaccines was part of investigation in the cross-sectional studies of CHAPTER 5 and 6, as well 
as in the intervention study of CHAPTER 7. The focus in these studies was not on specific vaccines, but 
rather on the number of pathogens vaccinated against (CHAPTER 5 and 6) or the herd specific 
implementation or adjustment of the vaccination scheme (CHAPTER 7). An increased vaccination level 
was believed to be the fifth effective alternative to AMU and the number one in feasibility by pig health 
experts (CHAPTER 4). CHAPTER 5 showed that a higher level of internal biosecurity was related to a 
higher number of pathogens vaccinated. This association might be related to a possible better 
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understanding of risk of transmission of disease. These farmers probably tend to take more preventive 
measures such as biosecurity measures in combination with vaccinating against more pathogens. In 
CHAPTER 6 the number of pathogens vaccinated against was associated with a higher TI from birth till 
slaughter. This finding was a bit of a surprise since many studies reported the beneficial impact of 
vaccination on animal health as well as on a reduced AMU (Bak et al., 2011; CDC, 2012; Coube et al., 
2012; Del Pozo Sacristán et al., 2014). On the other hand previously two studies also reported to find 
associations between higher levels of biosecurity in combination with using more vaccines and spend 
more on veterinary services (Dors et al., 2013; Zhang et al., 2013). When both the findings from 
CHAPTER 5 and 6 are combined, the idea is created that possibly the herds responsible for the 
significant association between vaccination and TI had to deal with serious disease pressures which 
were not yet brought under control with biosecurity measures and vaccination and still needed 
treatment with AM. Furthermore one should take into account that some vaccines are used against 
diseases that in general do not require treatment with AMs, or only in limited amounts. And, certain 
vaccines (e.g. atrophic rhinitis or Escherichia coli) will not have their influence on the AMU in the animal 
category where they are administered (e.g. sows), but can have positive influences on the AMU in 
weaners or finishers (atrophic rhinitis) or suckling piglets (Escherichia coli). A type 1 statistical error 
could also be considered as the reason for this finding. Only experimental (field) research will be able 
to study the  direct causal relation between the level of vaccination and the AMU.  
In CHAPTER 7 the addition of vaccines or adjustment of the current vaccination scheme proved to be 
aiding in the improvement of productivity and the reduction of AMU. The recommendations on 
additional vaccination or adjustments in the scheme were herd specific, not allowing any statement 
on the effect of individual vaccines. In general more research needs to be done to provide further 
scientific proof on associations and causality between biosecurity, production parameters, AMU and 
other herd management factors. 
In general, all advices given in the study described in CHAPTER 7 were herd specific and therefore 
interventions were only suggested and implemented when deemed relevant to the specific situation. 
One should also be aware that the beneficial effect of the provided advice might be temporal. 
Therefore continuous aid and guidance by the herd veterinarian, other advisors, as well as the 
government and the sector, are needed to sustain these positive evolutions. This results in the fact 
that we can only conclude that the process of intervening and counselling was successful without being 
able to identify or rank the interventions. The results of the study are therefore somewhat comparable 
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to what was found in dairy production where Derks et al. (2014) proved that the amount of milk 
produced per cow per year, the average milk somatic cell count and other parameters of importance 
in the sustainability of cattle production, benefit from the participation of farmers in a veterinary herd 
health management program. 
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THE WAY FORWARD: 
COACHING 
Coaching of pig farmers towards optimized herd management should be part of the herd veterinarians’ 
and other advisors jobs as explained in CHAPTER 1. Stimulation of the coaching and counselling 
techniques and proving that both the farmer and the coach could benefit from this cooperation is 
important. In CHAPTER 7 this coaching was herd specifically performed with counselling from the herd 
veterinarian and the author of this dissertation.  
1. Psychology and behavioural changes 
Although some authors (Laxminarayan et al., 2013; Wallinga et al., 2015) prefer a more global 
approach, the results provided in CHAPTER 7 showed that aiming on prudent AMU at small scale (i.e. 
herd level) gives positive results. Awareness creation, the intent of the farmer to change and support 
and training by a coach as described to be useful in cattle farmers (Tschopp et al., 2015; van Soest  et 
al., 2015), also proved to be effective in the reduction of AMU on pig herds as described by Fortane et 
al. (2015) and in CHAPTER 7. The counselling of farmers resulted in the significant improvement of 
herd management and production results in combination with a reduced AMU. From CHAPTER 7 we 
furthermore learned that high AM using farmers, with a motivation to change, managed to obtain the 
greatest reductions in AMU when they received good guidance. The participating farmers evaluated 
the coaching as very useful. They perceived the advised interventions to be practically feasible and 
effective in the improvement of animal health and productivity as well as in the reduction of AMU. 
More importantly they perceived the insight in the level of herd management and benchmarking of 
AMU very useful. And they cherished the improved dialogue with their own herd veterinarian as a 
result of the interference of the external coach (Figure 22). Some farmers furthermore described the 
changes in routines to be more satisfactory and rewarding in work joy (Figure 22). 
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Figure 22 Frequency of evaluation scores of the project described in CHAPTER 7 based on scores from 
n= 58 farmers who returned an evaluation form scoring 9 statements from fully disagree, via neutral 
till fully agree. 
 
Based on the results described in CHAPTER 7 an economic evaluation was made of the costs of 
implementation of biosecurity and herd management and the revenues from using less AMs and 
improved productivity. The beneficial final average result was + € 2.67 per finisher pig per year or +  
€ 42.99 per sow per year (Rojo-Gimeno C. and Postma M. et al., 2016). These positive results can be 
used as incentives for others, e.g. veterinarians, herd advisor and farmers, in order to further spread 
the prudent usage principle and in the end help in the action against AMR on country level or even 
beyond. 
2. Coaching in prudent AMU 
AMCRA stated in her vision plan for 2020 to strive for a reduction in the AMU of 50% (AMCRA, 2014d). 
With an average reduction of 52% achieved by the participating herds in CHAPTER 7 this study proved 
that this reduction percentage if feasible in pig production in Belgium. The focus on prudent use of 
AMs helped farmers to improve the AM therapies that were deemed necessary to treat diseased 
animals. One of the main focuses of prudent use was the use of the correct AM product/AS and to stop 
unnecessary use of CIA. This resulted in important reductions in the use of these CIA as described in 
CHAPTER 7. International legislator bodies (WHO, 2013c; OIE, 2015b), as well as nationally AMCRA, 
request this important reduction in the use of CIA. In her action plan towards 2020 AMCRA strives for 
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a 75% reduction of CIA (AMCRA, 2014d). As proofed in CHAPTER 7 for the 3rd and 4th generation 
cephalosporins and (fluor)quinolones impressive reductions were obtained, highlighting that also this 
requested reduction of CIA by AMCRA could be achieved. General advice on the correct way of 
administration of AMs, usage of the correct dosage and stimulating correct storage of the products 
further helps in the optimization of AMU in pig herds. The correct usage and administration of AMs is 
described in the guidelines and formularies published by AMCRA (AMCRA, 2014b, 2015). 
3. Research and policy 
More research is needed to prove that reduced use of AMs results in a reduction of AMR, both in 
commensal bacteria as well as in pathogens. Monitoring of animal health and welfare should be part 
of the investigations in relation to reduced and prudent use of AMs. Recently, the Dutch counsel for 
animal affairs published a report on the effects and perspectives of the policy on AMU in the 
Netherlands. Their conclusions are that the currently available literature on the effect of the large AMU 
reduction on animal health and welfare is very limited and insufficient to draw conclusions (Raad voor 
dieraangelegenheden, 2016). Furthermore, more research is needed to study the associations and 
causalities between reduction in AMU and production parameters. 
Government and policy should stimulate the implementation of alternatives such as improved 
biosecurity and should help farmers, veterinarians and other herd advisors in making changes on herd 
level possible and (financially) feasible. Coaching as described in CHAPTER 7 and communication of 
result of this thesis and similar studies is needed to increase awareness and guide all who are involved 
in the pig sector in Belgium and the EU. 
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CONCLUSION 
Antimicrobial usage is relatively high in Belgian pig production in comparison to other EU countries. 
However, reduction is possible. A thorough quantification is however a first prerequisite. Only with 
comparable data benchmarking and a quantified reduction are possible. The optimization of herd 
management and improvement of the level of biosecurity will result in healthier animals and reduced 
risk of introduction or spread of disease, which in turn will reduce the necessity of AMU. Behavioural 
change in both the advisors (i.e. veterinarian, other herd advisors) and the farmer is needed and should 
be based on the stimulation to break routines and rewarding in the form of better production results. 
Cross-sectional studies (CHAPTERS 5 and 6) showed beneficial associations between herd management, 
biosecurity, production parameters and AMU. And the herds participating in the study in CHAPTER 7 
managed to obtain an overall reduction of 52% in AMU in an intervention study, with an important 
reduction in the use of CIA and in combination with improved production parameters. This dissertation 
proves that the goals set by AMCRA for 2020 are feasible in Flemish pig production when farmers are 
counselled following the principle of “Check, Improve and Reduce”.  
The recent resolution of the Flemish parliament regarding AMU in food producing animals (Vlaams 
Parlement, 2015) 14  is fully in line with the studies performed in this dissertation and actually requests 
more research in line with this dissertation that should find answers to the recommendations 
described in the previous paragraphs. 
  
                                                          
14  Vlaams Parlement, 2015. Voorstel van resolutie betreffende antibioticagebruik bij nutsdieren. In: 
Vlaams Parlement (Ed.), 572. Vlaams Parlement, Brussels, Belgium. 
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SUMMARY 
 
“Antimicrobial resistance is not a future threat looming on the horizon. It is here, right now, and the 
consequences are devastating.” These are the words of Dr. Margaret Chan, Director of the World 
Health Organization (WHO) at the Ministerial Conference on Antimicrobial Resistance in 2014 (Dr. 
Margret Chan, 2014)15.  
The general introduction of CHAPTER 1.1 presents an overview of the discovery of antimicrobials and 
describes the threat of antimicrobial resistance. It is furthermore described that pig production is one 
of the food producing sectors highly contributing to the antimicrobial usage and therefore to the risk 
for the selection of antimicrobial resistance. In order to reduce the use of antimicrobials and 
subsequently halt the selection of antimicrobial resistance or even make reversion possible, action is 
needed. To be able to do so a comparable quantification method (CHAPTER 1.2) of antimicrobial usage 
is needed to allow for comprehensive quantification, benchmarking and reduction. The optimization 
of herd management and improvement of the biosecurity status are seen as the most promising 
strategies since they are believed to improve animal health and subsequently reduce the need for 
antimicrobial treatment. The principles of biosecurity and herd management are described in detail in 
CHAPTER 1.3. In order for interventions to have effect, a behavioural change is needed in the herd 
advisors and the farmer. The influence of psychology behind a prudent antimicrobial usage is explained 
in CHAPTER 1.4. 
In CHAPTER 3, the establishment of Defined Daily Doses Animal (DDDA) as a value to quantify the 
potency of antimicrobial active substances and used as a denominator in the treatment incidence 
formula for quantification of antimicrobial usage is described. A total of 730 antimicrobial products 
were found to be licensed for use in pigs in Belgium, France, Germany and Sweden. For 116 unique 
combinations of active substance plus administration route a consensus DDDA was assigned. In the 
process of the establishment of these DDDAs remarkable differences in the licensed dosage 
prescriptions were found between and within countries. Only 6.8% of the active substances licensed 
                                                          
15 Dr. Margret Chan, 2014. Opening remarks at the Ministerial Conference on Antimicrobial 
Resistance: Joining forces for future health. The Hague, the Netherlands. 
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for use in feed or water and 29.4% of parenteral active substance groups had similar recommended 
dosages in the four countries. Up to ten-fold higher licensed prescribed dosages were found for the 
active substance tylosin (feed/water) for products licensed for usage in pigs in Belgium. Differences of 
more than 3.5 times the prescribed dosage in one country (e.g. Germany, spectinomycin) in 
comparison to the prescribed dosage in the other country (e.g. Belgium, spectinomycin) were 
observed. Newer products, falling under the central marketing authorization procedure, did not 
deviate from each other. The need for harmonization in prescribed dosage and duration was described 
as well as for the duration of action for long-acting products. Involvement of all EU members in the 
establishment of DDDAs and an improved accessibility of country-specific database was recommended. 
The action needed in the reduction of antimicrobial usage and the change in herd management 
required alternative strategies to optimize animal health and reduce the need for antimicrobial 
therapy. To investigate which alternatives are available and subsequently how they rank based on 
effectiveness, feasibility and return on investment, nineteen alternatives were given a score from 0 to 
10 by 111 pig health experts from Belgium, Denmark, France, Germany, Sweden and Switzerland in 
CHAPTER 4. The perceived top 5 most promising alternatives to antimicrobials related to effectiveness, 
feasibility and return on investment were improvements in biosecurity, increased use of vaccination, 
use of zinc/metals, feed quality improvement and regular diagnostic testing in combination with a clear 
action plan. A categorical principle component analysis showed that veterinary practitioners preferred 
the more practical, common and already known alternatives. Researchers perceived diagnostics and 
action plans to be more preferred. Financial incentives or penalties were ranked low by all experts in 
the participating countries. 
Since biosecurity was seen as the most promising alternative in the reduction of antimicrobial usage it 
was first investigated in a cross-sectional study how the level of biosecurity in pig production in Belgium, 
France, Germany and Sweden related to each other. Subsequently these scores were associated with 
herd management characteristics and production parameters in CHAPTER 5. A total of 232 farrow-to-
finish herds were included in the study. The level of biosecurity was quantified with the risk-based 
scoring tool Biocheck.UGent™, which was described in detail in CHAPTER 1.3. The external biosecurity 
status, all measures taken to prevent the introduction of disease in the herd, was highest in Germany 
and lowest in France. The internal biosecurity, all measures taken to prevent spread of disease within 
the herd, was highest in Sweden and lowest in Belgium. There was still substantial room for 
improvement in many of the participating herds. A causal path was developed based on the 
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associations that were statistically significant in a multivariable linear regression model. This causal 
path showed that the number of different vaccinations was significantly associated with the internal 
biosecurity status (p= 0.02), suggesting an overall more preventive approach against the risks of 
disease transmission. In herds with a higher external biosecurity score, more piglets were weaned per 
sow per year (p= 0.02). The hypothesis that biosecurity is an important strategy in the improvement 
of productivity could be confirmed. Furthermore, a higher level of biosecurity was associated with a 
lower estimated frequency of treatment against certain clinical signs. This was used as a proxy for 
disease incidence and confirms the hypothesis that a higher biosecurity results in healthier animals.  
With the DDDAs established in CHAPTER 3 the comparable quantification of antimicrobial usage was 
possible between Belgium, France, Germany and Sweden. This learned us that Germany was the 
highest using country in this cross-sectional study with an average treatment incidence (TI) for the pigs 
from birth till slaughter of 243, followed by Belgium with a TI of 143, France with a TI of 108 and 
Sweden with the lowest TI namely 23. For the breeding animals a similar pattern was seen, although 
here France had slightly higher TI in comparison to Belgium. These results were used in multivariable 
linear regression analyses in order to create a causal path for the associations between antimicrobial 
usage, production parameters, herd management and biosecurity (CHAPTER 6). The level of 
antimicrobial usage in sows was related to the level of antimicrobial usage in pigs from birth till 
slaughter (p< 0.01). Furthermore a higher antimicrobial usage from birth till slaughter was associated 
with more pathogens vaccinated against (p< 0.01), suggesting an overall high disease pressure in these 
herds which was not yet brought under control by vaccination or an risk aversive behaviour of the 
farmer and/or veterinarian. A longer farrowing rhythm (p< 0.01) as well as an older weaning age (p= 
0.06) or a higher external biosecurity level (p< 0.01) were associated with a lower antimicrobial usage 
from birth till slaughter. These findings support the hypothesis that improvement of the level of 
biosecurity could be beneficial in the reduction of antimicrobial usage. And, it shows that other herd 
management factors, such as the weaning age, play an important role in the possible reduction of 
antimicrobial usage as well. 
In CHAPTER 7 the above described beneficial actions in the improvement of animal health and the 
subsequent reduction of antimicrobial usage were combined in an intervention study performed in 61 
pig herds in Flanders. Antimicrobial usage was again quantified using the treatment incidence formula 
in combination with national DDDA values. The focus in the proposed interventions was on a reduction 
in the antimicrobial usage with especially a switch from standard treatment of groups of animals 
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towards the treatment of individual animals. Restriction of the use of critically important 
antimicrobials and a prudent use when antimicrobials were needed. Farmers were furthermore 
stimulated to break with routines and to make herd specific improvements in the implementation of 
biosecurity, as well as other herd management factors such as increased diagnostics and adjustments 
in the vaccination or anthelmintic therapy scheme. The herd veterinarian and if needed other herd 
advisors were actively involved in the study. After the recommendations were given, the herds were 
followed up over a period of on average 8 months. During this period, the level of external and internal 
biosecurity increased with 2.4 points (3.8%, p< 0.01) and 7 points (14.2%, p< 0.01), respectively. A 
significant reduction of 52% (p< 0.01) in the antimicrobial usage from birth till slaughter was obtained 
as well as a reduction of 32% (p= 0.06) in the breeding animals, including an important reduction in 
the use of critically important antimicrobials. The initially high users were able to significantly reduce 
more in comparison with medium or low users. Most importantly for farmers, these improvements in 
herd management and biosecurity and the significant reduction in antimicrobial usage were 
accompanied by significantly improved technical results; increase in the number of weaned piglets per 
sow per year (+1.1, p< 0.01), increased daily weight gain (+5.9 g/day, p= 0.01) and decreased mortality 
in the finisher period (-0.6%, p= 0.04). These results proved that guided interventions as a team effort 
of herd advisors and an external coach were very effective in the reduction of antimicrobial usage 
without jeopardizing productivity.  
In the general discussion (CHAPTER 8) the way forward is described. Recommendations are made to 
make progress in the comparable quantification of antimicrobial usage over herds and countries. 
Harmonization of DDDAs, but also prescribed treatment duration, duration of activity of long-acting 
products and the use of standard weights should be prioritized. Furthermore, the way forward includes 
the improvement of herd management and biosecurity. Only then the required reduction of 
antimicrobial usage is possible. It was recommended to quantify the level of biosecurity by means of 
the Biocheck.UGent™ risk-based scoring system in order to subsequently suggest herd specific possible 
improvements. Counselling of farmers in herd specific interventions related to vaccination, biosecurity 
and herd management has shown to be a key factor in the success of antimicrobial reduction as 
described in this dissertation. 
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“Antimicrobiële resistentie is geen risico dat in de verte aan de horizon gloort. Het is hier, op dit 
moment, en de consequenties zijn verwoestend”. Dit zijn de woorden van Dr. Margaret Chan, de 
directeur van de Wereldgezondheidsorganisatie (WHO) tijdens de ministeriële conferentie over 
antimicrobiële resistentie in 2014 (Dr. Margret Chan, 2014)16.  
De algemene introductie van HOOFDSTUK 1.1 geeft een overzicht van het ontstaan van antimicrobiële 
middelen en legt het risico op de ontwikkeling van antimicrobiële resistentie uit. Verder wordt 
beschreven dat varkensproductie één van de voedselproducerende diersectoren is die in hoge mate 
bijdraagt tot het hoge gebruik van antimicrobiële middelen en daardoor ook tot het risico op selectie 
van antimicrobiële resistentie. Om het gebruik van antimicrobiële middelen te reduceren en 
vervolgens een halt toe te roepen aan de selectie van antimicrobiële resistentie, of zelfs een reversie 
mogelijk te maken, is actie noodzakelijk. Om dit mogelijk te maken wordt een vergelijkbare 
kwantificeringsmethode voor antimicrobieel gebruik beschreven in HOOFDSTUK 1.2. die een 
alomvattende kwantificering, benchmarking en reductie mogelijk maakt. De optimalisatie van 
bedrijfsmanagement en de verbetering van de bioveiligheidsstatus worden gezien als de meest 
veelbelovende strategieën omdat ze de diergezondheid verbeteren en zorgen voor een verminderde 
noodzaak voor een antimicrobiële behandeling. De principes van bioveiligheid en bedrijfsmanagement 
zijn beschreven in HOOFDSTUK 1.3. Om te zorgen dat interventies effect hebben is een verandering in 
het gedrag nodig van de bedrijfsadviseurs en de varkenshouder. De psychologische achtergrond van 
het prudente gebruik van antimicrobiële middelen wordt voorgesteld in HOOFDSTUK 1.4. 
In HOOFDSTUK 3 wordt het vaststellen van “Defined Daily Doses Animal” (DDDA), als een waarde om 
de potentie van antimicrobiële actieve substanties te kwantificeren voor gebruik in de noemer van de 
formule voor het kwantificeren van antimicrobieel gebruik door middel van de behandelingsincidentie, 
beschreven. In totaal bleken 730 producten een licentie te hebben voor gebruik in de varkenshouderij 
in België, Frankrijk, Duitsland en Zweden. Voor 116 unieke combinaties van actieve substantie plus 
                                                          
16 Dr. Margret Chan, 2014. Opening remarks at the Ministerial Conference on Antimicrobial 
Resistance: Joining forces for future health. The Hague, the Netherlands. 
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toedieningsweg werd een DDDA toegewezen. In het proces van het vaststellen van deze DDDA’s 
werden opmerkelijke verschillen gevonden in de voorgeschreven doseringen tussen en binnen landen. 
Enkel 6.8% van de actieve substanties geautoriseerd voor gebruik via voer of water en 29.4% van de 
parenterale actieve substantie-groepen had vergelijkbare doseringen in de vier landen. Tot tienvoudig 
hogere voorgeschreven doseringen werden gevonden voor de actieve substantie tylosine (voer/water) 
voor producten toegestaan voor gebruik bij varkens in België. Verschillen van meer dan 3,5 keer de 
voorgeschreven dosering in het ene land (bv. Duitsland, spectinomycine) in vergelijking tot de 
voorgeschreven dosering in het andere land (bv. België, spectinomycione) werden waargenomen. 
Nieuwere producten, vallend onder de centrale registratieprocedure, verschilden niet van elkaar. De 
noodzaak voor harmonisatie in voorgeschreven dosering en duur van behandeling werd beschreven 
evenals voor de duur van activiteit voor langwerkende producten. Betrokkenheid van alle EU lidstaten 
in het vaststellen van de DDDA’s evenals het verbeterd toegankelijk maken van land-specifieke 
databases werd eveneens aangeraden. 
De actie die nodig is om het gebruik van antimicrobiële middelen te doen reduceren en een 
verandering in bedrijfsmanagement te bewerkstelligen, vergt alternatieve strategieën om 
diergezondheid te optimaliseren en de noodzaak voor antimicrobiële therapie te verminderen. Om te 
onderzoeken welke alternatieven beschikbaar zijn en vervolgens hoe zij zich onderling verhouden 
gebaseerd op effectiviteit, haalbaarheid en economisch rendement werden negentien alternatieven 
beoordeeld met een score van 0 tot 10 door 111 varkensgezondheidsexperts uit België, Denemarken, 
Frankrijk, Duitsland, Zweden en Zwitserland in HOOFDSTUK 4. De top 5 maatregelen gebaseerd op 
verwachte effectiviteit, haalbaarheid en economische rentabiliteit waren verbeteringen in 
bioveiligheid, toegenomen gebruik van vaccinaties, gebruik van zink/metalen, optimalisatie van 
voerkwaliteit en regelmatig diagnostisch onderzoek in combinatie met een duidelijk actieplan. Een 
categorische principiële component analyse toonde aan dat praktiserende dierenartsen meer 
praktische, algemene en reeds bekende alternatieven prefereerden. Onderzoekers gaven de voorkeur 
aan diagnostiek en actieplannen. Een financiële stimulans of straf scoorde laag bij alle experts in de 
deelnemende landen.  
Omdat bioveiligheid als het meest veel belovende alternatief in de reductie van het antimicrobiële 
gebruik gezien werd, werd eerst onderzocht in een dwarsdoorsnede studie hoe het niveau van 
bioveiligheid in de varkenshouderij in België, Frankrijk, Duitsland en Zweden zich verhield tot elkaar. 
Vervolgens werden deze scores geassocieerd met bedrijfsmanagement karakteristieken en productie 
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parameters in HOOFDSTUK 5. Een totaal van 232 bedrijven met varkens van geboorte tot slacht namen 
deel aan de studie. Het niveau van bioveiligheid werd gekwantificeerd met de risico gebaseerde 
kwantificatiemethode Biocheck.UGent™, welke in detail beschreven werd in HOOFDSTUK 1.3. De 
externe bioveiligheidsstatus, alle maatregelen die getroffen worden om de introductie van ziekte in 
het bedrijf tegen te gaan, was het hoogst in Duitsland en het laagst in Frankrijk. De interne bioveiligheid, 
alle maatregelen om de verspreiding van ziekte binnen een bedrijf te voorkomen, was het hoogst in 
Zweden en het laagst in België. In veel van de deelnemende bedrijven was er een substantiële 
mogelijkheid tot verbetering. Een causaal pad werd ontwikkeld gebaseerd op de associaties die 
statistisch significant waren in een multivariabel lineair regressiemodel. Dit causale pad toonde aan 
dat het aantal pathogenen waartegen gevaccineerd werd, significant geassocieerd was met de interne 
bioveiligheidsstatus (p= 0.02), wat kan wijzen op een algemeen meer preventieve benadering tegen 
het risico van ziektetransmissie. Op bedrijven met een hogere externe bioveiligheidsscore waren er 
meer gespeende biggen per zeug per jaar (p= 0.02). De hypothese dat bioveiligheid een belangrijke 
strategie is in het verbeteren van de productiviteit, werd daarmee bevestigd. Verder bleek dat een 
hogere score voor bioveiligheid geassocieerd was met een lagere geschatte frequentie voor 
behandeling tegen bepaalde klinische symptomen. Dit werd gebruikt als een indicator voor ziekte-
incidentie en bevestigt de hypothese dat een hogere bioveiligheid resulteert in gezondere dieren. 
Met het vaststellen van de DDDA’s in HOOFDSTUK 3 werd het kwantificeren van het gebruik van 
antimicrobiële middelen mogelijk tussen België, Frankrijk, Duitsland en Zweden. Dit leerde ons dat het 
gebruik het hoogst was in Duitsland in deze dwarsdoorsnede studie met een behandelingsincidentie 
(BI) van geboorte tot slacht van 243, gevolgd door België met een BI van 143. Frankrijk met een BI van 
108 en de Zweedse bedrijven hadden gemiddeld het laagste gebruik met een BI van 23. Voor de 
fokdieren werd een vergelijkbaar patroon gezien, alhoewel Frankrijk een iets hogere BI had in 
vergelijking met België. Deze resultaten van 227 bedrijven met varkens van geboorte tot slacht in 
België, Frankrijk, Duitsland en Zweden werden gebruikt in multivariabele lineaire regressie analyses 
om zodoende een causaal pad te creëren voor de associaties tussen antimicrobieel gebruik, productie 
parameters, bedrijfsmanagement en bioveiligheid (HOOFDSTUK 6). Het niveau van gebruik in de 
zeugen was gerelateerd aan het niveau van gebruik in de varkens van geboorte tot slacht (p> 0.01). 
Verder was een hoger gebruik van geboorte tot slacht geassocieerd met vaccinatie tegen meer 
pathogenen (p< 0.01), wat een algemeen hogere ziektedruk in deze bedrijven suggereert die nog niet 
onder controle gebracht was met vaccinatie of een algemeen meer risicomijdend gedrag van de 
varkenshouder/dierenarts. Een meerweeksysteem (p< 0.01), evenals spenen op oudere leeftijd (p= 
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0.06) of een hogere externe bioveiligheid (p< 0.01) werden geassocieerd met een lager antimicrobieel 
gebruik van geboorte tot slacht. Deze bevindingen steunen de hypothese dat verbeteringen in de 
bioveiligheidsstatus effectief kunnen zijn in de reductie van het antimicrobiële gebruik. Het toont ook 
aan dat andere managementfactoren, zoals de speenleeftijd, eveneens een belangrijke rol spelen in 
de mogelijke reductie van antimicrobieel gebruik. 
In HOOFDSTUK 7 werden de bovengenoemde verbeteringen in diergezondheid en de reductie in het 
gebruik van antimicrobiële middelen gecombineerd in een interventiestudie op 61 bedrijven in 
Vlaanderen. Antimicrobieel gebruik werd opnieuw gekwantificeerd op basis van de 
behandelingsincidentie in combinatie met het gebruik van nationale DDDA waarden. De focus in de 
voorgestelde interventies lag op reductie in het antimicrobiële gebruik met speciaal een omschakeling 
van standaard gebruik in groepen dieren naar de behandeling van individuele dieren. Restrictie in het 
gebruik van kritisch belangrijke antimicrobiële producten en enkel gebruik wanneer antimicrobiële 
middelen daadwerkelijk noodzakelijk zijn, waren andere belangrijke suggesties. Varkenshouders 
werden verder gestimuleerd om te breken met routines en om bedrijfsspecifieke verbeteringen op het 
gebied van bioveiligheid door te voeren, evenals andere managementfactoren zoals meer diagnostiek 
en aanpassingen in de vaccinatie- of ontwormingsschema’s. De bedrijfsdierenarts en indien 
noodzakelijk andere bedrijfsadviseurs werden actief betrokken in de studie. Nadat de adviezen 
gegeven waren, werden de bedrijven opgevolgd gedurende een periode van gemiddeld 8 maanden. In 
deze interventieperiode hebben de bedrijven een significante stijging in de externe en interne 
bioveiligheid van respectievelijk 2.4 (3.8%, p> 0.01) en 7 punten (p> 0.01) behaald. Een significante 
reductie van 52% (14.2%, p< 0.01) in het gebruik van antimicrobiële middelen van geboorte tot slacht 
werd behaald evenals een reductie van 32% (p= 0.06) in de fokdieren, inclusief een belangrijke reductie 
in het gebruik van kritisch belangrijke antimicrobiële producten. De initieel hoge gebruikers waren in 
staat om het gebruik significant meer te verminderen in vergelijking tot initieel gemiddelde of lage 
gebruikers. Nog belangrijker voor varkenshouders was de waarneming dat deze verbeteringen in 
bedrijfsmanagement en bioveiligheid en de significante reductie in antimicrobieel gebruik werden 
bijgestaan door een significante verbetering in de technische resultaten; verhoging in het aantal 
gespeende biggen per zeug per jaar (+1.1, p< 0.01), verhoogde dagelijkse groei (+5.9, p= 0.01) en een 
verminderde mortaliteit tijdens de vleesvarkensperiode (-0.6%, p= 0.04). Deze resultaten bewijzen dat 
begeleide interventies als een inspanning van een team bedrijfsadviseurs en een externe coach zeer 
succesvol waren in de effectieve reductie van het antimicrobiële gebruik zonder de productiviteit 
negatief te beïnvloeden. 
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De algemene discussie (HOOFDSTUK 8) bespreekt toekomstperspectieven. Aanbevelingen worden 
gedaan om vooruitgang te boeken in de vergelijkbaarheid van het kwantificeren van antimicrobieel 
gebruik over bedrijven en landen heen. Het harmoniseren van DDDA’s, maar ook de voorgeschreven 
behandelduur, duur van de activiteit van langwerkende producten en het gebruik van standaard 
gewichten moet geprioriteerd worden. Wanneer dit meten van het niveau van antimicrobieel gebruik 
onder controle is, moet de aandacht gericht worden op de verbetering in bedrijfsmanagement en 
bioveiligheid. Alleen dan is de gewenste reductie van antimicrobieel gebruik mogelijk. Het werd 
aangeraden om het niveau van bioveiligheid te kwantificeren met behulp van het risico-gebaseerde 
kwantificatiesysteem Biocheck.UGent™ om zodoende vervolgens bedrijfsspecifieke verbeteringen te 
kunnen aanduiden. Begeleiding van varkenshouders in bedrijfsspecifieke interventies gerelateerd aan 
bioveiligheid en bedrijfsmanagement bleek verder een sleutelfactor te zijn in het succes tot de reductie 
van antimicrobieel gebruik. 
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“Ohjee, wat hebben we nu in huis gehaald.” Dat is volgens mij wat velen binnen de vakgroep 
verloskunde, voortplanting en bedrijfsdiergeneeskunde hebben gedacht op vrijdag 15 oktober 2010, 
toen ik op mijn eerste werkdag aan de universiteit Gent gelijk mee ging op excursie naar de faculteit 
Diergeneeskunde in Utrecht. 
Sorry collega’s! Maar, mij treft natuurlijk geen blaam, ik geef gewoon de “schuld” aan Prof. Dr. Jeroen 
Dewulf en Prof. Dr. Dominiek Maes! Ze hadden ook iemand anders kunnen aannemen dan die gekke, 
flamboyante, kleurrijke, lange blonde Hollandse… 
Ik ben alleszins erg blij dat beiden heil zagen in mij! Bedankt om mij de kans te geven naar België te 
komen en dit bijzonder boeiende onderzoek te mogen uitvoeren. Echter, zonder jullie hulp en sturing 
in de afgelopen jaren waren we niet aanbeland waar we nu vandaag staan. Al heb ik het vast al vaker 
gezegd, bij deze nogmaals excuses voor het soms wat lang van stof zijn, het teveel hooi op m’n vork 
nemen en het soms te overmatige enthousiasme waardoor ik het jullie wel eens lastig maak(te)! Jeroen, 
bedankt voor het vertrouwen, het vrij laten, het begeleiden, het stimuleren, het motiveren, het 
uitdagen en op gepaste momenten de persoonlijke touch! Ik blijf graag nog met u samenwerken! 
Dominiek, bedankt voor de snelle reacties, de positief stimulerende kritiek, de puntjes-op-de-i, de 
duidelijke begeleiding, de expertise en het tot een hoger niveau stuwen. 
Als we het hebben over “schuldigen” aan mijn komst naar België dan mogen Prof. Dr. Leo van Leengoed, 
Dr. Inge van Geijlswijk en Dr. Hanneke Feitsma eigenlijk ook niet ontbreken. Zij, in samenwerking ook 
met Prof. Dr. Dik Mevius, hebben mijn onderzoeksstage over berekeningsmethoden voor 
antimicrobieel gebruik begeleid aan de universiteit Utrecht. Zij hebben er dus mede voor gezorgd dat 
mijn CV dusdanig interessant was voor Jeroen en Dominiek dat zij mij graag wilden inzetten voor het 
RED AB project in België. Ook alle andere docenten die mij begeleid hebben aan de faculteit 
diergeneeskunde te Utrecht ben ik natuurlijk zeer erkentelijk voor hun bijdrage aan het behalen van 
mijn diploma als veearts.  
Dat ik zo ver gekomen ben was natuurlijk ook niet mogelijk geweest zonder een zeer behulpzame 
examencommissie. Prof. Dr. Haesebrouck, dank voor uw kritische blik om de thesis nog net dat beetje 
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extra te geven. Prof. Dr. Devreese, dank voor alle zeer welkome suggesties en natuurlijk om de 
secretariële taken op u te nemen. Prof. Dr. Katharina Stärk, you are such a kind, sincere and wise 
person, a true motivator and inspiring personality! I love that I was able to get to know you both in 
professional as well as in more informal circumstances. I will miss your great driving force for the 
Minapig project, but I am glad that you will continue to be my ECVPH resident advisor for a couple 
more months! Prof. Dr. Jaap Wagenaar, wij kennen elkaar natuurlijk al van de faculteit in Utrecht. 
Gelukkig kwam er een tijdje geleden wederom een mooie gelegenheid om samen te werken, 
uiteindelijk resulterend in een mooie publicatie. Ook mocht ik als rapporteur, samen met David, 
aanwezig zijn bij een OECD bijeenkomst. Ik heb dit echt super gewaardeerd en hiervan veel geleerd en 
interessante mensen mogen ontmoeten. Dr. Erik Mijten, vanuit de Boerenbond heeft u mee het RED 
AB project geïnitieerd. Wij hebben elkaar ook regelmatig gesproken over hoe het project het beste 
uitgevoerd kon worden. Dank ook als lid van mijn examencommissie voor de goede input vanuit het 
perspectief van de sector en veehouders. Ook binnen de werkgroep datacollectie van AMCRA hebben 
we heel prettig samengewerkt. Dr. Davy Persoons, als ik jou toch niet had gehad… Jij hebt mij op 
faculteit en vakgroep wegwijs gemaakt, maar mij ook erg veel geleerd over hoe het er in België aan 
toe gaat (of alleszins hoort te gaan). Ik ben erg blij dat het cirkeltje weer een beetje rond is en dat je 
als lid van mijn examencommissie wederom een grote bijdrage hebt geleverd aan het (bij)sturen van 
“Mereltje”. En in de toekomst hebben we vast nog wel andere onderwerpen of getalletjes waarover 
we weer kunnen “stoeien”! Prof. Dr. Van Immerseel, hartelijk dank voor uw waardevolle suggesties en 
verbeteringen aan de thesis. Ik hoop dat we in de toekomst wellicht nog eens samen mogen werken 
op het gebied van bioveiligheid. Drs. Joris Vrielinck, niet enkel mijn grote dank aan u om in mijn 
examencommissie plaats te nemen, maar meer nog om meerdere varkensbedrijven aan te dragen en 
mede te begeleiden in het RED AB project. 
Natuurlijk ben ik ook erg veel dank verschuldigd aan alle veehouders, bedrijfsdierenartsen en andere 
adviseurs die mee hebben gewerkt aan het RED AB project, het Minapig project of één van de enquêtes 
die ik rond heb gestuurd in het kader van mijn onderzoeken. 
Mijn co-auteurs wil ik natuurlijk ook heel hartelijk danken voor hun hulp en inzet. First of all David 
Speksnijder and Cristina Rojo Gimeno since I share with both of them a first-authorship for two very 
nice publications! It was a true pleasure to work with you! Good luck for the both of you on your PhD! 
My colleagues from the Minapig consortium are also highly acknowledged for their great help in the 
study design, executing the field studies, performing the analyses and writing down our interesting 
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results! I would especially like to acknowledge the core team at meetings and for the field studies: 
Svenja Lösken, Lucie Collineau, Marie Sjölund, Annette Backhans, Elisabeth grosse Beilage, Katharina 
Stärk, Elisabeth Okholm Nielsen, Ulf Emanuelson, Catherine Belloc, Vivianne Visschers and in the initial 
phase Bernd grosse Liesner and Hugo Seemer. Loved our meetings in Zurich, Ekenas, Copenhagen, 
Nantes, Ingelheim and Brussels! 
En als we het over maatjes hebben dan moet er natuurlijk ook gesproken worden over “den 48” 
oftewel het Epi-team! Het “oude” epi-team met Sarah, Stefaan en Sebastiaan heb ik enkel mee mogen 
maken op zeer gezellige feestjes. “Mijn” epi-team bestond/bestaat uit de volgende geweldige mensen. 
Davy; samen ooit nog in de 1e kandidatuur gezeten op de Ledeganck, elkaar pas echt leren kennen in 
2010 en uiteindelijk heb ik mogen promoveren van achter t muurke naar jouw stekje in den 48 en dan 
zit je nu zelfs ook nog in mijn examencommissie… thanks! Loes; Nederlandse roots hebben we gemeen 
(je bent zelfs geboren in Twente!), maar jij spreekt wél vloeiend Vlaams, iets wat mij niet zal lukken. In 
het begin heb je me getoond hoe ik het beste de bedrijfsbezoeken bij de Vlaamse veehouders aan kon 
pakken (zodat ik niet teveel als een Hollandse over zou komen). Dank voor alles en ik hoop dat we 
elkaar snel nog eens treffen! Bénédicte: eigenlijk hebben wij best veel verschillende dingen samen 
beleefd als ik er op terug kijk. Serieuze zaken, intellectuele uitdagingen, elkaar helpen, elkaar een 
beetje stangen, persoonlijke gesprekken, elkaar “de vliegen af vangen”, grapjes rondsturen, Gentse 
feesten, wandelingen in Zuid Korea, congressen met boot- en kroegentochten en ga zo nog maar even 
door. Ik waardeer je ten zeerste en hoop dat we elkaar nog veel mogen zien en spreken de komende 
jaren! Steven; rots in de branding, mister-altijd-raad, statistiek-wonder en soms ook een beetje 
ondeugend. Kortom een geweldige vriend en collega! Ik ben blij dat we nog zeker een aantal jaar 
elkaars collega’s zullen blijven! Heel veel geluk samen met Sophie en prachtige Thibault! Laten we bij 
deze in ieder geval afspreken dat we elk jaar op 5 december onze vaste “date” hebben! Lotte; een 
schat, met een gouden hartje, een heel bijzondere creativiteit en zoveel goeds te geven, dat is onze 
Lotte, of ook wel Mini-Merel . Weet dat ik met je mee leef en dat ik er altijd graag voor je wil zijn! 
Kop op! KnuffelX! Sofie; je behoorde maar kort tot het Epi-team, maar het was wel een zeer leuke en 
verfrissende kennismaking. Ook Iris was er maar kort; het ga je goed! Philippe: samen op pad voor de 
bedrijfsbezoeken, veel lol, maar ook serieuze en goede gesprekken, je hebt me werkelijk waar super 
goed geholpen en ik ben heel erg blij dat ik je onlangs nog gesproken heb en dat je zo enthousiast bent 
over de plek waar je nu je kennis en kunde mag tentoon spreiden. Wannes; ik had ook de grote eer 
om jou te mogen rekenen tot “mijn” RED AB team, super bedankt voor al het werk dat je verzet hebt 
en de zeer gewaardeerde kritische blik die je op een heel fijne manier bracht. Super fijn om te zien dat 
ACKNOWLEDGEMENTS / DANKWOORD CHAPTER 12 
293  
 
jij helemaal je plek hebt gevonden bij AMCRA! Marjolijn; eindelijk een echte Hollandse erbij, inclusief 
producten en gadgets van de AH, Belgen-moppen en een lekkere direct aanpak. Succes met je nieuwe 
job en geniet van je terugkeer naar Nederland. Marilena; onze Griekse schone, you are such a genuine 
person, always helpful and in for a nice talk. We had a lot of fun and great meals (both in size and taste 
in Copenhagen) during our ECVPH trips. With your great networking capacities and pleasant way of 
structuring of things I predict that you will have a very exciting career. Ilias; our Greek “mobster”, at 
least when you are wearing your very cool sunglasses cruising around in your car. You are a great 
colleague with such a good knowledge of so many things. I still remember our nice talks and the 
shopping in Turin , and on the other side the cleaning of the housing of your chicks… two worlds far 
apart! Ilse: een super mama, volgens mij ben jij dat, en dan niet alleen voor je eigen meiden, maar ook 
voor de biggetjes. Doe dat goed over een paar maanden als je zelf mag verdedigen! Bert; sorry dat ik 
je in het begin een beetje aan het uittesten was, maar je bleek uit het juiste hout gesneden want je 
kunt er prima tegen. Volgens mij gaat het helemaal goed komen en zit jij wel op je plek in het Epi-team. 
Cornéll; our newest colleague from South Africa. I hope you will get used to the crazy Belgian weather 
and the smells at the pathology department. Thanks for helping out with editing my paper, good luck 
on your PhD. Onze “den 48 adoptie-kids” van het varkensteam (Linda, Klaas, Ioannis); dank voor de lol 
en reuring die jullie brengen! De overige leden van het varkensteam (Tommy, Annelies, Anneleen, 
Marlijn, en voorheen nog Ellen, Annelies Sierens, Rubén, Alfonso, Janne, Ruth (doe dat goed in Japan), 
Josine, An, Ruben, Silvana, Liesbet, Elena en hopelijk vergeet ik dan niemand…) wil ik ook graag 
bedanken voor alle gezelligheid, de interessante discussies tijdens de journalclubs en jullie bereidheid 
om jullie expertise te delen. 
Natuurlijk mogen ook de andere collega’s niet vergeten worden; Steven B(runeel), zonder jou had dat 
doctoraat hier nu niet gelegen met alle ICT problemen van de laatste tijd. En ook mede dankzij jouw 
mooie en goede ontwerp zijn de ABcheck en Biocheck website zo succesvol. Els; altijd gezellig, altijd in 
voor een babbeltje. Als je wat nodig hebt helpt Els je. Dank daarvoor. Leila; bedankt om altijd zo 
duidelijk en volledig alles te regelen op het gebied van de financiën. Sandra; redder in nood, hulp in 
bange dagen, oftewel een super goede secretaresse waar je op kan bouwen. Ria; koffie, batterijen, 
koekjes, niets is jou te gek om te regelen, dank. Marnik en de mannen in de stallen; jullie helpen altijd 
super om de proeven in de proefstallen van de varkens goed te laten verlopen waardoor voor mij de 
administratie makkelijk was, dank daarvoor. Ook onze vakgroepvoorzitter (eerst Prof. Dr. De Kruif, 
momenteel Prof. Dr. Van Soom), alle professoren, andere collega’s van de vakgroep voortplanting, 
verloskunde en bedrijfsdiergeneeskunde, dank voor de fijne samenwerking, mooie belevenissen en 
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gezellige kerstdiners. Alhoewel officieel niet behorende tot onze vakgroep heeft het team van AMCRA, 
in eerste instantie gevormd door enkel Evelyne, gezellig bij ons op de vakgroep vertoefd. Evelyne; je 
hebt een prachtige persoonlijkheid. Ik vind je carrière switch heel erg stoer en wens je heel veel succes! 
Veerle; jij kwam AMCRA versterken als data analist en vanuit daar heb ik regelmatig het genoegen 
gehad om je tegen te komen op meetings of gezellige borrels. 
Also my dear friends from the ECVPH college should not be forgotten. We had such wonderful times 
in Turin, Bakum, Belgrade, Copenhagen and other places we were so lucky to be able to visit! I really 
love your enthusiasm, the great drive of all of you to help each other, and the group spirit to achieve 
wonderful things such as the joint resident project with Elena, Riika, Timothee, Aurelie, Marnie, Carole, 
Clare, Pia, Ilias, Marilena, Gerty, Laura, Isabel, Jorge and Lucie! Gerty success met je examen! Wiebke 
(and Derk as well?): we are going to do our best to pass the exam later this year! Christina: I really love 
the pictures of you horseback riding in Switzerland. Let’s stay in touch! 
Mijn vriendinnen van Utrecht wil ik ook niet onbenoemd laten. Menke, Vivienne, Nicole, Eva Bervoets, 
Eva de Vries, Esther, Marije, oftewel de Veterinaire Vrijgezellige Meiden (VVM); dank dat jullie er 
waren en nog steeds zijn! Charlotte; zoveel lol samen, met onze bouquetjes en de roddels, graag houd 
ik dat er in de komende jaren! 
En dan mijn familie… Laat ik beginnen met mijn grootste nieuwe familie, de Livar-familie. Vader abt 
Dom Malachias, medewerkers, veehouders, dierenartsen en adviseurs, ik heb mij gelijk erg welkom en 
opgenomen gevoeld in jullie midden. Mijn schoonouders, Frans en Mia, vanaf het allereerste moment 
dat wij elkaar ontmoetten klikte het en heb ik mij echt thuis gevoeld bij jullie. Dank voor jullie goede 
zorgen. Ook de overige leden van mijn schoonfamilie wil ik graag danken voor hun gezelligheid, 
plagerige grapjes en anderzijds het hartelijke welkom in de familie. Mijn familie (klein, maar fijn!) heeft 
ook altijd veel interesse getoond in hetgeen ik deed. Dat heb ik altijd erg gewaardeerd. Net als oom 
Jurrie en tante Gerda, Kasper, Jasmijn en Tom. Eigenlijk zijn jullie ook familie en ik ben blij dat jullie al 
vanaf mijn jongste jaren deel uit maken van mijn leven! En tante Riki en oom Rudi, Erica en Berry, dank 
voor de goede opvang vroeger als jong meisje en de reeds jarenlange vriendschap. Papa, als ik in mijn 
werk met iets bezig was wat (zijdelings) te maken had met wild of de jacht dan was je interesse extra 
gewekt. Of als het over auto’s gaat natuurlijk. Dank je wel dat je er bent. Mam en Henk, tijdens mijn 
studie waren jullie het spoor soms wel eens bijster, maar mede door jullie onvoorwaardelijke steun en 
liefde, aangevuld met stimulerende gesprekken, sta ik waar ik nu sta. Zonder jullie was ik er niet 
gekomen! Ik hoop nog vele nieuwe hoofdstukken in mijn leven met jullie te mogen delen! Lieve schat, 
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Frank, een deel van de steunende en stimulerende taak heb je overgenomen van m’n ouders, maar je 
hebt er vooral ook een heleboel extra aan toegevoegd! Jouw drive wakkert bij mij het vuur aan. We 
gaan eerst over twee weken een super mooi feestje bouwen. En, daarna gaan we samen verder 
bouwen aan Livar en met de Livar Belevingswereld een uitzonderlijke beleving creëren. “Nou droem ik 
van ow in mien errem, van hoe ik ow teage mij aan druk. Ow wil ik altied verwerme, veur altied met 'n 
bitje geluk” (tekst afkomstig van: Rowwen Heze – Liefde). 
 
Merel 
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CURRICULUM VITAE 
Merel Postma werd geboren op 5 februari 1981 te Deventer, Nederland. Na het behalen van 
het diploma Voortgezet Wetenschappelijk Onderwijs aan de openbare scholengemeenschap 
“De Waerdenborch” te Holten, Nederland, werd de studie Diergeneeskunde gestart aan de 
Universiteit Gent, België. Na twee jaar in Gent zette Merel haar studie Diergeneeskunde voort 
aan de Universiteit van Utrecht, Nederland, waar zij in 2010 het diploma van dierenarts 
behaalde met als specialisatie landbouwhuisdieren. 
 
In oktober 2010 trad ze in dienst van de vakgroep Voortplanting, Verloskunde en 
Bedrijfsdiergeneeskunde als doctoraatsbursaal op een demonstratieproject naar de 
begeleiding van veehouders op het gebied van reductie van antibioticumgebruik, gefinancierd 
door de Boerenbond en Belpork vzw. Vanaf april 2012 was ze als assistent van Prof. Dr. Dewulf 
werkzaam op voorgenoemd project, evenals op het door ERA-Emida NET gefinancierde 
MINAPIG project en diverse overige projecten. 
 
Gedurende de ruim vijf jaar die ze besteedde aan de vakgroep Voortplanting, Verloskunde en 
Bedrijfsdiergeneeskunde stond ze mee in voor de opleiding van de studenten en nam ze 
diverse werkzaamheden voor de werking van de vakgroep, zoals de administratie van de 
proefstallen varken, voor haar rekening. 
 
Merel is auteur of medeauteur van meerdere wetenschappelijke publicaties in internationale 
tijdschriften en presenteerde haar onderzoeksresultaten op talrijke nationale en 
internationale congressen. 
BIBLIOGRAPHY CHAPTER 14 
297  
 
BIBLIOGRAPHY 
 
PUBLICATIONS 
 
Callens, B., Boyen, F., Catry, B., Ingenbleek, A., Butaye, P., Haesebrouck, F., Maes, D., Persoons, D., 
Postma, M., Laanen, M., Dewulf, J., 2012a. Implications for colistin use in patients with cystic fibrosis 
(CF) Letter in response to "Prophylactic and metaphylactic antimicrobial use in Belgian fattening pig 
herds" by Callens et al. Prey. Vet. Med. 106 (2012) 53-62 Reply. Preventive Veterinary Medicine 107, 
288-290. 
Callens, B., D. Persoons, D. Maes, M. Laanen, M. Postma, F. Boyen, F. Haesebrouck, P. Butaye, B. 
Catry and J. Dewulf, 2012: Prophylactic and metaphylactic antimicrobial use in Belgian fattening pig 
herds. Preventive Veterinary Medicine, 106, 53-62. 
Collineau, L., Belloc, C., Stärk K.D.C., Hémonic, A., Postma, M., Dewulf, J., Chauvin, C., 2016, submitted. 
Guidance on the selection of appropriate indicators for quantification of antimicrobial usage in human 
and veterinary medicine. Zoonoses and Public Health. 
Collineau, L., Backhans, A., Dewulf, J., Emanuelson, U., grosse Beilage, E., Lösken, S., Okholm Nielsen, 
E., Postma, M., Sjölund, M., Stärk, K.D.C., Visschers, V.H.M., Belloc, C., 2016, in preparation. What is 
the common profile of pig farms with high technical performances and low antimicrobial usage within 
four European countries?. The Veterinary Journal. 
Dewulf, J., Postma, M., 2013. International attention demanded: the antibiotic resistance dictates the 
use of a therapeutic minimum measure to reduce. Fleischwirtschaft 93, 25-26. 
Lösken, S., Postma, M., Dewulf, J., grosse Beilage, E., 2016, in preparation. Antimicrobial usage and its 
associations with production characteristics and biosecurity measures in German farrow-to-finish 
farms. 
Postma, M., Sjölund, M., Collineau, L., Lösken, S., Stärk, K.D.C., Dewulf, J., 2015a. Assigning defined 
daily doses animal: a European multi-country experience for antimicrobial products authorized for 
usage in pigs. Journal of Antimicrobial Chemotherapy 70, 294-302. 
BIBLIOGRAPHY CHAPTER 14 
298  
 
Postma, M., Stärk, K.D.C., Sjölund, M., Backhans, A., Beilage, E.G., Lösken, S., Belloc, C., Collineau, L., 
Iten, D., Visschers, V., Nielsen, E.O., Dewulf, J., 2015b. Alternatives to the use of antimicrobial agents 
in pig production: A multi-country expert-ranking of perceived effectiveness, feasibility and return on 
investment. Preventive Veterinary Medicine 118, 457-466. 
Postma M., Backhans A., Collineau L., Loesken S., Sjölund M., Belloc C., Emanuelson U., Grosse Beilage 
E., Stärk K.D.C., J., D., 2016. The biosecurity status and its associations with production and 
management characteristics in farrow-to-finish pig herds. Animal 10, 478-489. 
Postma, M., Backhans, A., Collineau, L., Loesken, S., Sjölund, M., Belloc, C., Emanuelson, U., Grosse 
Beilage, E., Nielsen, E.O., Stärk, K.D.C., Dewulf, J., 2016. Evaluation of the relationship between the 
biosecurity status, production parameters, herd characteristics and antimicrobial usage in farrow-to-
finish pig production in four EU countries. Porcine Health Management 2, 1-11. 
Postma M. and Speksnijder D. C., Jaarsma, A.D.C., Verheij, T.J.M., Wagenaar, J.A., Dewulf J., 2016. 
Accepted for publication 3 May 2016. Opinions of veterinarians on antimicrobial use in farm animals 
in Flanders and the Netherlands. The Veterinary Record. 
Postma, M., Vanderhaeghen, W., Sarrazin, S., Maes, D., Dewulf, J., 2016. Accepted for publication 5 
May 2016. Reducing antimicrobial usage in pig prodution without jeopardizing production parameters. 
Zoonoses and Public Health. 
Rojo-Gimeno C. and Postma M., Dewulf J., Hogeveen H., Lauwers L., Wauters E., 2016. Accepted for 
publication 5 May 2016. Farm-economic analysis of reducing antimicrobial use whilst adopting good 
management strategies on farrow-to-finish pig farms. Preventive Veterinary Medicine. 
Sjölund, M., Postma, M., Collineau, L., Lösken, S., Backhans, A., Belloc, C., Emanuelson, U., Groβe 
Beilage, E., Stärk, K.D.C., Dewulf, J., 2016 (submitted). Quantitative and qualitative antimicrobial usage 
patterns in farrow-to-finish pig herds in Belgium, France, Germany and Sweden. Preventive Veterinary 
Medicine. 
van Leengoed, L., Postma, M., van Geijlswijk, I.M., Feitsma, H., Meijer, E., van Groenland, G.J., Mevius, 
D., 2010. Transparent decision for antimicrobial therapy in pigs. Tijdschrift Voor Diergeneeskunde 135, 
282-289. 
BIBLIOGRAPHY CHAPTER 14 
299  
 
Visschers, V.H.M., Backhans, A., Collineau, L., Iten, D., Loesken, S., Postma, M., Belloc, C., Dewulf, J., 
Emanuelson, U., Beilage, E.g., Siegrist, M., Sjölund, M., Stärk, K.D.C., 2015. Perceptions of antimicrobial 
usage, antimicrobial resistance and policy measures to reduce antimicrobial usage in convenient 
samples of Belgian, French, German, Swedish and Swiss pig farmers. Preventive Veterinary Medicine 
119, 10-20. 
Visschers, V.H.M., Backhans, A., Collineau, L., Loesken, S., Nielsen, E.O., Postma, M., Belloc, C., Dewulf, 
J., Emanuelson, U., grosse Beilage, E., Siegrist, M., Sjölund, M., Stärk, K.D.C., 2016 in press. A 
Comparison of Pig Farmers' and Veterinarians' Perceptions and Intentions to Reduce Antimicrobial 
Usage in Six European Countries. Zoonoses and Public Health. 
Visschers, V.H.M., Postma, M., Sjölund M., Backhans A., collineau L., Loesken S., Belloc, C., dewulf J., 
Emanuelson U., grosse Beilage E., Siegrist, M., Stärk, K.D.C., 2016 (submitted). Higher perceived risk of 
antimicrobials is related to lower antimicrobial usage among pig farmers in four European countries. 
Preventive Veterinary Medicine. 
 
 
 
 
  
BIBLIOGRAPHY CHAPTER 14 
300  
 
ORAL PRESENTATIONS 
Apr 2016 Cutting costs - Irish Pig Health Society, Ireland; Antimicrobial use in pig 
production in different European countries and proven methods to 
reduce them 
Nov 2015 Training – Ghent University, Merelbeke, Belgium; Biocheck auditing 
training for international group of 20 trainees 
Nov 2015 PIGS - Society of Feed Technologists, Coventry, United Kingdom; 
Reducing antibiotics in pig production – A Belgian perspective 
Oct 2015 Agro tv recording – VILT tv, Belgium; Interview on results of reduction 
of antimicrobial usage 
Jun 2015 Promotion movie for farmers – Boerenbond (farmers union), Ledegem, 
Belgium; Tips om het antibioticumgebruik te reduceren (tips to reduce 
antimicrobial usage) 
Apr 2015 MINAPIG pre-conference of European Symposium of Porcine Health 
Management (ESPHM) – Nantes, France; Associations between 
biosecurity, antimicrobial usage and production parameters 
May 2015 Antibiotikaresistens I husdyrbruket – Animalia, Oslo, Norway; 
Antimicrobial reduction a team effort without jeopardizing production 
parameters 
May 2015 Conference – For Farmers Hendrix, Arnhem, the Netherlands; 
Bioveiligheid & bedrijfsbegeleiding als tool in verbeterde productie en 
minder AB gebruik (biosecurity and herd guidance as a tool in improved 
production and reduced antimicrobial usage) 
Mar 2015 Conference – Alltech, Ghent, Belgium;  Biosecurity and herd guidance 
as a tool towards reduced antimicrobial consumption  
Dec 2014 Farmers meeting – Hasselt, Belgium; Verantwoord omspringen met 
antibiotica & wat zijn de alternatieven (responsible use of 
antimicrobials and what are the alternatives) 
Nov 2014 Conference on antimicrobial resistance - Action Today to Ensure 
Effective Antibiotics for Tomorrow – Department of Agriculture, Food 
and the Marine (DAFM), Cork, Ireland; Biosecurity as a tool towards 
reduced antimicrobial consumption 
Oct 2014 ECVPH resident workshop – European College of Veterinary Public 
Health, Copenhagen, Denmark; Antimicrobial usage monitoring 
Belgium 
Sep 2014 Responsible use of antimicrobials conference – Amsterdam, the 
Netherlands; Antimicrobial reduction without jeopardizing production 
parameters 
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Jun 2014 Board of directors meeting – Belpork vzw, Brussel, Belgium; 
Antibioticumgebruik en –resistentie in de diergeneeskunde 
(antimicrobial usage and resistance in veterinary medicine) 
Mar 2014 Post graduate training veterinary medicine – Institute for permanent 
eduction faculty of veterinary medicine, Merelbeke, Belgium;  
Bioveiligheid – Van de theorie naar de praktijk (biosecurity – from 
theory to practise) 
Feb 2014 Farmers meeting – Veurne, Belgium; Verantwoord omspringen met 
antibiotica & wat zijn de alternatieven (responsible use of 
antimicrobials and what are the alternatives) 
Feb 2014 ECVPH resident workshop – European College of Veterinary Public 
Health, Bakum, Germany; Biosecurity and antimicrobial usage  
Dec 2013 Farmers meeting – Lumberlo, Belgium; Project “Reductie 
antibioticumgebruik” (project reduction antimicrobials) 
Dec 2013 Farmers meeting – Kalmthout, Belgium; Antibioticumgebruik en –
resistentie in de rundveehouderij (antimicrobial usage and resistance 
in cattle production) 
Nov 2013 Flemish society for veterinary epidemiology and economics 
conference – Drongen, Belgium; Antimicrobial reduction in pig 
production up to 70% possible without jeopardizing production 
parameters  
Oct 2013 Center of expertise on Antimicrobial Consumption and Resistance in 
Animals (AMCRA) seminar – Brussel, Belgium; Practical 
implementations of biosecurity measures in poultry and pigs  
Aug 2013 Visiting committee national pork board USA meeting – Merelbeke, 
Belgium; ABcheck calculator & project “reduction antimicrobial usage”  
Jun 2013 Center of expertise on Antimicrobial Consumption and Resistance in 
Animals (AMCRA) road show – Zedelgem, Belgium; Project “reductie 
antibioticumgebruik” (project reduction antimicrobial usage) 
Feb 2013 Veterinary practioners specialization pigs lecture – Merelbeke, 
Belgium; Verantwoord antimicrobieel gebruik en reductie (Responsible 
use of antimicrobials and reduction)  
Jan 2013 Farmers meeting – Poederlee, Belgium; Project “reductie 
antibioticumgebruik” (Project reduction antimicrobials)  
Nov 2012 Meeting with researchers from LEI Wageningen University – 
Merelbeke, Belgium; Quantification of antimicrobial usage in farm 
animals; ABcheck.UGent a free online web application and Project 
reduction antimicrobial usage 
Nov 2012 IPVS Belgian Branch conference – Merelbeke, Belgium; Preliminary 
results in reduction of antimicrobial usage on pig farms after 
management improvement interventions  
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Nov 2012 Colloque organisé par le de l’agriculture, de l’agroalimentaire et de la 
forêt dans le cadre de la journée européenne de sensibilisation à 
l’usage des antibiotiques – Paris, France; Quantification de L’utilisation 
des antibiotiques chez les animaux de ferme  
ABcheck.UGent une application d’internet gratuite  
Oct 2012 Center of expertise on Antimicrobial Consumption and Resistance in 
Animals (AMCRA) road show – Kasterlee, Belgium; Project “reductie 
antibioticumgebruik” (project reduction antimicrobial usage) 
Sep 2012 Post IPVS 2012 – Merelbeke, Belgium; Antibioticumgebruik en 
antimicrobiele resistentie (Antimicrobial usage and resistance) 
Sep 2012 Center of expertise on Antimicrobial Consumption and Resistance in 
Animals (AMCRA) road show – Merelbeke, Belgium; Project “reductie 
antibioticumgebruik” (project reduction antimicrobial usage) 
Aug 2012 Presentation for German journalists – Merelbeke, Belgium; 
Quantification of antimicrobial usage in farm animals: ABcheck.UGent; 
a free online web application 
Aug 2012 International Symposium on Veterinary Epidemiology and Economy 
(ISVEE) – Maastricht, the Netherlands; Preliminary results on reduction 
of antimicrobial usage on pig farms after management improvement 
interventions 
Jun 2012 International Pig Veterinary Society (IPVS) conference – Jeju, South 
Korea; Preliminary results on reduction of antimicrobial usage on pig 
farms after management improvement interventions 
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POSTER PRESENTATIONS 
Sep 2015 European College of Veterinary Public Health (ECVPH), Belgrade, 
Serbia  
 Contribution: Poster – “Associations between biosecurity herd & 
production parameters and antimicrobial usage in pig production in 
four EU countries”. Authors: Merel Postma, Annette Backhans, Lucie 
Collineau, Svenja Lösken, Marie Sjölund, Catherine Belloc, Ulf 
Emanuelson, Elisabeth Grosse Beilage, Katharina D.C. Stärk and  Jeroen 
Dewulf, on behalf of the MINAPIG consortium 
Apr 2015 European Symposium of Porcine Health Management (ESPHM), 
Nantes, France  
 Contribution: Poster – “Associations between biosecurity level and 
production and management characteristics in pig production in four 
EU countries”. Authors: Merel Postma, Annette Backhans, Lucie 
Collineau, Svenja Lösken, Marie Sjölund, Catherine Belloc, Ulf 
Emanuelson, Elisabeth Grosse Beilage, Katharina D.C. Stärk and  Jeroen 
Dewulf, on behalf of the MINAPIG consortium 
Mar 2015  Society for Veterinary Epidemiology and Preventive Medicine (SVEPM), 
Ghent, Belgium 
 Contribution: Poster 1 – “What is the profile of the top pig farmers with 
the best technical performances and lowest antimicrobial usage?”. 
Authors: L. Collineau, M. Postma, C. Belloc, J. Dewulf, V. Visschers, D. 
Iten, A. Backhans, M. Sjölund, U. Emanuelson, A. Lindberg, E. grosse 
Beilage, S. Lösken, E.O. Nielsen, K. Stärk, on behalf of the MINAPIG 
consortium 
 Contribution: Poster 2 – “Associations between biosecurity and 
production and management characteristics in pig production in four 
EU countries”. Authors: Merel Postma, Annette Backhans, Lucie 
Collineau, Svenja Lösken, Marie Sjölund, Catherine Belloc, Ulf 
Emanuelson, Elisabeth Grosse Beilage, Katharina D.C. Stärk and  Jeroen 
Dewulf, on behalf of the MINAPIG consortium 
Contribution: Poster 3 – “Reducing antimicrobial use and improving 
management strategies in farrow-to-finish pig farms: an economic 
evaluation”. Authors: C. Rojo Gimeno, M. Postma, J. Dewulf, H. 
Hogeveen, L. Lauwers, E. Wauters 
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Nov 2014  International Pig Veterinary Society (IPVS) - Belgian Branch, Drongen, 
Belgium 
 Contribution: Poster – “What is the profile of the top pig farmers with 
the best technical performances and lowest antimicrobial usage?”. 
Authors: L. Collineau, M. Postma, C. Belloc, J. Dewulf, V. Visschers, D. 
Iten, A. Backhans, M. Sjölund, U. Emanuelson, A. Lindberg, E. grosse 
Beilage, S. Lösken, E.O. Nielsen, K. Stärk 
Nov 2013 Flemish Society for Veterinary Epidemiology & Economics, conference, 
Drongen, Belgium 
 Contribution: Poster – “Veterinarians perception on antimicrobial 
consumption in The Netherlands and Belgium”. Authors: Postma M., 
Speksnijder D.C., Wagenaar J.,  Jeroen Dewulf 
Sep 2013  European College of Veterinary Public Health annual conference, Turin, 
Italy 
 Contribution: Poster – “Antimicrobial reduction in pig production up 
to 60% possible without jeopardizing production parameters”. 
Authors: Postma M., Gelaude P., Maes D., Jeroen Dewulf 
Jul 2013 5th Symposium on Antimicrobial Resistance in Animals and the 
Environment (ARAE), Ghent, Belgium 
Contribution: Poster – “Potential alternatives to antimicrobials in pig 
production based on perceived effectiveness, feasibility and return 
on investment”. Authors: Postma M., Stärk K., Sjölund M., grosse 
Beilage E.. Nielsen E.O., Iten D.,  Belloc C., Dewulf J. 
Sep 2012 Safepork, Portland, Maine, United States of America 
Contribution 1: Poster –  “Potential alternatives to antimicrobials in pig 
production based on perceived effectiveness, feasibility and return on 
investment”. Authors: Postma M., grosse Beilage E., Belloc C., Iten D., 
Nielsen E.O., Backhans A., Stärk K., Dewulf J. 
Contribution 2: Poster –  “Assigning defined daily doses animal”. 
Authors: Postma M., Sjölund M., Collineau L., Lösken S., Nielsen E.O., 
Stärk K., Dewulf J. 
May 2013 European Symposium of Porcine Health Management, Edinburgh, 
Scotland, United Kingdom 
 Contribution: Poster – “Results ranking alternatives for antimicrobials 
from 4th ESPHM”. Authors: Merel Postma, Katharina Stärk, Jeroen 
Dewulf 
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Mar 2013  OIE Global Conference on the Prudent Use of Antimicrobial Agents for 
Animals, Paris, France 
 Contribution: Poster – “Potential alternatives to antimicrobials in pig 
production based on perceived effectiveness, feasibility and return on 
investment”. Authors: Merel Postma, Katharina Stärk, Jeroen Dewulf 
Aug 2012 International Society for Veterinary Epidemiology and Economics, 
Maastricht, The Netherlands 
Contribution: Poster – “Quantification of antimicrobial usage in farm 
animals: ABcheck a free online web application”. Authors: Postma M., 
Persoons D., Maes D., Dewulf J. 
Jun 2012 International Pig Veterinary Society Congress, Jeju, South Korea 
Contribution: Poster – “Quantification of antimicrobial usage in farm 
animals: ABcheck a free online web application”. Authors: Postma M., 
Persoons D., Maes D., Dewulf J. 
Apr 2012 European Symposium on Porcine Health Management, Bruges, 
Belgium 
Contribution: Poster – “Preliminary results on prophylactic and 
curative antimicrobial usage on 20 pig herds and advices on 
improvement”. Authors: Postma M., Persoons D., Maes D., Dewulf J. 
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“If you keep following the herd, 
You’ll forever be stepping in its shit!” 
 
(adopted after Wayne D. Dyer) 
 
